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ABSTRACT 
This thesis describes results on the biosynthesis of fluoroacetate and 4-fluorothreonine 
by the bacterium Streptomyces cattleya. Exploratory 14C-radiolabelling experiments, 
designed to determine the relative incorporation of a range of metabolites into 
fluoroacetate, demonstrated that substrates such as glucose, glycine and serine were 
efficient precursors. [2-13C]-Glycolate, [1 ,2-13C2]-glycolate, [2,2-2H2]-glycolate, 
DL-[3,4,4,4-2H4]-threonine, DL-[ 4,4,4-2H3]-threonine, [3,3,3-2H3]-alanine, [3-2H]-
fluoropyruvate and [3-2H]-3-fluorolactate were synthesised and characterised. 
Incorporations of synthesised and commercially available putative precursors, 
[1-13C]-glycine, [2-13C]-glycine, [1 ,2-13C2]-glycine, [3- 13C]-serine, [1-13C]-pyruvate, 
[2-13C]-pyruvate, [3-13C]-pyruvate, [2-13C]-acetate, [3-13C]-alanine, [2,3,3-2H3]-
aspartate, [2,2,3,3-2H4]-succinate and [2-13C]-glycerol into fluoroacetate and 
4-fluorothreonine were assessed. [2-13C]-Glycerol appeared to be the highest 
incorporated precursor of those tested. The 13C label from [2-13C]-glycerol 
predominated at C-1 (-56%) of fluoroacetate and C-3 (57%) of 4-fluorothreonine. 
19F-NMR emerged as a powerful analytical tool by which to determine the regiospecific 
incorporation of 13C and 2H into the fluorometabolites. 
A conclusion to emerge from this study is that a glycolytic intermediate in 
S. cattleya appears to be a substrate for the bio-fluorination process. Incubation studies 
with [3-2H]-fluoropyruvate and [3-2H]-3-fluorolactate, tested as possible initial 
fluorination products, showed low incorporation of deuterium atoms into the 
fluorometabolites which did not reinforce a role for 2-phosphoglycerate, 
3-phosphoglycerate and glycerol-3-phosphate as substrates for the fluorinating enzyme. 
The incorporations which are almost identical into the two fluorometabolites strongly 
indicate that the assembly of the carbon skeleton of fluoroacetate and C-3 and C-4 of 
4-fluorothreonine involves a common biosynthetic intermediate. Thus the close 
metabolic relationship between the two fluorometabolites indicates the presence of a 
single fluorinating enzyme in S. cattleya. 
A three step route to 4-(2S,3S)-fluorothreonine was developed by a modification 
of Seebach's imidazolidinone methodology for the preparation of L-threonine and is the 
subject of Chapter 4. An X-ray crystal structure of the synthetic 4-(2S,3S)-
fluorothreonine assisted in assignment and confirmation of the absolute stereochemistry 
of the natural product. This modified methodology is amenable to isotope labelling by 
employing NaB2H4 to generate [3-2H]-4-fluorothreonine. Moreover it offers an 
alternative route to threo-amino acids and has the advantage of using acid chlorides in 
place of aldehydes when the required aldehyde is unavailable. 
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Biosvnthesis o,ffluoroacetate and 4-fluorothreonine inS. cattleva 
CHAPTER 1 
1. General introduction and background 
Time has witnessed humanity's quest in harnessing the natural resources available for its 
benefit and progress. Human civilisations have always been conscious of the numerous 
chemicals present in nature. Evidence of their acquaintance with these biomolecules has 
been manifested through the earliest disciplines in folk medicine, perfumery and the 
process of dyeing fabrics/ materials. Human awareness of natural poisons invited their 
use as potential weapons, the ancient . Chinese civilisation, for instance, were 
accustomed to using the arrow poison aconite, while Indian medicine, around 900 BC, 
was not unfamiliar with arsenic and opium. 1 Many of these natural compounds were 
derived from crude plant extracts and found their applications in early human cultures as 
medicines (1 ), poisons (2), stimulants (3), narcotics ( 4) and perfumes (5) 2 (Fig. 1.1 ). 
Such compounds derived from natural sources are termed 'natural products' or 
secondary metabolites. These products play a critical role in the homeostasis of the 
ecosystem, functioning as chemical messengers in complex communicative, defensive 
and attractive interactions3 between organisms as well as acting as the major source of 
therapeutic agents for humankind.4 The interest and excitement generated by the origin 
of natural products is sufficiently unique that it ranks as a separate discipline in the field 
of organic chemistry. 
Scientists working in the field of biosynthesis are fuelled by the structural 
curiosity of secondary metabolites plus the intriguing mechanisms and pathways by 
which they are produced and furthermore by their medicinal and pharmacological 
applications. It comes as no surprise that a great number of secondary metabolites have 
been isolated, identified and synthesised in a relatively short period of time. The myriad 
of known and unknown natural products offers an almost unlimited scope for probing 
the intricate ways in which nature has been programmed to synthesise these fascinating 
molecules. 
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1.1 Primary and Secondary Metabolism 
(2) 
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( 5 ) linalol (lavender oil) 
Me 
Natural products are synthesised (anabolism) and degraded (catabolism) by a series of 
biochemical reactions catalysed by enzymes. Anabolism and catabolism are the two 
processes collectively known as metabolism. Primary metabolic pathways operate in all 
living systems and are responsible for synthesis and utilisation of universal metabolites 
such as sugars, amino acids, fatty acids, RNA, DNA to sustain the basic functions of all 
cells. In bacterial batch cultures, these metabolites are formed during the active phase of 
.., 
.) 
cell growth (trophophase), while secondary metabolites usually accumulate after 
primary metabolite biosynthesis and cell growth has ceased during the period known as 
the stationary phase (idiophase) that follows the trophophase. 5 Therefore secondary 
metabolites (sometimes known as idiolytes)6 are synthesised by non-dividing cells and 
have no direct function in sustaining normal cell growth. Unlike primary metabolites, 
secondary metabolites tend to be restricted to individual genera, species or strains and 
are found mostly in plants and micro-organisms. 7 
1.2 Functions of Secondary Metabolites 
Various ideas have been proposed for the functions of secondary metabolites. There has 
been evidence to suggest that they serve sophisticated roles in the survival strategy of 
the producer by acting as chemical signals. s-11 It is now quite clear that many secondary 
metabolites mediate intra- and inter- specific interactions, i.e. plant-plant interactions 
(allelopathy),3' 12 plant-insect interactions, plant-micro-organism interactions. These 
types of interactions generally benefit their producers as poisons and consequently offer 
a defensive strategy assisting survival of the organism in competitive surroundings. 
1.2.1 Plant-plant Signalling 
Plant secondary metabolites exhibit inhibitory effects on the seed germination and 
growth of other plants in the same competitive environment (allelopathy). 13 The leaves 
and roots are usually responsible for the release of these particularly harmful chemicals 
either by evaporation into the atmosphere or by leaching through soil? Various types of 
air-borne monoterpenes arid water soluble phenols are used by these plants as 
'allelopathic' agents, examples include camphor (6) and vanillic acid (7). 
4 
Me 
C02H 
Me&0 
Me \ OMe 
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1.2.2 Plant-insect/ herbivore Signalling 
Plants have developed protection and survival strategies by producing offensive 
substances that act as antifeedants to a wide range of insects and herbivores. 14-18 Two 
examples include the potent cyanogenic glycosides19 (8) which hydrolyse to the poison 
HCN in predators, and azadirachtin (9) which has been exploited for centuries by the 
natives of the Indian subcontinent as an insect/ pest repellent.20 
HO 
H 
~0-glucose 
(8) 
O :C02Me 
: OH 
0 
OH 
( 9 ) azadirachtin 
(isolated from Indian neem tree) 
Not all plants, however, produce deterrents, many synthesise chemical attractants which 
serve to stimulate the visual (colour), olfactory (floral fragrances) and taste senses in 
host organisms.21 For example, the odour of the triene (10) attracts the honey bee and 
indirectly assists in the pollination of clovers.2 
5 
( 10) 
1.2.3 Insect-insect Signalling 
The major function of secondary metabolites in this type of interaction is thought to be 
in communication through sex or trail pheremones.22 These communication compounds 
are typically derivatives of phenols, monoterpenes and fatty acids. Sex pheremones (11) 
serve as chemical attractants for mating and sometimes hunting, e.g. the bolas spider is 
capable of producing female sex pheremones belonging to many species of moth.2 
These phoney pheremones attract male moths which become the victims of the predator. 
0 
_)lo 
( 11) 
Natural pheremone ofthe 'redbanded leaf roller' insect 
1.2.4 Animal-animal Signalling 
Toxic metabolites used for defence are not simply restricted to insects, many aquatic 
animals secrete metabolites to deter potential predators, e.g. the Pacific sole produces 
pavoninin (12) to repel sharks.2 
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0 ····oR 
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Tropical frogs have long been known by the natives to produce toxins, e.g. the 
Colombian frog discharges the poison batrachotoxin (13) in times of danger?3 
oco"tJ-{Me 
){ )\ 
~ Me N 
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An alternative suggestion for the functions of secondary metabolites is that they 
serve to maintain primary metabolism at a time when the products of primary 
metabolism cannot be used for cell replication, until such time as growth can resume. 24 
However, on a general note, secondary metabolite production appears to be prevalent in 
those organisms, plants and micro-organisms, which appear to lack an immune system. 
1.3 Secondary Metabolic Products and Man 
We are surrounded by many secondary metabolites in our daily life. Beverages and 
foodstuffs owe their distinctive aroma and flavour to various secondary products. The 
balance between good and bad smells and tastes is strongly dependent on the dosage or 
concentration of the metabolites present. 10 Various complex components are responsible 
for the characteristic essence of the foodstuffs but some fruits may contain only one 
such component, e.g. ethyl 2-methylbutyrate is responsible for the distinctive aroma of 
apples and the pungent odour of garlic is due to the chemical diallyldisulphide. A 
comparison of the flavouring principles in peach (undecalactone) and coconut 
( a-nonalactone) clearly demonstrates that there are no simple relationships between the 
chemical structure and flavour of secondary products. 10 
Secondary products are also found as principle components of drugs and 
medicines and a great number find their applications in the pharmaceutical industry. 
7 
Quinine (14) acts as an anti-malarial agent and L-scopolamine (15) is used as a cerebral 
sedative, and premedication prior to surgery for limiting saliva secretion. 
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Antibiotics are by far the major contributors to the treatment of disease e.g. penicillins 
(16) and tetracyclines (17). 
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Stimulants and narcotics are in widespread use in many countries. 25 Examples of 
these plant based stimulants include nicotine (18) a constituent of tobacco leaves, and 
arecaidine10 the main ingredient in betel nuts chewed by millions in Southeast Asia. 
The acute hallucinogenic properties ofthe narcotic, cocaine (19), have promoted its use 
and abuse throughout the world and like most narcotics it is able to support an economy 
of its own. 
8 
O .. p HMe _,0 N 
( 18) 
Me 
w::c 
0 
( 19) 
In contrast to the numerous beneficial aspects of secondary metabolites, many 
pose a direct threat to human life. Poisonous compounds have presented a widespread 
problem since the dawn of civilisation. Early humans used these products for hunting 
(curare alkaloids isolated from plants and frogs) and also for killing other humans, but 
today these metabolites serve as the toxic constituent of various pesticides. 10 Accidental 
poisoning from toxic fungi, berries and seeds accounts for a majority of acute poisoning 
cases
10 
and this can only be circumvented by increasing our knowledge of the natural 
toxins in our environment. 
1.4 Biosynthesis of the Major Classes of Natural Products 
There are several principal building blocks for the biogenesis of secondary metabolites. 
These are acetate, mevalonate, shikimate and the amino acids. Acetyl-CoA is the 
precursor of polyketides (including certain phenols and other aromatics) and fatty acid 
derived metabolites like the prostaglandins and leukotrienes. Mevalonate is the 
progenitor of isoprenoids and steroids, while shikimic acid is used in the production of 
aromatic amino acids and certain polyphenols. Amino acids are the biosynthetic 
precursors of the alkaloids and peptide antibiotics. However, one must note that many 
secondary metabolites are of mixed biosynthetic origin. 
9 
1.4.1 Fatty acids26-29 
Fatty acids are primary metabolites formed by the condensation of acetyl-CoA (20) 
units catalysed by fatty acid synthases (F AS) as outlined in Fig. 1.230 
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Acetyl-CoA (20) is activated to malonyl-CoA (21) by acetyl-CoA carboxylase and then 
malonyl-CoA undergoes transesterification with the ACP of the relevant F AS followed 
by a decarboxylative condensation to generate a P-keto intermediate. A series of 
reductive steps then generate a saturated fatty acid. This process repeats itself until the 
fatty acid is fully elaborated. 
1.4.2 Polyketides31 
Polyketides have a very diverse range of structures that are based on linear 
f3-polyketone chains. These chains can be assembled from the condensation of c2 units 
(-CH2CO)n-) or C3 propionate units (-CHMeCO)n-) in a rather analogous manner to the 
classical fatty acid biosynthesis. However, unlike the fatty acid backbone, the 
corresponding polyketide skeleton may contain double bonds, ketone or OH functional 
groups. [Fig. 1.3, Route 1]. The various types of polyketide metabolites that may be 
formed are illustrated in Fig. 1.3. Route 2 occurs mainly in bacteria and marine 
organisms where the incorporation of propionate and butyrate units lead to pendant 
methyl and ethyl groups, respectively. One such example is the macrolide antibiotic 
aglycone, 6-deoxyerythronolide-B30 (34). Route 3 provides an example of a polyketide 
chain with continuous P-keto groups which give rise to aromatic phenols. It may be of 
interest to note that the marine environment is pre-eminent in elaborating various 
polyketide metabolites. Maitotoxin, 32 for instance, is the largest secondary metabolite 
known and is isolated from the marine organism, G. toxicus. 
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1.4.3 Terpenes and Steroids 33,34 
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Terpenes and steroids are based on the repeating isoprene (2-methylbutadiene) unit 
which is ultimately derived from acetyl-CoA via mevalonic acid. Terpenes and steroids 
appear to be widespread in plants, animals and micro-organisms and include compounds 
12 
such as menthol (39) and cholesterol ( 40). The mechanism of the formation of the 
isoprene unit is outlined in Fig. 1.4. 
HO 
( 39) ( 40) 
The Claisen ester condensation, catalysed by thiolase, between two molecules of 
acetyl-CoA is followed by an aldol type reaction to generate (35) which undergoes 
reduction to produce mevalonic acid (MV A) (36). 
+ 
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Fig. 1.4 
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This key intermediate is phosphorylated to MV A-5-pyro-phosphate which is then 
decarboxylated and dehydrated to produce the C5 isoprene units isopentyl 
pyrophosphate (IPP) (37) and dimethylallyl pyrophosphate (38). Organisms condense 
C5 units to produce a vast array of isoprenoids such as monoterpenes35·36 (C 10), 
d. 37(C) 3839(C) .d4o d . 4I(C 1terpenes 20 , sesterterpenes · 25 , sterol s an tnterpen~s 30). 
1.4.4 Shikimate pathway 42 
The shikimate pathway generates L-phenylalanine, L-tyrosine and L-tryptophan which 
are important progenitors of numerous secondary metabolites. The pathway which starts 
from erythrose-4-phosphate and phosphoenolpyruvate is shown in Fig. 1.5. 
coz-~ co 2-
I \ T synthase p 0 ~ P--0 H DAHP D 
0):=:0 .. ---~0 ----
ENZ ) HO ~H \::._ H+ HO' ~H OH 
H 
8 ( 41 ) 
-rl 
HO.QOH 
OH 
( 46) 
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T T T 
L-phenylalanine 
L-tyrosine 
L-tryptophan 
( 42) 
( 45) 
Fig. 1.5 
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Shikimate derives from an aldol reaction between phosphoenol pyruvate and the sugar, 
erythrose-4-phosphate ( 41) to produce 3-deoxy-D-arabino-heptulosonate-7 -phosphate 
(DAHP) (42). This key intermediate loses phosphate and cyclises to 
5-dehydroquinic acid ( 44) which is subsequently transformed to 5-dehydroshikimate 
( 45) and shikimate ( 46). Secondary metabolites which derive from shikimic acid tend to 
be largely distributed in plants and micro-organisms since animals cannot carry out the 
de novo synthesis of shikimic acid using this pathway. Thus L-phenylalanine and 
L-tyrosine are essential amino acids that must be obtained in the diet of the animal. 
1.4.5 Alkaloids 43 
The alkaloids which are essentially non-peptidic, non-nucleosidic nitrogenous 
' 
compounds, are a diverse and complex class of secondary metabolites. 7 The large 
majority of the alkaloids isolated to date are plant based but a rapidly growing number 
have been identified in arthropods, marine organisms, fungi, micro-organisms and 
amphibians.44 They may be classified according to their ring systems, i.e. pyridine, 
pyrrolizidine, tropane, indole and purine alkaloids are but a few examples of the types 
of ring systems found in alkaloid structures. The majority of alkaloids are derived from 
amino acids or closely related compounds. For instance L-ornithine and L-lysine give 
rise to pyrrolizidine45'46 and piperidine alkaloids respectively, L-phenylalanine and 
L-tyrosine are the progenitors of opium alkaloids and L-tryptophan is used for the 
biosynthesis of the indole alkaloids.47 
In general, most alkaloids are toxic but some are known to act as antifeedants or 
as anti-microbial products. For example,48 the Tiger moth which feeds on the plant 
Senecio, accumulates the pyrrolizidine alkaloid (47) which is highly toxic and the 
venom secreted by the Red-fire ant is known to possess insecticidal and antibiotic 
properties. 
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1.5 Techniques used to Delineate Secondary Metabolic Pathways 
Generally, biosynthetic pathways are elucidated by experimental methods which lead to 
the establishment of precursor-product relationships. Once the structure of the 
metabolite has been rationalised it is possible to hypothesise a biosynthetic pathway 
from a particular precursor species. In the search for the origins and mechanism of 
formation of secondary metabolites a variety of techniques have developed. 
1.5.1 Radioisotopic Labelling 
The most important radioisotopes used in biosynthetic studies of secondary metabolites 
are the J3 emitters 14C (t1J2=5640years) and 3H (t1J2=12.lyears).49 The phosphorus isotope 
32 
P serves an important role in the field of molecular biology but has found few 
applications in secondary metabolite studies. 50 Using 14C and 3H, the fates of individual 
C or H atoms of a precursor can be traced to the metabolite and so a measure of the 
incorporation rates of the putative precursors is possible. Despite the high sensitivity, 
the drawback of deploying radioactive isotopes as tracers is that site-specific data or a 
complete labelling pattern is provided only through time consuming chemical 
degradation of the resultant labelled material. It is also difficult to assess whether certain 
portions of universally labelled substrates are incorporated intact or undergo scrambling 
and then recombination. However with the emergence of stable isotopes and 
sophisticated nuclear magnetic resonance (NMR) techniques, radioisotopic 
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investigations are now chiefly used to gain an insight into the nature of the carbon 
precursor involved in the biosynthetic pathway. 
Tritium labelling combined with 3H-NMR spectroscopy is proving to be a useful 
probe.49 3H-NMR spectra give sharp signals that are easily interpreted by virtue of the 
similarity of chemical shifts with proton resonances. Nonetheless, handling, storage, and 
cross contamination of radioactive materials continues to be a handicap. 
1.5.2 Stable Labelled isotopes 51 
The incorporation of NMR active stable isotopes into a secondary metabolite has the 
advantage of revealing important regiochemical data, i.e. the enriched atoms can be 
located quickly by a comparison of the resultant NMR spectrum with that of the natural 
abundance spectrum. The stable isotopes available for NMR spectroscopic analysis 
include 13C (I=\), 2H (1=1) 52, 1~ (/=1/ 2) 53 and 180 (1=0). 
2H-NMR is a valuable analytical tool with the advantage that assignments are 
straightforward because the chemical shift values in 2H-NMR are similar to those in the 
I 
corresponding H-NMR. In addition the low natural abundance (0.016%) makes it 
detectable at low incorporation levels. The main application of deuterium in this project 
is in conjunction with 13C and 19F nuclei (see Chapter 3) 
1.5.2.1 Intact Bond Incorporation 
a-shift 
The incorporation of 13C (natural abundance 1.1 %) atoms from enriched precursors into 
secondary metabolites can be followed to specific carbons by analysis of the 
enrichments in the 13C-NMR spectrum of the resultant metabolite. One effective 
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strategy is the incorporation of contiguous labelled (13C-13C) substrates which provide 
invaluable data about intact C-C bonds, e.g. the use of [1,2- 13C2]-acetate as a tracer 
species has been valuable particularly in polyketide biosynthesis. The presence or 
absence of a residual 13C- 13C coupling in the 13C-NMR spectrum of the metabolite will 
discriminate whether the C-C bond has been transferred intact from the precursor to the 
metabolite. 
In appropriate cases, atoms adjacent to 13C may be substituted for other NMR 
active nuclei such as 2H or 15N. For instance when a single deuterium atom is directly 
bonded to a carbon-13, it couples to the carbon, changing its multiplicity to a triplet CZH, 
1=1) and shifts its resonance to a lower frequency by .6.8 = 0.25-0.3ppm (a-effect/ shift). 
The multiplicity and magnitude of the shift correlates directly to the number of 
deuterium atoms attached to the carbon atom. Similarly 13C- 1~ intact bond 
incorporations display isotopic induced shifts and couplings. 54 
Oxygen-18 is not NMR active, however, its presence can be determined by 
13C-NMR where an isotope induced shift in the signal reveals the presence of one (.6.8 = 
O.Ol-0.03ppm) or two (.6.8 = 0.03-0.0Sppm) 180 atoms, directly bonded to the reporter 
carbon. 
~-shift 
An alternative approach to determining the incorporation of intact bonds is to make use 
of a precursor molecule in which the NMR active nucleus is two bonds away from 13C. 
A combination of 13C-12Ca- 13 C~, if incorporated intact, can be detected by a 
~-shifted resonance in the 13C-NMR spectrum. This ~-effect is smaller in magnitude 
than the a-shift, but is readily observable. Deuterium atoms located in a ~ position to 
13 13 12 2 13 . the C nucleus ( C- Ca- H~) cause the C-NMR resonance to shift to a lower 
frequency (.6.8 = 0.05-0.08ppm per deuterium atom). 1~ in a molecule containing the 
13c 12c 15N 54 al . . h . . hift . th 13c NMR sequence - a- ~ so g1ves nse to a c aractenst1c s m e -
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spectrum. These strategies have proven effective at detecting two adjacent bonds that 
have remained intact during a biosynthetic process. 
The single natural isotope of fluorine has an atomic mass of 19, and like 
hydrogen it has a spin quantum number /=1/2•55 The coupling constants and chemical 
shifts of fluorine are an order of magnitude higher than those for hydrogen. In the 
context of this thesis 
19
F-NMR spectroscopy emerges as a powerful analytical tool used 
to assess the incorporation of putative precursors into the fluorinated natural products, 
fluoroacetate and 4-fluorothreonine. A detailed discussion of the effect of deuterium ~ 
19 12 2 19 12 12 2 19 . ( F- Ca.- H13) andy ( F- Ca.- C13-lly) on F-NMR resonances IS deferred to Chapter 
3 (section 3 .1.1 ), but suffice to say at this stage a 19F-12C-2H combination induces an 
observable f3-shift in the 19 F-NMR spectra relative to 19F-12C-1H. Similarly, an 
observable but smaller y-shift is seen for 19F-12C-12C-2H. 
1.5.3 Cell-free Extracts and Mutants 56 
Incorporation rates from tracer experiments are often low since administered substrates 
can suffer metabolic degradation within the cell. Enzyme preparations/ cell-free extracts 
offer the possibility of obtaining detailed information about each step of a secondary 
metabolic pathway. However, enzymatic work can only be initiated after enzyme-
substrate relationships have been developed on the particular pathway in question. 
For a particular biosynthetic sequence, a primary metabolite (PM) may be 
converted by a series of enzymatic transformations (e.g. E1 to E4) to an end product 
(Z), via intermediates (W, X, Y). 
PM w X y z 
The sequence may be blocked at different stages by disrupting the expression of the 
relevant enzymes (E1 to E4). This can be achieved by inducing (chemically or by UV 
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radiation) a mutation in the wild type organism which damages the expression of a 
given enzyme. If, for example, E3 is no longer functional (in mutant strain I) then X 
may accumulate in this mutant and its structure can then be determined. If the 
expression of E4 is blocked in another mutant (strain 2), this may result in the 
accumulation of Y. Clearly if Y is incubated with strain 1 in a co-synthesis study then 
Z should be produced if it is a true intermediate in the pathway. Similarly if X is 
introduced to strain 2 then Y should be produced. By such co-synthesis studies, the 
biosynthetic pathway may be elucidated. 57 
1.6 Organofluorine Compounds 
Henri Moissan, in 1886, was the first to isolate fluorine by electrolysing anhydrous 
hydrofluoric acid in a platinum electrochemical cell containing dissolved potassium 
fluoride. 58 However, it was not until the late 1930's that fluorine was generated at any 
significant level and in this case for the preparation of fluorocarbons as refridgerants. 
Since then organofluorine compounds have attracted much attention from the chemical 
industry and they now play an increasingly significant role in the agrochemical and 
pharmaceutical industries. The widespread use of fluorine in organic chemistry is 
governed by its unique properties. The relatively high strength of the C-F bond 
(110 Kcal/ mol) compared with that for the C-H (99 Kcal/ mol) and C-CI bond 
(85 Kcal/ mol) confers considerable chemical and thermal stability to organofluorine 
compounds. Insertion of fluorine into a compound induces minor steric, but significant 
electronic effects which can influence the chemical properties of that compound, e.g. 
monofluorination and trifluoromethylation of saturated aliphatic groups decrease 
lipophilicity,59 a property which is an important consideration in the design of 
biologically active compounds. However introduction of a trifluoromethyl group into 
aromatic systems tends to increase the lipophilicity of the organic molecule. Fluorine 
has been used as both a -Hand an -OH mimic in bio-organic chemistry and the CF2 
group has been used in certain cases to mimic -0.60"62 
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1.6.1 Uses of Organofluorine Compounds 
Fluorine containing substances can be divided into two categories on the basis of their 
preparation and use. The first category is comprised of compounds which are : 
(i) multiply fluorinated, and these include ; 
fluorine containing anaesthetics, in particular halothane ( 48) which is extensively used 
in medicine. 
H 
F3C~Br Cl 
( 48 )_ 
Bromine containing fluoroalkanes are the principal ingredient of fire extinguishers, e.g. 
CF3Br, CF2ClBr.
63 The major use of fluorine in organic compounds has been in the 
form of chlorofluorocarbons (CFC's) such as CC13F, CC12F2 which were commonly 
employed as aerosol propellants, refridgerants and cleaning fluids prior to the Montreal 
Protocol. The production of HFC-134a. (F3C-CH2F), having a considerably shorter 
stratospheric half-life is, however, on the increase. There is a growing market for 
fluorinated polymers, in particular PTFE (polytetrafluoroethylene) which owes its 
common usage to its outstanding chemical inertness and heat resistance. In addition, 
perfluorinated cycloalkanes are under development as potential blood substitutes64 due 
to their low toxicity and ability to dissolve relatively high concentrations of oxygen. 
(ii) Compounds with a low fluorine content (selectively fluorinated) have found 
applications as pharmacologically active substances, e.g. triamcinolone (49) which is 
used in the treatment of rheumatoid arthritis. 65 
0 
( 49) 
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Fungicides (50), insecticides and herbicides (51) dominate this category of 
organofluorine compounds and function mainly as agents for plant protection.66 The 
properties of certain azo dyes can be changed by the introduction of a fluorine 
substituent into the molecule. e.g. its colour can be tuned depending upon the type and 
position of the fluorine containing substituent. 
FCI,CS 9 SO,N(CH,), 
(50) CH3 (51 ) 
Euparen Thiazafluron 
None-the-less by industrial standards, fluorine technology is still in its infancy. 
This is exemplified by the relatively crude and often unspecific methods of inserting 
fluorine into organic molecules. The current techniques for introducing fluorine into 
organic compounds require the use of catalysts such as the antimony halides, plus 
reagents such as hydrogen fluoride, metal fluorides, halogen fluorides and SF 4 which are 
difficult to handle on an industrial scale. Only recently has the direct fluorination (F2) to 
selectively fluorinated compounds been explored in its application to fme chemicals. 
Biological fluorination, on the other hand, emerges as an attractive alternative but this is 
an arena which remains totally unexplored. 
1. 7 Fluorinated Secondary Metabolites in Nature 
Of all of the elements, fluorine ranks 13th in natural abundance and is the most common 
halogen found in the Earth's crust. 67 Most of this fluorine is present as insoluble fluoride 
salts and therefore chlorine, due to its comparatively higher availability, is the most 
readily available halogen to living organisms. The fluoride content in soils is ultimately 
derived from minerals such as fluorospar (CaF2), fluorapatite (CasFP30 12) and cryolite 
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(Na3AlF 6) amongst others. In addition, investigations have shown that the concentration 
of fluoride increases with soil depth. 68 
In sea water, fluoride is present in minute quantities (1.3ppm) in contrast to 
about 19 OOOppm for chloride.69 Nonetheless, inorganic fluoride is present in notable 
concentrations in certain marine life, such as the sponge Halichondria moorei which is 
capable of accumulating 10% fluorine on a dry weight basis as potassium 
fluorosilicateJO Terrestrial plants, particularly those of the genus Camellia can build up 
fluoride from quite low soil concentrations. 71 Plant species growing in areas with 
fluoride rich bedrock or areas polluted with fluorospar mining waste can selectively 
concentrate up to 1 0 OOOJ..Lg g·1 dry weight fluoride. 72 
Organically bound fluorine is however scarce in nature. Only ten (five, plus five 
homologous fatty acids) naturally occurring organofluorine compounds have been 
identified in a small number of tropical and subtropical plants, and in only two micro-
organisms. The unique physico-chemical properties of fluorine may provide an answer 
to the infrequent occurrence of these fluorinated natural products when compared to 
other halogenated metabolites. For comparison, over 130 chlorinated natural products 
are known to exist in plants alone, 73 and many more have been isolated from marine 
orgarusms. 
Fluorine has been referred to as a 'superhalogen'.74 This description can be 
appreciated from the data in Table 1.1 which shows a comparison of the physico-
chemical parameters of fluorine and its family ofhalogens. 
X Bond Bond Vander Hydration Electro negativity Standrad oxid/ 
dissociation length C-X Waals energy, x- (Pauling scale) red. potential 
energy CH3-X (A) radius (kcal/ mol) E0 for 
(kcal/ mol) (A) 2X-~X2 + 2e-
F 110 1.39 1.35 117 4.0 -3.06V 
Cl 85 1.78 1.80 84 3.0 -1.36V 
Br 71 1.93 1.95 78 2.8 -0.07V 
I 57 2.14 2.15 68 2.5 -0.54V 
H 99 1.09 1.20 2.2 
Table 1.1 
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It has the highest electron withdrawing power of all the elements forming the strongest 
single bond to carbon. In fluoroacetate for instance the bond remains intact when boiled 
in concentrated sulphuric acid and even a few hours are required to decompose it in hot 
concentrated alkaline conditions. 
The small size of the fluoride ion and its consequent high charge density account 
for its unique susceptibility to bind to water molecules. It is indeed capable of 
containing up to five water molecules in its hydration sphere which can be compared 
with three for chloride, two for bromide and three or four for iodide. 58 As a direct result 
of the ease of solvation (high enthalpy of hydration) the nucleophilicity of the fluoride 
anion is significantly compromised in water. The high heat of hydration is also 
responsible for the high redox potential (-3.06V) for the oxidation of fluoride and this 
clearly highlights the difficulty in generating both the fluorine radical and cation, 
reactive forms which are essentially inaccessible in biochemistry. Haloperoxidases, for 
example, cannot oxidise fluoride, as hydrogen peroxide is not a sufficiently strong 
oxidising agent (Fig. 1.6). These properties of fluorine coupled with the difficulty of 
releasing a heavily hydrated fluoride ion within the cell are probably the most important 
factors restricting fluorine from playing an active role in biochemical processes. 
2F- F2 + 2e 
1. 7.1 Fluorinated Natural Products in Plants 
(Eo= -3.06 v J 
(E0 = +1.71 v J 
Plants have been found to be the richest source of fluorine containing natural products 
with over 40 varieties producing fluoroacetate, and in one case Dichapetalum 
toxicarium which produces a range of ro-fluorinated lipids (see 1.7.1.2). Fluoroacetate 
tends to accumulate in high concentrations in certain plants originating from tropical 
and subtropical regions of the world. 
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I. 7.1.1 Fluoroacetate 
Of the ten naturally occurring organofluorine metabolites, the most ubiquitous is the 
toxin fluoroacetic acid. In 1943 Marais75,76 identified it from the S. African plant 
Dichapetalum cymosum, which was responsible for a considerable loss of cattle in the 
Transvaal region.77 This low growing shrub, named Gifblaar (poison leaf) by the 
natives, proved to be exceptionally difficult to eliminate because of its persistent and 
extensive underground stem and root system. 78 The young leaves of the plant can 
accumulate fluoroacetate up to 2500 )lg g·1 dry weight.79 Plants generally contain 0.1 to 
10 )lg fluoride.g dry weight-1,80 but a few can- store greater amounts from comparatively 
low soil concentrations. Recently fluoroacetate concentrations of up to 8000 )lg g ·1 dry 
weight have been recorded in the young leaves and seeds of D. braunii from south-
eastern Tanzania.81 This is the highest recorded level of the compound reported in a 
plant to date. 
In Australia alone fluoroacetate has been identified as the toxic principle of at 
least 35 plant species.82 The most widely studied Australian plant, Acacia georginae 
found in Queensland, accumulates the toxin in its leaves and seeds and can contain up to 
250 and 400 )lg g·I offluoroacetate in dry weight respectively.83 There has been a report 
of a Brazilian species, Palicourea margravii, with a capacity to biosynthesise up to 
5000 )lg g·I dry weight.84 These reports suggest that fluoroacetate producing plants 
appear to be distributed in all tropical and subtropical regions of the globe. 
The concentration of this toxin varies significantly between different organs in 
the plant. 85 The levels may also depend on the climate, geographical location, time of 
year and age of the species in question, e.g. at springtime the young shoots and leaves 
have high levels of fluoroacetate but as it matures the levels subside becoming 
negligible within a few months. 86 
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1.7.1.2 ro-Fiuorofatty acids 
ro-Fluorinated fatty acids constitute about 3% of the lipids in the seeds of 
D. toxicarium found in Sierra Leone. 87 The major fluorinated constituent is ro-fluoro-
oleic acid (52) with traces of fluorocapric (53) ro-fluoromyristic (54) and 
ro-fluoropalmitic (55) acids. 88 Recent re-examination of such seeds using GC-MS 
revealed the presence of more ro-fluorinated lipid derivatives.89 
0 
OH 
OH 
F 0 F 
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F 
(55) 
GC-MS investigations of the seed lipids of D. toxicarium revealed the low level 
presence of ro-fluoro derivatives of palmitoleic (C16:1), stearic (C18:0), linoleic (C 18:2), 
arachidic (C 20:0), eicosenoic (C 20:1) and docosanoic (C 22:0) acids. These ro-fluorofatty 
acids are extremely toxic waxes since they are readily absorbed through the skin and 
broken down to fluoroacetyl-CoA by P-oxidation processes. 
In the fluorinated fatty acids identified from D. toxicarium, fluorine only occurs 
at the terminal carbon, and is consistent with fluoroacetyl-CoA replacing acetyl-CoA as 
the starter unit in fatty acid biosynthesis. A study conducted on the distribution of 
fluoroacetate within D. toxicarium suggested that fluoroacetate used in ro-fluorofatty 
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acid biosynthesis in the seed was not formed in situ but it is transported from the young 
leaves to the seeds. 86 This would explain why fluoroacetate was detectable in the young 
leaves and not the seeds. 
1.7.1.3 Fluoroacetone 
When Peters and Shorthouse 90 incubated homogenates of A. georginae and other 
plants with inorganic fluoride, they noticed a substantial loss of total fluorine from the 
solution. This loss could only be correlated· in terms of its conversion into a volatile 
form. The volatile constituent in the homogenate was identified as fluoroacetone (59)_91 
Other volatile fluorinated compounds which were unidentified may have been produced, 
since fluoroacetone (hydrazone derivative) only accounted for 13% of the loss. The 
biosynthesis of fluoroacetone may be an early branching of fatty acid biosynthesis as 
depicted in Fig.l.7. 
0 0 0 COz 
( ~ , "'-::./ CoASH 
F 
0 0 
~SACP ------
F 
POH 
F Jl\;'JCoA H -oMsACP + 
(56) (57) /(58) 
(59) 
Fig. 1.7 
Iffluoroacetyl CoA replaced acetyl CoA in conventional fatty acid biosynthesis (section 
1.4.1), a fluorinated J3-ketothioester (57) would be formed. Hydrolysis would yield 
4-fluoroacetoacetate (58) which could decarboxylate to give fluoroacetone (59). Since 
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the fluoroacetate concentration in plants, in particular D. braunii, drops dramatically 
from spring (7200 ).lg g -1 dry weight) through to summer (200 ).lg g-1)81 , Peters 
speculated that here was a plausible detoxification strategy which could be induced 
whenever the requirement for the toxin diminished. 
1. 7.1.4 (2R.3R)-2-Fiuorocitrate 
The co-metabolite of fluoroacetate, (2R,3R)-2-fluorocitrate (61), is produced via 
condensation of fluoroacetyl-CoA (56) with oxaloacetate (60), a reaction mediated by 
citrate synthase. Fluorocitrate has been detected at various but low concentrations in 
forage plants such as soya bean and alfalfa,92 and at low levels in oatmeal, while 
commercial tea 92 can contain up to 30).lg g-1 dry weight. Stereochemical studies93 on 
the citrate synthase reaction with fluoroacetyl-CoA have shown that the 2-pro-S 
hydrogen of the fluoroacetyl group is .removed exclusively prior to condensation. 
Attack occurs with inversion of configuration at C-2 to liberate (2R,3R)-2-fluorocitrate 
as the single stereoisomer of four possibilities (Fig. 1.8). 
Si - face attack 
citrate synthase 
Inversion at C-2 
( 60) ( 61) 
Fig. 1.8 
It is interesting to note that unlike malate synthase, citrate synthase is capable of 
distinguishing the difference between the prochiral protons of CH2F.
94 Recent studies 
by O'Hagan eta/. have proposed that this selectivity arises due to the intermediacy of a 
more stable E enol (over the Z enol) intermediate.95 
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Plants which accumulate high levels of fluoroacetate must clearly have 
mechanisms for preventing autotoxicity. Fluoroacetate, however, poses a problem to 
mammalian cells as it inhibits the central pathway responsible for generating metabolic 
energy - the citric acid cycle. Its toxicity has rendered it a rodenticide under the 
tradename 'Compound 1080'.96 The oral lethal dose in humans is in the order of 
6 mg kg-I and 1080 has been responsible for accidental deaths and suicides. 97 
The toxicity arises when fluoroacetate (62) is converted to fluoroacetyl-CoA 
(56) which competes with acetyl-CoA (20) for the enzyme citrate synthase. The 
(2R,3R)-2-fluorocitrate stereoisomer (the other 3 isomers being non-toxic) is a potent 
mechanistic inhibitor of aconitase [E. C. 4.2.1.3.] (see Fig. 1.9). 
H02C OH 
H02C~C02H 
F 
( 61) 
Aconitate 
hydratase 
(EC.4.2.1.3) 
~ )o 
Fig. 1.9 
Metabolic block of the TCA cycle 
More recently the studies of Kun and co-workers98 have indicated that the 
inhibition of citrate transport was a more significant factor in fluoroacetate toxicosis. 
Their experiments suggested that a covalent bond is formed between 14C radiolabelled 
fluorocitrate and inner mitochondrial membrane bound proteins leading to inhibition of 
citrate transport across the cell's mitochondrial membrane. Recently, Lauble et a/., 
showed that the crystal structure of the aconitase - (2R,3R)-2-fluorocitrate, enzyme-
inhibitor complex, did indeed provide evidence of a strong interaction beween the 
enzyme and the inhibitor. 99 
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1.7.2 Fluorinated Natural Products in Mammals and Insects 
Organofluorine compounds are not restricted to the plant and microbial kingdoms. 
Animals such as the moth (Nygmia pseudoconspersa) feeding on a tea plant is capable 
of concentrating fluoride to a level of 5000j.lg g·1 dry weight in the wings and 
11 00j.lg g·I in the cocoon_loo Caterpillars of the moth Sindris a/bimaculatus feed on the 
young leaves and fruit of the fluoroacetate containing plant, D. cymosum. These 
caterpillars are highly toxic to predators and it has been postulated that fluoroacetate 
accumulates in vacuoles within the larvae_IOI 
Human plasma has been reported to contain 1-4 J.lM of organic fluorine.I02 
About 30% of this fluorine can be accounted for by perfluorofatty acids which are used 
in oil and water repellents for fabric treatment and in the formulation of waxes. The 
remaining 70% is probably anthropogenic in origin but this remains to be answered. 
Marsupials, emus and bush rats of some regions of Australia have a remarkable 
tolerance to fluoroacetate poisoning compared with those from other parts of the 
continent. 103 Although no conclusive biochemical explanation has been given for this 
tolerance, one suggestion, bearing in mind that a glutathione-dependant defluorinating 
enzyme was found in the liver of the brush-tailed possum, is that glutathione may play a 
role in the resistance process. This may be achieved by either defluorination of 
fluoroacetate or fluorocitrate or possibly by affecting the enzyme aconitase, or citrate 
metabolism more generally. 
1.7.3 Fluorinated Natural Products from Micro-organisms 
1.7.3.1 Nucleocidin 
NH2 
&> 0 ;QN N II 0 
H N_,.~,O 
2 0 
F 
I HO OH 
( 64) 
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Streptomyces calvus, isolated from an Indian soil sample, 104 was shown to elaborate an 
adenine-containing antibiotic named nucleocidin (64). This compound was the first 
fluorinated metabolite to be characterised from a microbial source, and it showed 
antibiotic activity against a broad spectrum of bacteria. It was particularly effective as 
an anti-trypanosoma! agent. 105 However, its toxicity placed limitations on its clinical 
use. The total synthesis of this molecule confirmed the structure and absolute 
configuration as shown.I06 Fluoride was not an added component of the microbial 
culture media, however the medium contained trace levels in the mineral salts and tap 
water. Subsequent but unsuccessful attempts to re-isolate nucleocidin from S. calvus 
have prevented biochemical studies with tliis system. Nucleocidin is not obviously 
derived from fluoroacetate and may therefore involve a C-F bond-forming enzyme 
unique to S. calvus. 
1. 7.3.2 4-Fluorothreonine and Fluoroacetic Acid 
Sanada et al., 107 discovered that S. cattleya, when incubated in a culture medium 
containing inorganic fluoride, biosynthesised millimolar concentrations of the 
metabolites fluoroacetate and 4-fluorothreonine (65). Evidence from 19f-NMR studies 
showed that fluoroacetate accumulated in the culture medium to a concentration of 
2-3mM. 
( 65) 
The compound is an optically active single stereoisomer proposed to be 
stereochemically analogous to L-threonine. Studies in this Thesis confirm this 
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stereochemistry. An acetylenic amino acid (66) was also isolated during purification of 
4-fluorothreonine from the fermentation broth of S. cattleya. 1D8 The similarity in 
structure between this amino acid and 4-fluorothreonine may suggest a common 
biosynthetic origin however this is no experimental evidence in support of this. The 
identification of nucleocidin (64) and 4-fluorothreonine (65) are exciting and indicate 
that bacteria may emerge as an Wltapped source of novel fluorinated metabolites. 
It is interesting to note that Streptomyces sp. OH 5093 has recently been foWld 
to secrete the metabolite, 4-chlorothreonine109 (67) which is probably stereochemically 
analogous to 4-fluorothreonine (65). The biosynthesis of these two amino acids in 
Streptomyces could be similar. 
OH 0 
~OH 
~ 
(66) (67) 
1.8 Fluoroacetate Dextoxification Strategies 
Various explanations have been forwarded for the resistance of organisms to 
autotoxicity from fluoroacetate production. In plants it is thought that the toxin may be 
compartmentalised within cell vacuoles remote from the mitochondria, so avoiding 
conversion to fluorocitrate. 110 Plant aconitase may be less sensitive to fluorocitrate than 
animal aconitase, i.e it was reported that aconitase from sycamore (Acer 
pseudoplatanus) cells was 2000 times less sensitive to fluorocitrate than that from pig 
heartll 1 and similarly it has been speculated that D. cymosum possesses a citrate 
synthase enzyme which has a low affinity for fluoroacetyl-CoA. Recently a hydrolase 
enzyme, capable of hydrolysing fluoroacetyl-CoA to fluoroacetate without affecting 
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acetyl-CoA, was discovered in cell free extracts of D. cymosum. 112 This enzyme would 
restrict the accumulation and processing of the metabolically active fluoroacetyl-CoA. 
A number of micro-organisms namely Pseudomonas spp., Penicillium spp., and 
Fusarium oxysporium, possess enzymes capable of cleaving the very stable C-F bond 
of fluoroacetate.m Pseudomonas cepacia (a symbiotic parasite of D. cymosum) has 
been found to defluorinate fluoroacetate114 and it probably does this with the use of a 
halido hydrolasell5 (Fig. 1.10). The mechanism proposed involves attack of a thiol 
group (since the enzymes are quite sensitive to thiol blocking agents) to fluoroacetate 
displacing fluoride and generating a thioether which hydrolyses to glycolate (63), the 
defluorinated product. The defluorinating activity of a variety of soil inhabiting micro-
organisms, found in Western Australia, is well documented in the literature. 116 
-
Fluoride 
( 63) 
Fig. 1.10 
Some mammals and birds in the same region appear to have an increased 
fluoroacetate tolerance compared with animals in other areas of Australia and 
concomitantly have increased glutathione levels.m Interestingly, the moth Sindris 
albimaculatus is capable of degrading fluoroacetate to inorganic fluoride and co2. 101 
1.9 Proposed Mechanisms to Organofluorine Metabolites 
1.9.1 Pyridoxal Phosphate- Catalysed Incorporation of Fluoride 
Plants contain a multitude of ~-substituted alanines1I8 which are believed to be 
formed by nucleophilic attack at C-3 of a pyridoxal phosphate enamine adduct. 
33 
A. georginae elaborates at least seven P-substituted alanines suggesting that the process 
is mediated by a non-specific synthase which catalyses the incorporation of a range of 
nucleophiles to generate the various structures (Fig. 1.11 ). 
In the light of these findings, Mead and Segal 119 postulated that the biosynthesis 
of fluoroacetate could involve a pyridoxal phosphate enamine with fluoride as the 
nucleophile (Fig. 1.12). The hypothesis essentially involves the attack of a pyridoxal 
phosphate enamine intermediate (68) by a fluoride ion to produce pyridoxamine 
phosphate-bound fluoropyruvate (72). This intermediate (74) may undergo hydrolysis to 
fluoropyruvate (74) which can then decarboxylate to form fluoroacetic acid (62). The 
hypothesis was tested by investigating the effect of cyanide and fluoride ions on the 
conversion of L-cysteine to pyruvate in cell-free extracts of A. georginae. Cyanide 
inhibited this conversion and P-cyanoalanine was isolated, which indicated that the 
enamine adduct underwent nucleophilic attack by CN-. However, there was no evidence 
of fluoropyruvate (74) formation and no detectable traces of P-fluoroalanine (73). 
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These results tend to suggest that this pathway for fluoride incorporation is not 
operating in A. georginae. Studies conducted by Meyer and O'Hagan have shown that 
fluoropyruvate (74) is readily 'biotransformed' to fluoroacetate (62) in D. cymosum 
tissue cultures. 120 
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1.9.2 Acetate, Ethylene and Halometabolites as Precursors to Fluoroacetate 
Acetate is unlikely to be a direct precursor to fluoroacetate as its methyl group is 
not activated for fluoride attack. Some support, albeit negative, is provided from 
experiments demonstrating the failure of D. cymosum leaves to label fluoroacetate when 
incubated with [2-14C]-acetate. 121 In the course of their studies, Peters and Shorthouse 
found that the plant hormone ethylene was also a by-product of the biosynthesis of 
fluoroacetone. 122 On the basis of this finding, Peters speculated that fluoroacetate could 
be derived from ethylene via vinyl fluoride (75) or fluoroethane (76) as depicted in Fig. 
1.13. 
( 75) 
H H 
>=< 
H H 
>=< H H F H F 
( 62) 
( 76) 
Fig. 1.13 
An alternative pathway shown in Fig. 1.14 involves ethylene oxide (77), 123 
however there is no experimental evidence to suggest that either of the two pathways 
are operating in A. georginae or indeed any other plant system. 
H H (0) 0 HF OH ~on >=< D r H H F F 
( 77) ( 78) ( 62) 
Fig. 1.14 
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Peters also investigated the possibility of chloroacetate as an intermediate in the 
biosynthesis of fluoroacetate in A. georginae. 124 Despite observing a relatively high 
uptake of chloride ions by the plant homogenates, no chlorinated organic compounds 
were detected. Vickery et al., 125 observed chloroacetate as a major product of the 
reaction between malonic acid and sodium hypochlorite at 25°C. The addition of 
fluoride to the mixture resulted in the detection of trace amounts of fluoroacetate which 
appeared to be formed by attack of a fluoride ion on the C-Cl bond of 2-chloromalonic 
acid which decarboxylates to generate fluoroacetate. 125 
1.10 Streotomvces cattleva 
:J.. ..- .. 
The vast majority of Streptomyces, the largest genus of Actinomycetes, are soil 
inhabiting bacteria. They may constitute as much as one fifth of the total culturable soil 
population. 126 The odour of moist earth is largely due to the Streptomyces releasing 
volatiles such as geosmin (79). These bacteria are perhaps best known for their 
elaboration of a multitudinous array of antibiotics which have found application in 
medical clinics. Examples include chloramphenicol (80), erythromycin and tetracycline 
(17) (see also section 1.3). 
cb NHCOCHCI2 
OH~ 
(79) (80) 
Kahan et al., 127 was responsible for isolating Streptomyces cattleya from a soil 
sample in New Jersey, USA. Solid media cultures of the micro-organism give rise to 
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aerial mycelia with a characteristic orchid pigmentation, 127 and appropriately, the name 
'cattleya' originates from the botanical orchid genus. 
Streptomyces cattleya NRRL 8057 has been known to elaborate a range of P-
lactam antibiotics including thienamycin, cephamycin C, penicillin N. Thienamycin 
(81) is a broad spectrum antibiotic that possesses a carbapenem ring system and is 
highly active against both Gram positive and Gram negative bacteria. 59 Thienamycin is 
resistant to a multitude of P-lactamases which normally hydrolyse penicillins and 
cephalosporins. Biosynthetic studies on the antibiotic have shown that the pyrrolidine 
ring was derived from glutamate, 128 the cysteaminyl side chain from cysteine, and 
acetate formed C6 and C7 of the P-lactam -ring while two methionines donate two 
methyl groups for the synthesis of the hydroxyethyl group. 
(81) 
S. cattleya also produces 2-hydroxymethylcyclopent-4-ene-1 ,3-dione (82), a 
cyclopentenedione antibiotic which is weakly active against Gram positive and Gram 
negative bacteria but inactive towards fungi. 129 
(82) 
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Sanada et al., suggested a condensation reaction between fluoroacetaldehyde and 
glycine as the process for the biosynthesis of 4-fluorothreonine (Fig. 1.15). 107 
( 84) 
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Fig. 1.15 
During the course of this work, Tamura eta/., 130 in Japan reported the only other 
biosynthetic study of fluoroacetate in S. cattleya (S. cattleya mG 29). They showed that 
14 14 14 • 14 [U- C)-glucose, [U- C)-glycerol, [ C]-senne and [U- C]-P-hydroxypyruvate were all 
incorporated (0.2% - 0.4%) more efficiently than [3- 14C]-pyruvate, [2,3- 14C]-succinate 
and [U- 14C]-aspartate (0.04% - 0.08%). Furthermore, incubation of [2- 13C]-glycerol 
resulted in a clear enrichment at C-1 ( 40%) of fluoroacetate (Fig.l.16, 1.17). These 
authors concluded that the fluoroacetate backbone was derived from C-1 and C-2 of 
glycerol through P-hydroxypyruvate and proposed that the hydroxyl group of P-
hydroxypyruvate was ultimately replaced by fluoride. 
OH 
II S. cattleya NTG 29 
OH OH 
( 85) ( 85a) ( 62a) 
Fig. 1.16 
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Fig. 1.17 12F-NMR of [1-11C]-fluoroacetate and non-labelled fluoroacetate from culture 
suspensions incubated with [2-11C]-glycerol. Tamura et a/. 130 
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-2\6 
41 
Biosynthesis qffluoroacetate and 4-fluorothreonine in S. cattleva 
42 
CHAPTER 2 
Exploratory experiments on fluorometabolite biosynthesis in S. cattleya 
2.1 Background 
A clear reason for the limited literature on the biochemistry and enzymology of 
biological fluorination is that plant tissue cultures of the fluoroacetate producing plants 
have proved difficult to generate and culture. Only two bacterial strains, Actinomycete 
soil bacteria of the genus Streptomyces, have been shown to secrete fluorinated 
metabolites. One of these, S. calvus, appears to biosynthesise nucleocidin (64)131 
however only S. cattleya is a candidate organism for biosynthetic studies as it is capable 
of producing fluoroacetate and 4-fluorothreonine in appreciable concentrations and is 
therefore an extremely attractive system to investigate. The discovery of these two 
micro-organisms suggests that bacteria may be a more common source of fluorinated 
metabolites. At the moment however, details of possible substrates and mechanism of 
fluorination remain ill-defmed and speculative. Thus the current studies represent the 
first substantial investigation on the biosynthesis of organofluorine compounds. 
2.1.1 Growth of S. cattleya 132 
The growth of S. cattleya NRRL 8057 was first established on solid agar medium at 
28°C. After a suitable incubation period (24-48h), the surface of the agar was examined 
visually for the presence of individual cell colonies. Smooth white spores were apparent 
after 96h and the petri-dishes were left for a further 4 days [Fig. 2.1(a), (b)]. The spores 
were then transferred by loop from solid agar medium to liquid culture media. 
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Streptomyces cattleya 
(Defined Medium) 
Streptomyces cattleya 
8 days 
(Defined Medium) T= 27°C 
T= 27°C 
8 days 
21 days 
Fig. 2.1 (a). (b) Photo~aphs showing spores of S. cattleva grown on solid agar medium 
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2.1.2 Preparation of suspension cultures of S. cattleya 
In general suspension (batch) cultures were prepared by inoculating several Erlenmeyer 
flasks (500ml) containing sterilised defined medium (100ml) by loop transfer from agar 
slants. The flasks containing the media were subsequently incubated for 28 days in an 
orbital shaker (28°C and 200 rpm). 
Colonies of S. cattleya developed after 1-2 days and continued to grow until 
approximately 4 days at which stage the culture acquired a pink coloration 
corresponding to the end of the growth phase (trophophase ). The culture subsequently 
entered the static phase (idiophase) where the mycelial network disintegrated and the 
supernatant appeared golden brown in colour. Aliquots of culture supernatant from 
batch suspensions of S. cattleya cells of different ages were collected and analysed by 
I9f-NMR to assess fluorometabolite production. The fluorinated metabolites were not 
generally detectable by 19F-NMR until after 10 days had elapsed and the production of 
fluoroacetate and 4-fluorothreonine continued for a further 14 days. It is interesting to 
note that the production of geosmin24 (76) by S. cattleya appears to be concomitant with 
the biosynthesis of the two fl.uorometabolites. The odour of this compound serves as an 
indicator of the presence offl.uoroacetate and 4-fluorothreonine in the culture medium. 
Incubation experiments with putative isotopically labelled precursors involved 
pulse feeding batch cell suspensions of S. cattleya on the 6th, 8th and 1Oth days. After 
an additional 14 days the cells were separated by centrifugation and the supernatants 
were stored at 4°C pending analysis of incorporation into fluoroacetate and 4-
fluorothreonine. 
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2.1.3 Fluoride uptake and fluorometabolite production in batch culture by 
132 S. cattleya 
The production of the fluorometabolites by S. cattleya has been monitored several years 
ago by the Belfast Group. It is apparent that in the absence of fluoride, batch cells 
reached their growth maximum after 2 days, however the presence of 2mM fluoride 
inhibits growth, taking a further 2 days to reach the end of the trophophase. Fluoride 
uptake by the cells commenced after 4 days until complete consumption after 28 days 
(Fig. 2.2). 
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The fluoride ion concentration began to fall after six days and was concomitant with 
total fluorometabolite (fluoroacetate and 4-fluorothreonine) production. Accumulation 
of the fluorometabolites was approximately linear with respect to time between 4 and 10 
days and reached a plateau after 12 days. It is noteworthy that the initial concentrations 
of fluoroacetate and 4-fluorothreonine are approximately equal after 6 days but with 
time the concentration of fluoroacetate exceeded that of 4-fluorothreonine reaching a 
ratio of 70:30 after 28 days and a final concentration of 1.2mM. 
2.1.4 Preparation of resting cell cultures of S. cattleya 
The term resting cells is applied to those cells whose growth has ceased and have 
subsequently entered a secondary stage of metabolism (idiophase ). Resting cells 
suspended in buffer offer a substantially cleaner medium than the batch cultures for 
feeding experiments. This has the advantage of washing away any extraneous organic 
material often improving precursor incorporations. 
Typically five Erlenmeyer flasks of S. cattleya cells were grown in batch culture 
on a defined medium for six days, and harvested cells (usually 1 0-15g) were washed 
with MES buffer (pH 6.5). The resultant cell mass was usually between 1 0-15g wet 
weight per flask. Thereafter washed cells were resuspended in the buffer at a 
concentration of 0.15g wet wt mr1. For feeding experiments washed cells were 
incubated with lOmM precursor and 2mM NaF at 28°C on an orbital shaker at 200 rpm 
for 96h. Cells were then separated by centrifugation and the supernatant analysed for 
incorporation of putative precursors into the fluorometabolites using GC-MS and I9p_ 
NMR. (see sections 2.3) 
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2.1.5 Fluorometabolite production by resting cultures of S. cattleva 132 
The effect of time on fluorometabolite biosynthesis was studied by Reid et a!., 132 by 
preparing resting cell cultures harvested from batch cells aged between 4 and 16 days 
and incubating them in the presence of fluoride for 96h. No significant fluorometabolite 
production was detected using 4 day old cells, but cells aged 6 days had the capacity to 
biosynthesise low concentrations of both fluorometabolites. Fig. 2.3 illustrates the level 
of production of the fluorometabolites by resting cells of S. cattleya (harvested from 6 
day old batch culture) monitored over a period of 96h. 
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The profile clearly indicates complete conversion of fluoride to the fluorometabolites 
within 96h and an almost equal concentration of fluoroacetate and 4-fluorothreonine by 
SOh. Resting cells prepared from 10, 12 and 16 day old cells displayed a progressively 
lower fluoride uptake and a declining rate of fluorometabolite biosynthesis. These 
results indicate that the optimum harvesting age of cells from batch cultures is 6 days 
and thus this preparation was used throughout the feeding experiments. 
2.1.6 Parameters affecting fluorometabolite production by resting cells of 
S. cattleya 132 
Fluorometabolite production is strongly dependent on the pH of the culture medium. 
The optimum pH is 6.0 and production declines markedly at higher pH values, 
particularly in the case of fluoroacetate. It was speculated by Sanada et al., 107 that 4-
fluorothreonine was derived from fluoroacetate but studies carried out by Reid et al., 132 
contradicted this and suggested that the rate of interconversion of both fluorometabolites 
was too low to account for the normal resting cell concentrations of fluoroacetate and 4-
fluorothreonine indicating that neither fluorometabolite was derived by metabolism of 
the other. The low-level interconversion observed was judged to be due to the ability of 
the resting cells of S. cattleya to defluorinate the fluorometabolites. The fluorinating 
system would then recycle the released fluoride for de novo fluorometabolite 
biosynthesis. Further incubation experiments with a variety of putative organofluorine 
precursors showed a similar result, i.e. elimination and subsequent reincorporation of 
fluoride to produce the fluorometabolites. Similar cases of fluoride release from 
organofl.uorine compounds have previously been documented. 133' 134 Further, albeit 
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negative, evidence for this conclusion was provided after incubation experiments with 
fH2]-fluoroacetate which was not incorporated into 4-fluorothreonine 
In contrast to Sanada et a!. 's107 suggestion that fluorocitrate was inert to 
metabolism by S cattleya, Reid eta!., 132 have shown that resting cells were capable of 
producing low concentrations of fluoroacetate and 4-fluorothreonine when incubated 
with DL-fluorocitrate. It would appear therefore that S. cattleya aconitase is not 
inhibited by fluorocitrate but rather the latter is metabolised and defluorinated. These 
authors also assessed the effect of possible precursors on fluorometabolite production 
through incubation studies with various TCA cycle intermediates and a-amino acids. 
However, no significant change in the overall ratios of the fluorometabolites was 
observed during such studies. 
2.2 Incorporation of MC-radiolabelled substrates into fluoroacetate by 
resting cell cultures 
This investigation was designed to provide an insight into the metabolic source of the 
carbon substrate for the fluorinating enzyme. Resting cell cultures were prepared as 
described in section 2.1.4 and incubated in the presence of 2mM NaP, 40 f.1.moles of 
unlabelled fluoroacetate and a selection of 14C-labelled putative precursors ranging from 
the amino acids, L-threonine, glycine, L-serine, L-aspartate and L-glutamate; glucose 
and glycerol representatives of the glycolytic pathway; glycolate from the glyoxylate 
cycle plus acetate, citrate and succinate, intermediates of the TCA cycle. After the 96h 
incubation period, an aliquot of supernatant was retained for fluoride and 
fluorometabolite determination in Belfast while the remaining portion was derivatised 
(see section 2.3.1) and analysed using radiochemical scintillation counting in Durham. 
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2.3 Analytical methods 
Three different procedures were adopted to determine the incorporation of putative 
precursors into the fluorometabolites. In the case of radiolabelled substrates, a chemical 
derivatisation of fluoroacetate was used to generate a crystalline compound. 
Recrystallisation allowed a given sample to be purified to constant radioactivity. For 
stable isotopes, GC-MS and 19F-NMR were employed to determine the incorporation of 
13C and 2H labelled substrates. 
2.3.1 
14 
Investigation of the incorporation of -c- radiolabelled compounds into 
fluoroacetate 
A number of analytical techniques have been reported for the analysis of fluoroacetate 
particularly in small quantities from organic materials. Colourimetric procedures have 
been used for the analysis of fluoroacetic acid in D. cymosum. 135 A fluoride ion-
selective electrode has also been used to detect fluoride ion release after pretreatment of 
a fluoroacetate containing am 1 136,137 s p e. In 1972 · Hall138 suggested 
19 . . 139 F-NMR as an alternative assay method, and more recently Baron eta!., reported 
that the limit of detection of fluoroacetate by NMR was -41J.g/g. In comparison to gas-
chromatographic (O.l!J.g/g)140' 141 and liquid chromatographic methods,[1421 19F-NMR is 
significantly less sensitive but technically easier since derivatisation of the fluoroacetate 
is unnecessary. The GC-MS method described by Vertainen and Kauranen143 is 
apparently the most sensitive technique for fluoroacetate determination to date, capable 
of detecting down to 0.0051J.glg of fluoroacetate. Recently however Burke et a!., 144 
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reported a novel derivatisation method for the quantitative determination of 
fluoroacetate by converting it to its dodecyl ester. The advantage of this technique over 
other chromatographic procedures is the low volatility of the fluoroacetate derivative 
enabling a high recovery of the analyte. 
The method developed in Durham, several years ago, involves a simple 
derivatisation of fluoroacetate with p-phenylphenacyl bromide which can be analysed 
either by GC-MS or radiochemical scintillation counting depending upon the nature of 
the isotopes under investigation. After a given feeding experiment, cold sodium 
fluoroacetate is added to a freeze dried sample of the supernatant and the mixture treated 
with 4-phenylphenacyl bromide in the presence of a phase transfer catalyst, 18-crown-6 
(Scheme 1). Following filtration and solvent removal the solid residue is purified by 
preparative tlc using toluene as the eluant. The silica band containing the ester 
derivative (87) (UV identification) is scraped off and extracted into dichloromethane. 
Subsequent removal of the solvent and recrystallisation of the crystalline derivative 
from ethyl acetate allows an accurately weighed sample of the derivative to be prepared. 
The recystallised material is dissolved in Ecoscint scintillation fluid and the sample is 
then ready for radiochemical counting. 
0 
Toluene/ MeCN 
18-crown-6 
Scheme 1 
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2.3.2 Quantification offluoroacetate and 4-fluorothreonine by GC-MS 
The production of fluoroacetate and 4-fluorothreonine by S. cattleya was assayed by 
19F-NMR or alternatively by GC-MS and HPLC techniques. The GC-MS procedure, 
used to assay fluoroacetate, is based on the derivatisation of fluoroacetate with 
p-phenylphenacyl bromide. For quantification, the peak area is compared to an internal 
standard (sodium propionate) response curve. The limit of detection using this 
procedure is O.OlmM in a given supernatant aliquot. 
Determination of 4-fluorothreonine is carried out by a fluorometric HPLC 
procedure commonly employed for amino acid analysis. 145 For quantification the peak 
area for 4-fluorothreonine is compared to an internal standard (tyrosine) response curve. 
The limit of detection is again O.OlmM in a given supernatant aliquot. 
2.3.3 Determination of% incorporation into fluoroacetate by GC-MS 
Isotope incorporations into the carbon skeleton of fluoroacetate can be determined by 
monitoring the increase in mass of the 4-phenylphenacyl derivative (m/z 272; molecular 
ion, M) of fluoroacetate. Fig. 2.4 shows the mass spectrum, obtained under EI (electron 
ionisation) conditions, illustrating the fragmentation pattern of this derivative. Detection 
of ions 273 (M+ 1) and 274 (M+2) indicates incorporation of single and double label 
respectively. Prior to calculations of% incorporations, corrections were made to each of 
the ion peak areas for natural isotope abundances. The level of incorporation into 
fluoroacetate is calculated by dividing the corrected peak area for each ion by the sum of 
total corrected peak areas for ions 272,273 and 274. The natural abundances of ions 273 
and 274 were determined experimentally using control samples. 
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2.3.4 Determination of% incorporation into 4-fluorothreonine 146 
Isotope incorporations into the vanous carbon atoms of 4-fluorothreonine were 
determined by monitoring the mass of selected fragments from a silylated derivative 
4-fluorothreonine. This derivative of 4-fluorothreonine was prepared by reacting a 
sample of the freeze dried culture supernatant with N-methyl-N-(trimethylsilyl)-
trifluoroacetamide (MSTF A). From the fragmentation pattern (depicted in Fig. 2.5) of 
the MSTF A derivative, detected under EI conditions, it is evident that two main 
fragments are present (m/z 236,. mlz 218). 
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Since the silylated derivative of 4-fluorothreonine yielded no significant molecular ion 
for monitoring the molecule as a whole, it is only possible to evaluate fragments of the 
molecule. Ions 218, 219, 220, and 221 permit an assessment of the incorporation into 
positions 1 and 2 of 4-fluorothreonine and ions 236, 237, 238 and 239 allow 
incorporations into positions 2, 3 and 4 to be determined. The natural abundance of the 
various ions was determined experimentally using control samples. 
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2.3.5 ~-NMR Spectroscopy 
Cell supernatants may of course be analysed directly by 19F-NMR without recourse to 
extraction and derivatisation. The clear advantage with 19F-NMR is that it permits easy 
identification and quantification of the fluorometabolites produced by 
S. cattleya. The sensitivity of 19F-NMR is not a problem since fluorine-19 possesses a 
large magnetic moment and has a natural abundance of 100%.55 The majority of C-F 
resonances occur within a 300ppm sweep width, and the region of interest to this 
programme (CH2F) is between -IOOppm and -250ppm. Since I= 1/2 for fluorine-19, 
coupling patterns to other nuclei (e.g. 13C, 1H, 2H) are relatively easily evaluated. 
Fluorine-19 coupling is influenced by the nature of the atoms attached, and the number 
of intervening bonds between the fluorine atom and the active nucleus. The value of the 
coupling constants are typically 2] =47Hz for a geminal interaction to hydrogen and 
F·H 
3 J = 25Hz for a vicinal coupling to hydrogen. However solvent and temperature effects 
f·H 
are considerably greater in 19F-NMR than in 1H-NMR and consequently can give rise to 
significant changes in 19F-NMR chemical shift. 
2.3.5.1 12F -NMR Analysis of S. cattleya supernatants 
Proton decoupled 19F eH}-NMR spectra proved to be advantageous in simplifying 
complex peak multiplicities and the coupling patterns arising from each fluorinated 
metabolite. In general the decoupling strategy involved irradiation of protons with a 
separate radiofrequency (500.13MHz in this case) to that already applied (operating 
frequency 471.54MHz). This has the effect of saturating all of the proton resonance 
transitions such that signal splittings caused by fluorine-hydrogen couplings are 
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removed. In consequence the signals from the undecoupled 19F-NMR spectrum, collapse 
to singlets as illustrated in 19F eH}-NMR spectrum (Fig.2.7). 
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Fig. 2. 7 ErH} NMR spectrum of a suspension culture supernatant from S. cattleva 
cells aged 28days 
The fluoride signal (F) was used as an internal chemical shift reference. Despite the 
potential fluctuation of the F- signal it was given a chemical shift value of -119ppm in 
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all of the spectra that were recorded. The triplet eJF·H = 47Hz) at -216.78ppm is a 
typical pattern that arises due to the fluoromethyl group of fluoroacetate. Also present in 
the culture supernatant is 4-fluorothreonine which appears a further 1 0-15ppm to lower 
frequency, as a doublet Oftriplets eJF·H= 47Hz, 3JF-H= 25Hz). The additional splitting Of 
the fluoromethyl triplet is due to the vicinal C-3 proton of 4-fluorothreonine. 
Close inspection of the 19F-NMR spectra (Figs. 2.6 and 2.7) clearly demonstrate 
that 19F eH}-NMR is the more sensitive technique facilitating analysis of spectra (see 
Chapter 3).The slight fluctuations in the chemical shift values of fluoroacetate, 
and 4-fluorothreonine are probably due to temperature, concentration and pH effects. 
Although the sample is run in a fairly constant ambient temperature, long aquisition 
times under continuous decoupling conditions causes sample heating, usually by 1-2 oc. 
In addition, individual samples may contain different concentrations of fluoride and 
fluorometabolites possibly due to small changes in the physiological age and state of 
cells. 
2.3.5.2 The consequence of introducing ~H and 13C nuclei adjacent to fluorine in 
19F-NMR 
19p 2H 1. . . ---=.- coup mg mteracttons 
Deuterium atoms adjacent to fluorine induce an additive shift to lower frequency in the 
19 
F-NMR spectrum. A model study investigating the exchange of the C-3 protons for 
deuterium in 3-fluoropyruvic acid elegantly illustrates that a single geminal deuterium 
adjacent to fluorine, alters the multiplicity of the signal and shifts it to lower frequency 
(p shift= 0.60ppm), Fig. 2.8. The number of energy states allowed for a nucleus where I 
= 1, is three. Consequently one deuterium geminal to fluorine generates a triplet, while 
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two deuterium atoms geminal to fluorine produces a shifted (2 x ~ shift = 1.2ppm) 
pentet. 
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The sensitivity of the method can be increased by applying 19F eH} decoupling which 
removes proton coupling, thus deuteriwn incorporation into the fluorometabolites is 
readily observed. 
Retey et al., 93 has demonstrated this ~-effect in a 19F-NMR spectrum of (2R,JR)-
2-[2-2H]-fluorocitric acid which was prepared from the condensation of (2R)-[2-2H]-
fluoroacetyl CoA and oxaloacetate catalysed by citrate synthase. Fig. 2.9 illustrates the 
doublet at 8 = -198.6ppm eJH-F =47Hz) generated by 2-fluorocitric acid and the triplet 
~t 8 = -199.2ppm eJD-F = 6.5Hz) resulting from the substitution of1H-12C-19F by 2H-
12C-19F in (2R,JR)-2-[2-2H]-fluorocitric acid. 
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Fig. 2.9 12F-NMR spectrum of (2R.3R)-2-[2-:fH]-fluorocitric acid 21 
12F-llc coupling interactions 
For carbon-13 I= 1/2 and a given nucleus can occupy one of two energy levels. An intact 
19F-13C coupling pattern gives rise to a doublet (1 Jc-F = 165Hz) in the 19F { 1H} NMR. 
System 
13c-F 
13C-C-F 
13C-C-C-F 
13 c C-C- -C-F 
Type 
1JcF 
2JcF 
3JcF 
4JcF 
Typical J value/ Hz 
160-370 
15-45 
5-15 
1-5 
T bi bi I' . . I 13 19F 1' 146 a e 2.1 Ta e 1stmg some typ1ca -c-- coup mg constants. J (Hz). 
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eJc-F =18Hz) and a doublet of doublets (1Jc-F =165Hz, 2Jc-F =18Hz) respectively. 
Fig. 2.10 ~E.{.1H} NMR offluoroacetate and [1,2-11C2]-fluoroacetate 
., 
~ ~ : 
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Fig. 2.10 Shows a high field 19F { 1H} NMR of fluoroacetate acid containing a 
population of molecules with contiguous 13C atoms both coupling to the 19F nucleus to 
generate the shifted (a+ ~ shift= 0.12ppm) doublet of doublets. This spectrum is for 
illustration only at this stage and will be discussed in detail later (see section 3.3). 
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2.4 Results and discussion 
2.4.1 General calculation of levels of incorporation 
Levels of incorporation of a given precursor can be calculated in a number of ways. The 
common terms applied are Absolute Incorporation, Specific Incorporation and 
Enrichment. 
% Absolute incorporation (in the case radiochemical precursors) is defined by 
the following equation ; 
%Absolute incorporation = Total activity (dpm) in the isolated natural product x 100 
Total activity (dpm) in the administered precursor 1 
In the case of stable labelled precursors; 
%Absolute incorporation = Total excess isotope in the isolated natural product x 100 
Total excess isotope in the administered precursor 1 
Absolute incorporation gives a correlation between the amount of administered 
precursor and the amount incorporated into the metabolite. Its value can vary greatly 
because it depends on determining the total amount of metabolite biosynthesised during 
the experiment, which can be difficult. 10 A more reliable method is specific 
incorporation which is defined by the following equation; 
% Specific incorporation = 
Specific activity of the isolated natural product 
(dvmlmMor% excess isotove) 
l. J.. 
Specific activity of the administered precursor 
( dpmlmM or % excess isotope) 
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X J00 
1 
The inverse of the value of% specific incorporation is known as Dilution. This 
particular method gives a measure of the amount of product formed from the 
administered labelled precursor relative to that formed from the pool of endogenous 
unlabelled precursor. 10 Determination of the Specific Activity of the product is generally 
more straightforward than the Absolute Incorporation since only a portion of the product 
requires isolation. 
2.4.2 Calculation of incorporation rates of potential precursors into fluoroacetate 
and 4-fluorotbreonine 
% Incorporation rate was calculated using the following equation; 
Specific activity affluoroacetic acid X I 00 = % Specific incorporation 
Specific activity of precursor 
The potential precursor (20 !J.Ci) was administered to resting cells of S. cattleya, thus for 
each experiment 4.44 x 107 dpm in all was added (1 !J.Ci = 2.22 x 106 dpm) with a few 
milligrams of cold carrier. This equates to total'counts in' and the results are calculated 
as a percentage; 
(total 'counts out') in fluoroacetic acid x I 00 = % incorporation 
(total 'counts in? 
By adding 30mg of fluoroacetate to the resultant fluoroacetate containing 
supernatants from feeding experiments, the total 'counts out' in fluoroacetate may be 
determined, 30mg = 0.3mmoles. The endogenous mass was considered to be zero. The 
fluoroacetate was derivatised to give a maximum of 0.3mmoles of p-phenylphenacyl 
derivative (Mwt = 272) and therefore a maximum weight of 81.6mg. The compound 
was recrystallised to constant radioactivity and a value of dpm/mg (subtracting 
background radiation) for each sample was obtained. 
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Precursor 
threonine 
glycolate 
1164 dprnl mg 
1917 dprnl mg 
For L-[U-14C]-threonine; 1164 x 81.6mg = 94982.4 dpm = Total 'counts out' m 
fluoroacetic acid, therefore% incorporation= [94982.4/ 4.44 x 107] x 100 = 0.21% 
Likewise for [U-14C]-glycolate; 1917 x 81.6mg = 156427.2 dpm =Total counts out in 
fluoroacetic acid, therefore% incorporation= [156427.2/ 4.44 x 107] x 100 = 0.35% 
Precursor Incorporation (%) 
a b c 
[U-'4C]-glycolate 3.25 4.05 1.73 
D-[U-'4C]-glucose 1.42 1.92 -----
[U-14C]-glycerol 1.08 1.12 -----
L-[U-'4C]-threonine 0.80 0.82 0.88 
[U- 14C]-glycine 0.71 0.84 -----
L-[U-'4C]-serine 0.60 0.84 -----
[2,3-'4C]-succinate 0.64 0.37 -----
L-[U-'4C]-aspartate 0.50 ----- ----
L-[U-'4C]-glutamate 0.43 ----- -----
[U - 14C]-acetate 0.15 0.17 -----
[1 ,5-'4C]-citrate 0.015 0.028 -----
14 
Table 2.2 ill %Incorporation of-C-labelled precursors into fluoroacetate. Columns a 
b. and c denote repeat experiments. 
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2.5 Discussion 
Generally higher levels of incorporation were recorded from feeding [U- 14C]-glycolate 
although the variability of incorporation is noted. On average the level was about twice 
14 14 
that from D-[U- C)-glucose and three fold that from [U- C)-glycerol. The 
biochemically related amino acids; L-[U-I4C]-threonine, [U-I4C]-glycine and L-[U-I4C]-
serine all exhibited comparatively lower but similar levels of incorporation. The TCA 
cycle intermediate [2,3-14C]-succinate showed levels of incorporation similar to that of 
L-[U-I4C]-aspartate and L-[U-I4C]-glutamate-which feed into the TCA cycle. Finally, 
there is a very poor transfer of carbon atoms from acetate and citrate to fluoroacetate. 
The comparatively low incorporation levels of L-[U-14C]-aspartate (0.50%) and 
L-[U-I4C]-glutamate (0.43%) suggest that they are not direct intermediates in the 
biosynthesis of fluoroacetate. Aspartate is produced by transamination of oxaloacetate 
and can be further converted to asparagine (Fig. 2.11 ), reconverted to oxaloacetate or 
even converted to alanine by the action of aspartate-~-decaboxylase. 147 Alanine thus 
formed may enter the glycolytic or TCA pool via pyruvate 
Like aspartate, glutamate can derive from a minor branch point of the TCA 
cycle. It may be converted to proline or glutamine but can further be processed into the 
TCA cycle via a-ketoglutarate as shown in Fig. 2.11. Thus glutamate can enter the TCA 
pool and experience a similar fate to that of the carbon atoms of aspartate. This may 
explain the similar levels of incorporation observed between these two amino acids. A 
route to fluoroacetate via proline is unlikely as this would imply that the substrate for 
fluorination is metabolically related to glutamate and one would anticipate an 
appreciable level of incorporation here. 
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Fig. 2.11 A schematic of the TCA cvcle 
Succinate, an intermediate in the TCA cycle, is converted to fumarate by the 
action of succinate dehydrogenase and one of the routes for further metabolism of 
succinate is via the final stages of the TCA cycle. Its level of incorporation, given that 
only two of its four carbon atoms were labelled, is higher than aspartate and glutamate 
which were both universally labelled with 14C atoms. This raised the possibility that 
succinate may be a closer intermediate to the fluorination event than the aforementioned 
amino acids. It also implies that carbons 2 and 3 of glutamate and aspartate are solely 
processed, probably via succinate, while the other carbons suffer a certain degree of 
scrambling. In spite of these deductions, succinate appears less close to the substrate for 
fluorination than for example [U- 14C]-glycerol which is incorporated at a substantially 
higher level than [2,3-14-C]-succinate. It is not clear why citrate shows poor levels of 
incorporation as it is expected to have a similar profile to glutamate, aspartate and 
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succinate. However this may be due in no small part to the complexity of citrate 
transport across the mitochondrial membrane. 
Acetate was also poorly incorporated into fluoroacetate, one reason for this 
could be the heavy dilution it experiences in the metabolic pool. It is of interest to note 
that Eloff and Grobelaar121 observed no incorporation of label from [2-14C]-acetate into 
fluoroacetate produced in leaves of the D. cymosum plant. 
The metabolically related amino acids threonine, glycine and serine all exhibited 
similar levels of incorporation with threonine showing the highest incorporation of the 
three and was judged to warrant further investigation as a potential precursor. Threonine 
can be degraded to glycine and acetyl-CoA by the action of threonine dehydrogenase 
and a-amino-~-ketobutyrate lyase. 148 The glycine thus produced can be further 
metabolised to serine. The similar incorporation values of glycine (0.71 %, 0.84%) and 
serine (0.60%, 0.84%) suggests that they undergo very similar metabolic processing. 
Serine and glycine interconvert by the action of serine hydroxymethyl transferase and 
their close metabolic relationship inS. cattleya is discussed in detail in the Chapter 3, 
where stable isotope incorporations are explored. 
The high incorporation of carbon atoms from glucose is perhaps not surprising 
as it is readily utilised as a carbon source in cell metabolism. None-the-less an intimate 
role in fluorometabolite production cannot be dismissed. Glycerol also appears to label 
fluoroacetate very efficiently and this may implicate the glycolytic pool as the source of 
the direct precursor. However, again the high incorporation may be due to glycerol 
acting as the major carbon source, used in the defmed culture medium, on which the 
organism was grown. It is relevant however that during the course of this work Tamura 
et al., 130 have demonstrated the efficient incorporation of [2- 13C]-glycerol into 
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fluoroacetate produced by a mutant strain of S. cattleya, and this has been further 
confirmed by our studies with [2-13C]-glycerol. 
Glycolate incorporations were surprisingly high in these early 14C experiments, 
particularly with respect to subsequent stable isotope incorporations using [2-13C]-
glycolate. However in later 13C/ 2H labelled glycolate studies (Chapter 3), 
incorporations were very low but this was found to be due to changes in the resting cell 
density and precursor concentration (refer to Chapter 3, section 3.2.2, p79) 
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2.6 Conclusions 
It is difficult to draw definitive conclusions from these preliminary radiolabelling 
results. The radiochemical results can be summarised as illustrated in Fig. 2.12 with 
glycolysis as a central pathway. It became necessary to prepare the corresponding stable 
labelled compounds and assess them as potential precursors of fluoroacetate and 4-
fluorothreonine as it was judged at this stage that stable isotope investigations would 
provide much required regiospecific data and would test the radiochemical results. 
Fluoroacetate 
+ 
4-Fluorothreonine 
+ 
Fig. 2.12 A schematic representation of metabolite relationships in fluorometabolite 
biosynthesis in S cattleva 
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Biosvnthesis o.ffluoroacetate and 4-fluorothreonine in S. cattleya 
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Chapter 3 
3. Stable isotopic labelling studies on the biosynthesis of fluoroacetate 
and 4-fluorothreonine in S. cattleya 
On the basis of the radiochemical results discussed in Chapter 2, it was judged 
appropriate to carry out incorporation experiments with stable isotope labelled 
compounds, such that incorporations could be analysed directly by 19F-NMR. Analysis 
of deuterium incorporation into fluoroacetate and 4-fluorothreonine was explored 
initially to assess the level of labelling in certain positions of the fluorometabolites. The 
presence of carbon-13, one and two bonds away from the fluorine-19 nucleus is readily 
identified by the magnitude of the J!3C-F coupling constant. Examples are explored in 
this thesis. The focus of the following stable isotope studies was to identify the relevant 
pathway (TCA pool, glycolytic pool etc.,) accommodating the fluorination event. 
Suspension culture feeding experiments were all conducted at Durham University and 
resting cell feeding studies were carried out at Queen's University in Belfast. 
3.1 Investigation ofS. cattleya cells supplemented with ~~~~Q 
The objective of this experiment was to determine if protons derived from 2H20 are 
readily exchanged into fluoroacetate and 4-fluorothreonine during their biosynthesis. 
The experiment was conducted in batch and in resting cell suspensions of S. cattleya. 
Batch cells were incubated with 2H20 administered at a level of 10%. Three volumes of 
2H20 were pulse fed to the cells on the 6th, 8th and 1Oth days and the cells were 
harvested after 28 days. Resting cells were incubated with 2H20/ H20 (50:50) at 28°C 
for 10, 24, 48, and 96h, and the supernatant from each experiment was centrifuged, 
freeze-dried and analysed by GC-MS. 
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3.1.1 Isotope incorporations after supplementing suspension cultures with 
10% 1H;z0 
High field 19F eH}-NMR analysis of the fluorometabolites after growing S. cattleya 
cells in 2H20 (10%) clearly indicated the incorporation of one and two deuterium atoms 
into the fluoromethyl carbons of both fluorometabolites (Fig. 3.1). Fig. 3.1 highlights 
the P and 2P shifted signals (-218.7ppm and -219.3ppm) corresponding to [2-2H]-
fluoroacetate and [2,2-2H2]-fluoroacetate respectively. 
The four signals, shifted progressively to lower frequency from the parent 
4-fluorothreonine signal, can be assigned to the labelled species shown as a result of y, 
p, p+y and 2P shifts. The closest upfield shifted signal to that for unlabelled 
4-fluorothreonine is assigned to (93) where deuterium is located 3 bonds away from 
fluorine atom and is assigned as a y-shift (-0.30ppm). It is perhaps interesting to note 
that the observed y-shift ( -0.30ppm) 1s half the value of a 
P-shift (0.60ppm). Unfortunately the peak multiplicities cannot be clearly assigned due 
to the decoupling conditions under which the NMR spectrum was acquired. The second 
peak (expected triplet) at 8 = -233.3ppm is attributed to a P-shift (0.6ppm) 
corresponding to single deuterium label at C-4 (94). Similarly two deuterium atoms 
geminal to the fluorine atom of 4-fluorothreonine generate a peak (pentet) shifted by 
-1.2ppm. The results appear to suggest that under batch cell conditions, protons from 
water are assimilated into fluoroacetate and sites C-3 and C-4 of 4-fluorothreonine. This 
experiment did not allow the detection of deuterium incorporation at C-2 of 
4-fluorothreonine as the value of the 8-shift is too small. The results from GC-MS 
analysis (in Belfast), did however reveal significant incorporation into this site (see 
Table 3.2). 
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Fig. 3.1 12EeH}-NMR spectrum of the supernatant from resting cells of S cattleva 
incubated with 10% 2H20 after 28 days 
3.1.2 Results of the incubation experiment with resting cells of S. cattleva 
supplemented with ~H~ 
The GC-MS data in Tables 3.1 and 3.2 clearly demonstrate that deuterium atoms are 
incorporated into both fluoroacetate and 4-fluorothreonine at all incubation times 
studied. After lOh, the incorporation of both one (22.9%) and two (6.0%) deuterium 
atoms into fluoroacetate were detected. The level of deuterium exchange at the 
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fluoromethyl carbon offluoroacetate appears to increase with incubation time reaching a 
maximum of36% single label after 96h. 
Table 3.1 GC-MS incorporation data of 2H into fluoroacetate by resting cells of 
S. cattleva supplemented with 2H201 H20 (50/ 50) 
Incubation % label 
time 
Treatment (hrs) None Single Double 
2H20 10 71.1 22.9 6.0 
2H20 24 63.1 28.0 8.9 
2H20 48 55.7 32.8 11.5 
2H20 96 50.8 35.5 13.8 
(as determined in Belfast) 
A high level of exchange is clearly evident for 4-fluorothreonine with over 50% 
being labelled after 96h. Significant amounts of single (29.5%), double (12.0%) and 
triple (3.0%) labelled 4-fluorothreonine are apparent only after IOhrs (Table 3.2). The 
labelling pattern observed for positions 1 and 2 of fluoroacetate is very similar to that 
for positions 3 and 4 of 4-fluorothreonine. 19F-NMR results of the resting cell 
experiments are consistent with those obtained under batch culture conditions. It is 
satisfying that the proportions of single and double label (19F { 1H}-NMR, Fig. 3.1) into 
positions 2, 3 and 4 from the batch cell experiment closely parallel those obtained by 
GC-MS. It is obvious from Fig. 3.1 and Table 3.2 that the proportion of single label 
[(93) + (94)] in ion 236 is twice that for double label. Populations of triple labelled 4-
fluorothreonine (-4.0%) can be detected by GC-MS but are not evident in the 
19F {1H}-NMR highlighting this limitation. A significant amount of single label (-8.0%) 
in ion 218 (positions 1 and 2 of 4-fluorothreonine) is also observed indicating that the 
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deuterium label predominates in position 2 of 4-fl.uorothreonine since no exchangeable 
protons are present on the neighbouring carboxylate carbon. 
Table 3.2 GC-MS incorporation data of 2H label into selected positions of 
4-fl.uorothreonine by resting cells of S. cattleva supplemented with 2H2QLH20 (50/ 50) 
Treatment Incubation % label in ion %label in ion 236 (Positions 2,3 and 4) 
time 218 (Positions 1 
and2) 
(hrs) None Single None Single Double Triple 
2H20 10 92.0 8.0 55.6 29.5 12.0 3.0 
2H20 24 91.6 8.4 48.2 32.7 15.1 4.0 
2H20 48 91.6 8.4 44.5 35.2 16.0 4.2 
2H20 96 90.5 9.5 42.3 34.9 18.1 4.7 
Control 
incubation of 4- 168 100 0 99.4 0.6 <0.5 <0.5 
FTwith 2H20 
(as determined in Belfast) 
3.1.3 Conclusion 
Deuterium is exchanged into the fluoromethyl position of fl.uoroacetate and three 
different sites of 4-fl.uorothreonine from 2H20, although the process of exchange into 
the various positions can only be speculated. One plausible explanation for the presence 
of deuterium in position C-3 of 4-fl.uorothreonine (93) (X to the fluorine moiety) is the 
reduction of a 3-keto analogue of 4-fl.uorothreonine by NAD2H. Accumulation of a 
labelled pool of such a co-factor is not unlikely (Fig. 3.2). NAD(P)+f NAD(P)H are 
co factors for a large number of biological redox reactions. When a substrate is oxidised, 
hydride is transferred from the substrate to C-4 of the nicotinamide ring of NAD(P)+ 
(97) thus producing NADP(H) (Fig. 3.2). 
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+ R=H, NAD 
(97) 
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II 
R= ~P-o-, NADP+ 
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Fig. 3.2 Founation ofNAD~H 
X)l l __ j NH2 
N 
I 
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(98) 
[3-2H]-4-Fluorothreonine (93) may then be generated as a result ofNAD2H acting on 
the P-carbonyl group, reducing it to the alcohol (Fig. 3.3). 
NAD2H Reduction 
0 "'\ 0 (\N ~ OH 
Exchange ~ 
F 0 ) 
Transamination 
(99) 
Fig. 3.3 
DOH 0 DNOH 
F DNH2 
(100) 
The C-2 of 4-fluorothreonine is most probably labelled with deuterium arising from the 
transamination of the a-carbonyl group (Fig. 3.3). Thus transamination at C-2, NAD2H 
reduction at C-3 and deuterium exchange at C-4 of (99) may account for the observed 
labelling pattern. 
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3.2 Experiments to determine the relative efficacy of glycine and glycolate as 
precursors to fluoroacetate and 4-fluorothreonine in S. cattle.ya 
Radiolabelled glycolate exhibited the highest incorporation of carbon-14 into 
fluoroacetate. However, this finding is not consistent with the recent work carried out by 
Tamura et al., 130 who demonstrated ·a relatively low incorporation of [2-14C]-glycolate 
and [1,2-13C2]-glycolate into fluoroacetate. It became important at the time of this 
publication to determine whether the disparity is due to differences in cell density and 
precursor concentration. Accordingly [2-13C]-glycolate was incubated at two different 
concentrations under two different conditions of resting cell density. Controls using [2-
13C]-glycine were employed in these experiments. 
3.2.1 Synthesis of [2..1JC]-Glycolate and [1.2..1JC2]-Glycolate130 
Glycolate was prepared from 2-bromoacetic acid by treatment with aq KOH. The 
reaction was heated at l20°C in a sealed tube for 3h. The resulting acidified mixture was 
loaded onto an Extrelute column and glycolic acid was eluted using diethylether as the 
eluant. The free glycolic acid was neutralised and freeze dried to give sodium glycolate 
in 75% yield. An identical protocol was followed for the preparation of 
[2-BC]-glycolate (102) and [1,2-BC2]-glycolate (104) using [2-BC]-bromoacetic acid 
(101) and [1,2-BC2]-bromoacetic acid (103) respectively (Scheme 2 and 3). However 
the yields of [2-13C]-glycolate and [1 ,2-13C2]-glycolate were comparatively poor, 40% 
and 27% respectively. The presence of carbon-13 isotopes were obvious by 1H-NMR 
analysis. For example, in the 1H-NMR spectrum for [1,2-13C2]-glycolate, the methylene 
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signal appears as a doublet of doublets (1JH_ 13c = 143.24Hz; 2JH_ 13c_ 13c = 4.02Hz., Fig. 
3.4). 
0 0 
~OH ~OH 
Br OH 
(101) (102) 
Scheme 2 (i) aq. KOH, sealed tube/ l20°C/ 3h 
0 0 
?oH ~OH 
Br OH 
(103) (104) 
Scheme 3 (i) aq. KOH, sealed tube/ l20°C/ 3h 
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Fig. 3.4 1H-NMR spectrum of (1.2-11C2]-glycolate 
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3.2.2 Results of the incorporation of varying concentrations of [2-13C)-glycolate 
and [2-13C]-glycine at differing resting cell densities 
The synthesised materials were sent to Belfast for feeding studies and GC-MS analysis. 
It is apparent from Tables 3.3 and 3.4 that at a cell density of 3g/ 18ml and 2mM 
precursor, [2- 13C]-glycolate gives rise to both single (5.4%) and double (8.0%) labelled 
fluoroacetate whereas 13C atoms from [2- 13C]-glycine produced lower levels of single 
(2.8%) and double (1.1 %) labelled fluoroacetate. It is noteworthy that similar cell 
density (3g) and precursor concentration (2mM) ratios, used in the radiochemical 
investigations, resulted in a relatively high incorporation of label from [U- 14C]-glycolate 
into fluoroacetate (1.75%- 4.05%), a level which was approximately 2- 5 times greater 
than that from [U-14C]-glycine (0.71% - 0.84%) (refer to Chapter 2). However 
[2- 13C]-glycine (1 OmM) incubated at a cell density of 0. 75g/ 20ml shows a significantly 
higher level of incorporation (approx. 50%) of 13C into both fluorometabolites 
compared with [2- 13C]-glycolate (approx. 12%). A parallel situation was found for 
4-fluorothreonine. 
The graph (Graph 3.1) shows the relationship between precursor concentration 
(glycine and glycolate) and cell mass versus% incorporation of 13C into fluoroacetate. It 
can be seen that, by increasing the precursor concentration per unit mass of cells, there 
is a linear increase in the % incorporation of [2-13C]-glycine whereas the incorporation 
of [2- 13C]-glycolate appears to be independent of such precursor concentration and cell 
mass variations. It is interesting to note that below a value of 3 mMI g cells, the 
incorporation of [2-13C]-glycolate and indeed [U-14C]-glycolate is higher than the 
corresponding labelled glycines, however incubation at values above 3 mM/g cells 
results in a greater incorporation of [2-13C]-glycine. 
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Table 3.3 GC-MS incorporation data of 11C into fluoroacetate after 48h incubation of 
resting cells [2-11C]-glycine and [2-11C]-glycolate 
(as determined in Belfast) 
Treatment 
0.75y cells/ 10mM 
[2- 3C]-glycine 
0.7~~ cells/ 10mM 
[2- C)-glycolate 
0.75S cells/ 2mM 
[2-1 C)-glycine 
0. 75g cells/ 2mM 
[2- 13C]-glycolate 
3g cells/ 10mM 
[2-13C]-glycine 
3 g cells/ 1 OmM 
[2- 13C]-glycolate 
3g cells/ 2mM 
[2- 13C]-glycine 
3y
3
cells/ 2mM 
[2- C)-glycolate 
c 
.!:: 
-;;; 
.... 
0 
c.. 
0 
u 
..5 
~ 
0 2 4 
None 
50.5 
88.3 
85.7 
82.5 
81.2 
87.5 
96.2 
86.6 
6 8 
mM/ g cell 
% label 
Double Single 
Position I Position 2 
38.2 8.5 2.8 
9.2 2.5 <0.5 
8.9 5.4 <0.5 
13.1 3.8 0.6 
8.6 8.5 1.6 
8.4 3.2 0.8 
1.0 1.9 0.9 
8.0 4.5 0.9 
--D- [2-1 3q.GL YCINE 
········<> ... •··•· [2-1 3q-GL YCOLA TE 
10 12 14 
Graph 3.1 
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Table 3.4 GC-MS incorporation data ofJJ.C into positions 2.3 and 4 of 
4-fluorothreonine after 48h incubation of resting cells with [2-JJ.CJ-glycine and 
G=JJ.C]-glvcolate 
% Incorporation into positions 2,3 and 4 (Ion 236) 
Treatment None Single Double Triple 
0.75~_cells/ IOmM 
[2- "C)-glycine 50.0 14.7 29.5 5.8 
0.75~ cells/ IOmM 
[2-l.>C]-glycolate 89.3 2.8 7.9 <0.5 
0.75B cells/ 2mM 
[2-1 C)-glycine 86.8 6.1 7.1 <0.5 
0.75g cells/ 2mM 
[2- 13C]-glycolate 85.5 3-.3 11.2 <0.5 
3g cells/ 10mM 
[2- 13C]-glycine 85.4 6.6 8.0 <0.5 
3g cells/ IOmM 
90.1 2.5 7.3 <0.5 I' [2- "C)-glycolate 
3g cells/ 2mM 
[2- 13C]-glycine 96.3 2.1 1.6 <0.5 
3~3cells/ 2mM [2- C)-glycolate 90.9 2.5 6.7 <0.5 
(as determined in Belfast) 
Unlike glycolate, glycine incorporations are particularly sensitive to cell density, 
possibly due to the rapid utilisation of glycine as a carbon source by the resting cells. A 
low precursor (glycine) concentration and high resting cell mass is consistent with the 
rapid metabolism of glycine such that the availability of glycine for incorporation into 
the fluorometabolites is short-lived. 
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3.2.3 Study to investigate the fate of label from [1.2-13C2]-glycolate. 
2 2 
.Q.=-H]-glycolate and [2.2--H2]-glycolate 
3.2.3.1 Synthesis of [2-1H]-glycolate and [2.2)H2]-glycolate 
The incorporation of a single deuterium atom from [2-2H]- and [2,2-2H2]-glycolate into 
the fluorometabolites produced by S. cattleya cells was investigated. [2-2H]-Glycolate 
was synthesised by sodium borodeuteride (NaBD4) reduction of glyoxylic acid. 
Glyoxylic acid was found to be partially stable to reduction with NaBD4 generating 
eHJ-glycolate with incomplete conversion (-50%). The resulting basic mixture did not 
favour complete reduction to the alcohol and it was rationalised that this may be due to 
the formation of a stable hydrate of glyoxylic acid. Consistent with this, acidification 
(pH 2) of the partially reduced mixture reconverted the base stable hydrate of glyoxylic 
acid to the aldehyde, which was then reduced with NaBD4 resulting in its complete 
reduction to the alcohol, thus achieving up to 100% conversion. (Scheme 4). The 
deuterium labelled glycolate is readily identified by 13C-NMR. The signal 
corresponding to C-2, of the hydrate of glyoxylic acid, appears as a singlet at 8 = 
89.5ppm, but after reduction, it becomes a triplet due to 2H- 13C coupling at 8 = 
63.8ppm. 
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0 H00H 
0 
(105) 
0 
HO. Jl Y 'OH 
OH 
Stable in base 
Scheme 4 
0 D00H 
0 
50% (106) 
pH=2 
H000H 
OH 
50% (107) 
Glycolate was synthesised using an alternative route by treatment of bromoacetic acid, 
with a sat. aqueous suspension of calcium carbonate. The filtered mixture was stored at 
-1 ooc for 24h to yield the calcium salt of glycolic acid. 149 In order to introduce both 
2 
deuterium atoms, [2,2- H2]-bromoacetic acid (109) was prepared from eH3]-acetic acid 
(108). Treatment of (109) with calcium carbonate afforded a white calcium salt of 
2 [2,2- H
2
]-glycolic acid (110) (Scheme 5). 
0 
D_ Jl 
n->( 'OH 
D 
(108) 
Scheme 5 
0 B0 OH 
D 
ii 
D 
(109) 
(i) Trifluoroacetic anhydride, phosphorus, Br2/ 60°C/ 4h 
(ii) sat. CaC03/ 90°C/ 60h 
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(110) 
3.2.3.2 Incorporation of [2-1H)-glycolate. [2.2)H1)-glycolate and [1.2-u.C11= 
glycolate into the fluorometabolites 
[2-2H]- And [2,2-2H2]-glycolate were incubated with suspension cultures of S. cattleya 
at a final concentration of 1.29mM in each case. 19F-NMR spectra of lyophilised batch 
cell extracts of these feeding experiments showed the presence of a shifted signal ( dt) at 
the base of the fluoroacetate peak indicating that one deuterium was incorporated into 
fluoroacetate at a low level (approx. <2%) (Fig. 3.5(a)). 
0 D00H 
F 
(b) 
19f {'H)- NMR 
(a) -21S'r -2\S 4 -215 0 
Fig. 3.5 (a) 200MHz 12F-NMR spectrum and (b) 500 MHz 12E.{1H}-NMR 
spectrum of S. cattleva resting cell supernatants from (2_2)H2)-glycolate feeding 
experiment. 
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The triplet in the corresponding 19F eH}-NMR (Fig. 3.5(b)) unambiguously 
demonstrates the presence of a single deuterium, albeit with a low incorporation, into 
fluoroacetate. The GC-MS analysis of this sample further reinforced this conclusion 
(Table 3.5). A similar incorporation level of deuterium atoms into 4-fluorothreonine is 
also observed. In general however the resting cell experiments showed a very low level 
of incorporation of isotopes from both [2-2H2]-glycolate and [2,2-2H2]-glycolate. 
Furthermore the incorporation oflabel was not significantly affected by the length of the 
incubation time. Single and double label were present to an extent of <2.0% and <0.5% 
(Table 3.5 and 3.6). 
Table 3.5 GC-MS incorporation data of [2)H]-glycolate. [2.2)H2]-glycolate and 
[1.2-.uCz]-glycolate into fluoroacetate 
Incubation time 
Precursor (hrs) 
[1,2- 13C2]-glycine 24 
(control) 48 
[2-2H]-glycolate 24 
48 
[2,2-2H2]-glyco1ate 24 
48 
I' [1,2- "'C2]-glycolate 24 
48 
(as determmed in Belfast) 
0 
nVoH 
OH 
(110) 
Scheme 6 
S. cattleya 
None 
48.3 
52.1 
100 
100 
100 
98.9 
94.1 
86.2 
85 
% 
Double 
41.0 
33.7 
<0.5 
<0.5 
<0.5 
<0.5 
2.5 
8.3 
(90) 
label 
+ 
Single 
Position I Position 2 
6.6 4.1 
8.1 6.1 
- <0.2 
- <0.2 
- <0.2 
- 1.1 
<0.5 3.4 
2.7 2.7 
OH 0 DNOH 
F NH2 
(94) 
Table 3.6 GC-MS incorporation data of [2-2HJ-glycolate. (2.2-2H2J-glycolate and 
U2=11C2J-glycolate into selected positions of 4-fluorothreonine 
Precursor Incubation %label in ion 218 %label in ion 236 (Positions 2,3 
time (Positions 1 and 2) and 4) 
(hrs) None Single Double None Single Double Triple 
[ 1 ,2-13C2]-glycine 24 74.3 7.4 18.3 43.8 17.6 29.4 9.2 
(control) 48 78.8 5.8 15.4 46.4 19.0 29.6 7.0 
[2-2H]-glycolate 24 100 <1.0 <1.0 100 <1.0 <1.0 <1.0 
48 100 <1.0 <1.0 100 <1.0 <1.0 <1.0 
[2,2-2H2]-glycolate 24 100 <1.0 <1.0 100 <1.0 <1.0 <1.0 
48 100 <1.0 <1.0 98.7 1.3 <1.0 <1.0 
[1,2- 13C2]-glycolate 24 100 <0.5 <0.5 91.4 3.6 5.0 <0.5 
48 100 <0.5 <0.5 87.5 5.1 7.4 <0.5 
(as determined in Belfast) 
The results indicate comparatively low levels of incorporation of label into 
fluoroacetate from [1 ,2-13C2]-glycolate after both 24 and 48h incubation periods (Tables 
3.5 and 3.6) where labelled fluoroacetate was present at levels of 5.9% and 13.8%. The 
proportion of single label (2. 7%) into positions 1 and 2 of fluoroacetate was very similar 
after 48h and it is perhaps interesting to note that the amount of double labelled 
fluoroacetate increases from 2.5% after 24h to 8.3% after 48h. However no significant 
incorporation was observed in positions 1 and 2 of 4-fluorothreonine demonstrating that 
the carbon atoms of glycolate are not direct precursors to C-1 and C-2 of 
4-fluorothreonine. These results are illustrated in the 19F { 1H}-NMR spectrum (Fig. 3.6) 
of the corresponding feeding experiments which clearly show the incorporation of a 
single 13C label into the terminal carbon atoms of both fluorometabolites. The observed 
labelling patterns can be rationalised if [1,2-13C2]-glycolate undergoes cleavage 
followed by incorporation of one of the carbon fragments. Furthermore it is evident that 
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the incorporation of label from [I ,2- 13C2]-glycolate into both flurometabolites proved to 
be significantly lower than that for [I ,2- 13C2]-glycine. 
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Fig. 3.6 12E{.1H}-NMR spectrum of the sup~matant from resting cells of S. cattleva 
incubated with [1.2-llC2]-glycolate 
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3.2.4 Conclusion 
Due to the low levels of incorporation of label from stable isotope labelled glycolates it 
is concluded that glycolate is not a direct precursor to fluoroacetate or 
4-fluorothreonine. The low level incorporation of a single deuterium atom from 
[2,2-2H2]-glycolate may have been a direct incorporation, however the experiment does 
not rule out the reintroduction of label from an enriched pool of NAD(P)2H 
co-factor. Differences in the% incorporation from radio e4C) and stable (13C) labelled 
glycolate relative to glycine are in fact due to changes in the ratio of resting cell density 
and precursor concentration. Furthermore it is important to note that investigations 
carried out in Belfast have shown that a substantial amount of exogenous glycolate is 
present in the supernatant after incubation of resting cells with isotopically labelled 
glycolate for 48 hours indicating either a low rate of uptake or slow metabolism of 
glycolate. Indeed Tamura et al., 130 did not consider intact cells to be permeable to 
glycolate and used benzyl alcohol to mediate permeability of S. cattleya cells prior to 
the addition of glycolate. 
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3.3 Metabolism of glycine during the biosynthesis of fluoroacetate and 
4-fluorothreonine 
The high incorporation of label from [1,213C2]-glycine into the component carbon atoms 
of both fluorometabolites warranted a more detailed investigation of its role in the 
biosynthetic pathway. The objective of this investigation was to determine the % 
incorporation of label from various stable labelled glycines incubated at a final 
concentration of 1 OmM with resting cells of S. cattleya. The incorporation of the 13C 
and 2H atoms into the fluorometabolites was examined using GC-MS after 24h and 48h, 
19 
and F-NMR after 48h. 
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Fig. 3.7 12E.{1H}-NMR spectrum of the supernatant from resting cells of S. cattleva 
incubated with [ 1-11C]-glycine 
From the GC-MS data presented in Tables 3.7 and 3.8 it would appear that cells 
of S. cattleya supplemented with [1-13C]-glycine showed no appreciable incorporation 
of label into either positions of fluoroacetate or position 3 and 4 of 
4- fluorothreonine. This is reinforced by the 19F { 1H}-NMR of the supernatant after the 
[1-13C]-glycine incubation experiment as no 13C satellites are associated with the 
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fluoroacetate and 4-fluorothreonine peaks (Fig. 3.7). However a low but significant 
incorporation (-2%) of single label from [1-13C]-glycine was evident in positions 1 and 
2 of 4-fluorothreonine by GC-MS analysis. 
In contrast to [1-13C]-glycine, incubation of [1 ,2-13C2]-glycine with the resting 
cells of S. cattleya showed significantly higher levels of incorporation into fluoroacetate 
(>50%) and positions 2, 3 and 4 of 4-fluorothreonine (>50%). Again, a very similar 
labelling pattern is observed for both fluorometabolites, particularly positions 1 and 2 of 
fluoroacetate and positions 3 and 4 of 4-fluorothreonine (Tables 3.7 and 3.8). 
Table 3.7 GC-MS incorporation data of.!lC and 2H labelled glycines into fluoroacetate 
Incubation time % label 
Precursor (hrs) None Double Single 
Position 1 Position 2 
[ 1,2-13C2]-glycine 24 48.3 41.0 6.6 4.1 
48 52.1 33.7 8.1 6.1 
[1-13C]-glycine 24 97.7 <0.5 2.0 <2.0 
48 96.0 <0.5 1.3 2.4 
[2- 13C]-glycine 24 49.2 39.2 5.8 4.4 
48 54.7 31.9 8.3 5.1 
eH2]-glycine 24 93.9 0.6 - 6.0 
48 95.8 <0.5 - 3.8 
(as determined in Belfast) 
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Table 3.8 GC-MS incorporation data of11C and 2H labelled glycines into selected 
positions of 4-fluorothreonine 
·Precursor Incubation %label in ion 218 %label in ion 236 (Positions 2,3 
time (Positions 1 and 2) and 4) 
(hrs) None Single Double None Single Double Triple 
[ 1 ,2-13C2]-glycine 24 74.3 7.4 18.3 43.8 17.6 29.4 9.2 
48 74.8 5.8 15.4 46.4 19.0 29.6 7.0 
[ 1-13C]-glycine 24 92.1 7.9 <1.0 96.4 3.0 <1.0 <1.0 
48 94.0 6.0 <1.0 95.9 3.5 <1.0 <1.0 
[2- 13C]-glycine 24 75.1 13.2 11.7 44.7 17.7 28.4 9.2 
48 79.6 10.7 9.7 48.2 18.8 26.3 6.7 
eH2]-glycine 24 100 <1.0 <1.0 92.9 6.0 1.1 <1.0 
48 100 <1.0 <1.0 93.8 5.2 1.0 <1.0 
(as determined in Belfast) 
One striking feature to emerge was that cells supplemented with 
[1,2- 13C2]-glycine generated labelling patterns, in both fluorometabolites, that were 
almost identical to that observed for [2-13C]-glycine. This indicated that only C-2 of 
' 
glycine is contributing any label. 19F eH}-NMR Analysis of the supernatants from 
resting cell experiments incubated with [1,2-13C2]-glycine (Scheme 7 and Fig. 3.7) and 
[2-13C]-glycine (Scheme 8 and Fig. 3.8) allowed an immediate assessment of the 
incorporation of 13C label into positions 1 and 2 of fluoroacetate and positions 3 and 4 
of 4-fluorothreonine which complemented the GC-MS data. It is noteworthy that both 
one and two 13C atoms are incorporated from [1,2-13C2]-glycine and [2-13C]-glycine into 
positions 1 and 2 of 4-fluorothreonine whereas only a single label is detected in these 
positions from [1-13C]-glycine. 
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Fig. 3.8 12U 1H}-NMR spectrum ofthe supernatant from resting cells of S cattleya 
incubated with [1.2-.UC2]-glycine 
k ~ i ~I ~~ E ~I ~ I. I r J' I ! 
! 
Fig. 3.9 12U 1H}-NMR spectrum of the supernatant from resting cells of S cattleva 
incubated with [2-.UC]-glycine 
0 S. cattleya 0 OH 0 !oH --'--...___ !oH + HoH / 
NH F F NH 
2 2 
(111) (112) (113) 
Scheme 7 
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0 S. cattleya 0 OH 0 
rOH ~OH HoH '- + > / 
NH F F NH 
2 2 
(114) (112) (113) 
Scheme 8 
The 19F eH}-NMR signals for each of the two fluorinated metabolites possess 
similar multiplicities indicating that the incorporations into fluoroacetate mirror those 
into C-3 and C-4 of 4-fluorothreonine. A closer inspection of the insets from Figures 3.8 
and 3.9 show that in each case the parent (unlabelled) signal (singlet) has a predominant 
doublet of doublets (160 Hz, 18 Hz, a+ ~-shift= 0.09ppm) associated with it due to 
populations (-40%) of fluoroacetate and 4-fluorothreonine with an intact 19F- 13C- 13C 
combination. The small increase in intensity of the left hand arms of the doublet of 
doublets (del) in each case is due to populations (-5%) with a 19F-13C-12C combination 
(a shift= 0.07ppm, 165Hz). The right hand arm of a doublet (18Hz, ~-shift= 0.02 ppm) 
at the base of the dominant parent peaks for fluoroacetate and 4-fluorothreonine is also 
apparent and are due to molecules (-7%) with a 19F-12C- 13C combination. Clearly then 
the GC-MS and 19F-NMR data provide convincing evidence of the similarity of 
labelling patterns from [1,2-13C2]-glycine and [2-13C]-glycine indicating that the high 
level double incorporation (-40%) in the [1,2-13C2]-glycine experiment is not due to the 
incorporation of glycine as an intact two carbon unit but rather that C-2 of glycine is 
recombining during the biosynthesis. The high level of recombination of C-2 atoms of 
[1 ,2-13C2]-glycine and the lack of retention of C-1 of glycine suggests an efficient 
conversion of glycine to serine. 150 An analogous pathway has been shown to operate in 
the bacterium D. glycinophilus. 151 
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A mechanistic interpretation of the metabolic conversion of glycine to serine 
catalysed by serine hydroxymethyl transferase, is shown in Fig. 3.10 and Fig. 3.11. The 
former illustrates the transfer of a methylene group to the tetrahydrofolate cofactor 
generating 5,10-methylene tetrahydrofolate (THFA) (119). 152 
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The metabolic conversion of glycine to serine essentially requires two molecules 
of glycine for every molecule of serine produced. Fig. 3.11 shows the transfer of the C-2 
atom from a pyridoxal bound glycine molecule (122a) to the N-hydroxymethyl 
intermediate (119b) commonly derived from the reaction between a water molecule and 
the methylene group of methylene tetrahydrofolate (119a). The Schiff base (123) is then 
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hydrolysed to produce serine (124) with the regeneration of pyridoxal-5-phosphate 
(121) 
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Fig. 3.11 
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The recombination process involves the attack of 13C-labelled methylene 
tetrahydrofolate (126) to [2- 13C]-glycine (101) which is already bound to pyridoxal-5-
phosphate (125) to produce a [2,3- 13C)-serine-pyridoxal-5-phosphate complex (127). 
Hydrolysis of this complex gives [2,3-13C)-serine (128) as depicted in Fig. 3.12. The 
13C-13C bond of serine is then presumably incorporated intact into fluoroacetate and 
positions 3 and 4 of 4-fluorothreonine via an appropriate intermediate. 
(US) 
HzO 
(128) (Ul) 
(U7) 
Fig 3.12 The recombination of.UC atoms derived from [2-llC]-glycine during 
the course ofbiosynthesis offluoroacetate and 
4-fluorothreonine inS. cattleva 
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It is interesting to note that the incubation of [2-2H2]-glycine (129) resulted in an 
appreciable level of single isotope incorporation into both fluorometabolites (Tables 3.7 
and 3.8) accompanied by a small but measurable level of double label into fluoroacetate 
and 4-fluorothreonine. These incorporations are observed in the 19F { 1H}-NMR 
spectrum ofthe resultant supernatant (Fig. 3.13). 
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Fig. 3.13 12EeH}-NMR spectrum of the supernatant from resting cells of S. cattleya 
incubated with [2-2H2]-glycine 
The appreciably lower incorporation into the fluorometabolites from 
[2-2H2]-glycine compared to [2-13C]-glycine (7% versus 50% respectively) suggests a 
significant level of hydrogen exchange during the biosynthesis of the fluorometabolites. 
This is consistent with the earlier complementary experiment using 2H20 which 
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demonstrated a high level of deuterium labelling into both of the fluorometabolites. The 
low incorporation of deuterium from [2-2H2]-glycine is consistent with its conversion to 
L-serine as discussed above. The fact that some molecules of fluoroacetate retain both a. 
deuterium atoms from [2-2H2]-glycine indicates that there is no obligatory oxidation 
occurring at C-2, consistent with the mechanism outlined in Figures 3.11 and 3.12. 
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3.4 Incorporation of (3uC]-serine into the fluorometabolites 
If glycine is converted to senne during fluorometabolite biosynthesis in 
S. cattleya, a comparatively high incorporation of serine into both fluoroacetate and 
4-fluorothreonine is anticipated. With this in mind, resting cells of S. cattleya were 
incubated with [3-13C]-serine at a final concentration of 1 OmM. The resultant levels of 
incorporation into fluoroacetate and 4-fluorothreonine are given in Tables 3.9 and 3.10. 
To allow a relative comparison of the labelling results from the feeding experiments, 
this study was carried out simultaneously with a [1 ,2-13C2]-glycine control feeding 
experiment. 
Table 3.9 GC-MS incorporation data of [3-.UC]-serine into fluoroacetate produced bv 
resting cells of S. cattleva 
Incubation time % label 
Precursor (hrs) None Double Single 
Position 1 Position 2 
[I ,2-13 C2]-glycine 24 52.9 35.2 7.3 4.6 
48 50.7 30.4 9.6 9.3 
[3-13C]-serine 24 71.5 2.7 6.3 I9.4 
48 77.6 1.8 5.5 14.1 
(as determined in Belfast) 
Table 3.10 GC-MS incorporation data of [3-.UC]-serine into selected positions of 
4-fluorothreonine produced by S. cattleva 
Precursor Incubation %label in ion 218 %label in ion 236 (Positions 2,3 
time (Positions I and 2) and 4) 
(hrs) None Single Double None Single Double Triple 
[I ,2-13C2]-glycine 24 88.6 4.0 7.4 56.5 13.0 27.9 2.6 
48 91.0 3.1 5.9 52.8 I6.6 28.9 1.7 
[3- 13C]-serine 24 82.7 14.9 2.4 62.5 31.9 5.6 <1.0 
48 86.4 I2.0 1.6 71.0 25.3 3.7 <1.0 
(as determzned zn Belfast) 
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The GC-MS data (Table 3.9/ 3.10) clearly show a significant incorporation from 
[3-13C]-serine into the fluorometabolites, as anticipated. The incorporation of label from 
[3-13C]-serine is mainly into position 2 of fluoroacetate (-19%) with an appreciable 
level in position 1 ( -6% ). A significant proportion of label is also apparent in positions 
2,3 and 4 of 4-fluorothreonine (ion 236), positions which cannot be uniquely evaluated 
by GC-MS. However inspection of the 19F eH}-NMR spectrum of the supernatant from 
the [3-13C]-serine experiment reveals an identical labelling pattern for fluoroacetate and 
positions 3 and 4 of 4-fluorothreonine (Fig. 3.14 ). 
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Fig. 3.14 ~F-{1H}-NMR spectrum ofthe S. cattleva supernatant from the [3-.UC]-serine 
incubation experiment 
Fig. 3.15 illustrates the presence of doublets (165Hz, a-shift= 0.07ppm) associated 
with each parent peak (singlet) dominant for both fluoroacetate and 4-fluorothreonine, 
indicating populations of molecules with a 19F-13C-12C combination. We deduce 
~~ ~ 
therefore that most of the 13C label in the ion 237 (M+l) exists in positions 3 and 4 of 
4-fl.uorothreonine rather than in position 2. Again the striking feature about the spectrum 
(Fig. 3.15) is the similar labelling pattern for fluoroacetate and 4-fluorothreonine 
suggesting a single fluorinating enzyme operating in S. cattleya. 
v S. cattleya 
0 OH 0 (oH HoB OH ~ + 
NH F . F NH 
2 2 
(130) (131) (132) 
Scheme IQ 
There is an appreciable level of double labelled fluoroacetate (2. 7%) and double 
label into positions 2,3 and 4 of 4-fl.uorothreonine (5.6%) from [3- 13C]-serine. This can 
be accounted for by the recombination via [2-13C]-glycine to produce [2,3-13C2]-serine 
in vivo. The presence of single label in positions 1 and 2 of 4-fl.uorothreonine from 
incubation experiments with [3-13C]-serine is consistent with the idea of a three carbon 
symmetrical intermediate as discussed in section 3.6. In view of the GC-MS 
incorporation and 19F-NMR data, it is concluded that C-3 of serine contributes C-2 of 
fluoroacetate and C-4 of 4-fl.uorothreonine, results which reinforce the hypothesis that 
glycine is converted to serine prior to incorporation into the fl.uorometabolites. 150 
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• 13 13 13 3.5 Incorporation oflabel from [1--C]-, [2--C]- and [3--C]-pyruvates. 
Serine is closely related to pyruvate in metabolism. It is well known that the conversion 
of L-serine into pyruvate is catalysed by the pyridoxal phosphate-dependent enzyme, L-
serine dehydratase (EC 4.2.1.13) and it was anticipated that the carbon atoms of 
pyruvate would become incorporated into the carbon skeletons of both 
fluorometabolites and furthermore show a similar labelling pattern to that of serine. 
[1-13C]-, [2-13C]- And [3-13C]-pyruvates were separately incubated with resting cells of 
S. cattleya at a final concentration of 1 OmM in each case. Again to allow a relative 
comparison of the labelling results, the feeding experiments were carried out 
simultaneously with a [1 ,2-13C2]-glycine control feeding experiment. 
In general, the GC-MS incorporation data in Tables 3.11 and 3.12 show a high 
incorporation of carbon-13 label from [2- 13C]-pyruvate and [3- 13C]-pyruvate into the 
fluorometabolites. However, it is noteworthy that [1-13C]-pyruvate gives rise to a single 
label in position 2 of fluoroacetate (4.0%) and therefore position 4 of 
4-fluorothreonine (4.3%), an observation which is clearly evident in the 19F eH}-NMR 
spectrum (Fig. 3.15) of the supernatant from the [1-13C]-pyruvate feeding experiment. 
The accompanying doublets with each dominant peak are due to populations of 
fluorometabolite molecules containing a 19F-13C-12C combination. It is not clear how 
[1-13C]-pyruvate is incorporated into the terminal carbon atoms ofthe fluorometabolites, 
but for this to occur, the carboxyl moiety of [1-13C]-pyruvate must undergo reduction to 
a hydroxymethyl functionality which may then be activated for fluorination. 
Alternatively, decarboxylation of [l-13C]-pyruvate would generate carbon dioxide 
which can be reincorporated via tetrahydrofolate. 
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Fig. 3.15 12F-{1H}-NMR spectrum ofthe S cattleya supernatant from the [1-.u.c]= 
pyruvate feeding experiment 
Table 3.11 Incorporation oflabel into fluoroacetate from stable labelled (.UC) pvruvates 
Incubation time % label 
Precursor (hrs) None Double Single 
Position I Position 2 
[I ,2-13C2]-glycine 24 47.6 38.8 9.I 4.5 
48 54.5 29.6 8.1 7.7 
I~ [I- .)C)-pyruvate 24 97.8 <1.0 1.2 1.0 
48 94.9 <1.0 1.1 4.0 
I~ [2- .)C)-pyruvate 24 54.7 <1.0 41.5 3.8 
48 57.5 <1.0 36.0 5.6 
I~ [3- .)C)-pyruvate 24 57.0 3.3 8.3 31.4 
48 70.2 2.3 6.8 20.7 
(as determined in Belfast) 
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Table 3.12 Incorporation oflabel into selected positions of 4-fluorothreonine from 
stable labelled c-I1c) pyruvates 
Precursor Incubation %label in ion 218 % label in ion 236 (Positions 2,3 
time (Positions 1 and 2) and4) 
(hrs) None Single Double None Single Double Triple 
[I ,2-13 C2]-glycine 24 90.0 3.1 5.9 52.5 13.5 31.7 2.3 
48 93.2 2.6 4.2 58.0 17.4 24.6 <1.0 
)" [1- "'C)-pyruvate 24 97.2 2.8 <1.0 100 <1.0 <1.0 <1.0 
48 95.4 4.6 <1.0 94.8 4.6 <1.0 <1.0 
)" [2- "'C)-pyruvate 24 88.9 10.5 <1.0 54.9 43.7 1.4 <1.0 
48 88.4 11.6 <1.0 55.9 42.1 2.0 <1.0 
13 [3- C)-pyruvate 24 93.1 6.6 <1.0 56.9 38.2 4.9 <1.0 
48 95.2 4.4 <1.0 69.2 27.8 3.0 <1.0 
(as determined in Belfast) 
Inspection of the GC-MS results of [2- 13C]-pyruvate and [3- 13C]-pyruvate 
indicate that the labelling pattern, for carbons 1 and 2 of fluoroacetate are virtually 
identical to that for carbons 2,3 and 4 of 4-fluorothreonine in each case. Poignantly the 
results indicate that the label from [2-13C]-pyruvate is almost exclusively incorporated 
into position 1 ( -40.5%) of fluoroacetate and those from [3-13C]-pyruvate indicate 
incorporation primarily into the fluoromethyl group (-31.4%) of fluoroacetate. Thus 
these incorporations closely mirror those of [3-13C]-serine, as anticipated. 
19F eH}-NMR Analysis of the supernatants from the [2-13C]-pyruvate 
experiment (Fig. 3.17) shows the parent fluoroacetate and 4-fluorothreonine peaks (8 =-
214.6ppm and -229.0ppm) with an accompanying doublet (18.8Hz, B-shift = 0.02ppm) 
due to populations offluoroacetate and 4-fluorothreonine molecules containing 19F-12C-
13C combinations. Since incorporation of label from [2-13C]-pyruvate into the 
fluoromethyl carbon of fluoroacetate is low (-4%) the signal representing [2- 13C]-
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fluoroacetate e ]13 = 165Hz) is visible in the baseline. From the Belfast GC-MS 
C-F 
incorporation data of [2-13C]-pyruvate (Table 3.12), it is difficult to assign the enriched 
site of 4-fluorothreonine (2,3 or 4), however this becomes obvious by 19F{ 1H}-NMR 
analysis as shown in Fig. 3.16. 
0 0 OH 0 S. cattleya YoH foH HoH > + 
0 F F NH2 
(133) -(134) (135) 
Scheme 11 
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Fig. 3.16 12F-{1H}-NMR spectrum ofincm:poration oflabel into fluoroacetate 
and 4-fluorothreonine bv resting cells of S. cattleva incubated with 
L2.=11C]-pyruvate 
The 4-fluorothreonine signal has an accompanying doublet (D = -229.07ppm) with a 
coupling constant value of 18.3Hz indicative of carbon-13 in position 3 of 
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4-fluorothreonine. This analysis clearly demonstrates that the majority of the single 
label from [2- 13C]-pyruvate resides in the 3 position of 4-fluorothreonine as illustrated 
in Scheme 11. A similar analysis of the 19F { 1H}-NMR spectrum of the supernatants 
from [3- 13C]-pyruvate (Fig. 3.17) shows that the 13C primarily occupies the 
fluoromethyl carbons of both fluorometabolites, generating in each case a doublet 
(165Hz) due to a combination of 19F-13C-12C (Scheme 12). These results show that C-2 
and C-3 of pyruvate contribute to C-3 and C-4 of 4-fluorothreonine and carbons 1 and 2 
offluoroacetate as illustrated in scheme 13.153 
0 S. cattleya 0 OH 0 
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Fig. 3.17 12F-{1H}-NMR spectrum of the incorporation of (3-.!lC]-pyruvate into 
fluoroacetate and 4-fluorothreonine produced bv resting cells of S. cattleva 
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Scheme 13 
3.6 Origin of the C-1 and C-2 fragment of 4-fluorothreonine 
The GC-MS analysis (discussed in Chapter 2) of the incorporation of isotopes into 
4-fluorothreonine produced by S. cattleya allows determination of label into C-1 and 
C-2 of 4-fluorothreonine. However it must be noted that it is not possible to uniquely 
discriminate the position of the label on the C-1 and C-2 fragment of 4-fluorothreonine. 
For the purpose of this investigation, reference will be made to the GC-MS 
incorporation data for the 13C labelled pyruvates (Table 3.12). It can be seen from Table 
3.12 that [2_13C]-pyruvate is incorporated (single label) at a level (-11.6%) 
approximately twice that for either [I- 13C]-pyruvate (-4.6%) or [3- 13C]-pyruvate (4.4%) 
into positions 1 and 2 of 4-fluorothreonine. This suggests the possibility of scrambling 
of carbons 1 and 3 of pyruvate prior to its incorporation into the a.-aminocarboxylate 
portion of 4-fluorothreonine. One hypothesis, which also accounts for the incorporation 
pattern of 13C from [1- 13C]-glycine (compare Tables 3.8 and 3.10 for incorporation of 
[1-13C]-glycine and [3-13C]-serine respectively into ion 218) via [1-13C]-serine 
envisages the formation of a symmetrical 3-carbon intermediate from serine, as depicted 
in Fig. 3.18. 
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Fig. 3.18 A hypothetical route to positions 1 and 2 of 4-fluorothreonine by 11C label 
from [1-11CJ-glycine 
This hypothetical route suggests the conversiOn of serine to 
2-aminopropanedioic acid (140) or 2-ketopropanedioic acid (141), followed by 
decarboxylation and condensation with a fluoroacetaldehyde (68) equivalent. During the 
decarboxylation step there exists an equal likelihood that either C-1 or C-3 of the 
symmetrical 3-carbon intermediate is lost. Thus a 13C-atom in position 1 or 3 of serine 
or C-2 of glycine would contribute to position 1 of 4-fluorothreonine. 
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3. 7 The incorporation of isotopically labelled alanine into fluoroacetate and 
4-fluorothreonine 
L-Alanine is the transamination product of pyruvate. In view ofthe role of pyruvate as a 
precursor to the fluorometabolites, an investigation into the relative incorporation of 
stable isotope from DL-[3-13C]-alanine, DL-[3,3,3-2H3]-alanine and DL-[3- 13C-3,3,3-
2H3]-alanine was initiated. It proved easier to prepare deuterium labelled alanines than 
deuterium labelled pyruvates, and thus alanine was used here essentially as a pyruvate 
surrogate. The deuterium labelled alanines were synthesised using a modification of 
Seebach's imidazolidinone methodology 154 for the preparation of amino acids (refer to 
Chapter 4 for a detailed discussion of the methodology) 
3.7.1 Synthesis ofDL-alanine and [3.3,3-1H~]-alanine 
-~-lfo Me 0 7-(XCD ii N 
Bz Bz 3 
(~) (:;:) 
(144) (145) (146) 
Scheme 14 (i) LDA/ CD3I! -1 oooc (ii) 6N HCV 180°C/ Carius tube/ 12h 
DL-[3,3,3-2H3]-Alanine may be prepared in two steps by coupling the imidazolidinone 
(144) with eH3]-methyliodide (Scheme 14). Accordingly the racemic auxiliary (144) 
was deprotonated with LDA and reacted with eH3]-methyl iodide to give the 
eH3]-adduct (145). The desired DL-[3,3,3-2H3]-alanine (146) was obtained after acid 
hydrolysis of (145) and purification on acidic ion-exchange resin. 
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3. 7.2 Results of the incorporation of isotopically labelled alanines 
To allow a relative comparison of the labelling results, the feeding experiments 
were carried out simultaneously with a [1,2-13C2]-glycine control experiment. 
Table 3.13 GC-MS incorporation data of (11CI 2ID alanines into fluoroacetate 
Incubation time % label 
Precursor (hrs) None Double Single 
Position I Position 2 
[I ,2- 13C2]-glycine 24 47.2 39.4 8.3 5.1 
48 50.1 34.0 IO,I 5.8 
[3-13C]-alanine 24 62.3 3.6 3.2 30.9 
48 72.0 2.6 6.7 I8.7 
[3,3,3-2H3]-alanine 24 86.6 6.4 - 7.0 
48 90.0 5.1 - 4.9 
(as determzned in Belfast) 
Resting cells of S. cattleya supplemented with [3- 13C]-alanine showed an almost 
exclusive incorporation (30.9%) into position 2 of fluoroacetate. The labelling pattern 
for [3- 13C]-pyruvate is similar suggesting that alanine and pyruvate are equally effective 
precursors offluoroacetate and 4-fluorothreonine as anticipated. Moreover a comparable 
proportion of single label (-37%) from [3-13C]-alanine was observed in positions 2,3 
and 4 of 4-fluorothreonine. From the resultant 19FeH}-NMR spectrum (Fig. 3.19), it is 
apparent that the label from [3-13C]-alanine, like that from [3-13C]-serine and [3-13C]-
pyruvate, predominates in the fluoromethyl carbons of each fluorinated metabolite. 
Inspection of the insets from Fig. 3.19 shows that the dominant unlabelled signal in each 
case has an associated doublet (168-177Hz, a-shift= 0.08-0.09ppm) due to populations 
offluoroacetate and 4-fluorothreonine containing a 19F-13C-12C combination. The small 
Ill 
increase in intensity of the right hand arms of each doublet is due to molecules of 
fluoroacetate and 4-fluorothreonine with a 19F_I3C_I3C pattern. The right hand arm of a 
doublet (18Hz, 13-shift = 0.02ppm) at the base of the parent peaks for fluoroacetate and 
4-fluorothreonine is also apparent and is due to molecules with a 19F- 12C-13C 
combination. 
J 0 ;;\ 
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0 N ~ ~ ~~f J1 1 __ jQ_ Ju l __ lJ ~~ 
J -215.35-21S.45-21s.55-21's.s5-21'5.75 ppm '~22s.s6-229.s6-23o.oo-23o.16~23'o.26 ppm lJ 0'-------------'U_ 
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Fig. 3.19 12E{1H}-NMR spectrum ofthe supernatant from resting cells of S cattleya 
incubated with [3-11C]-alanine 
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Table 3.14 GC-MS incorporation data of [3.3.3-2Hr3-11C]-alanine into fluoroacetate 
Precursor Incubation %label 
time 
(hrs) None Double Single 
Pos. 1 Pos. 2 
[1,2-13C2]- 24 59.0 28.7 7.9 4.4 
glycine 
48 39.2 45.6 9.7 5.5 
Incubation % label in positions 1 and 2 % label in position 2 Precursor time 
(hrs) None Single Double Triple None Single Double 
(3,3,3-2HT3-
13C]- 24 64.7 17.5 8.1 9.7 71.5 13.3 6.0 
alanine* 
48 64.7 17.6 6.9 10.8 74.2 14.5 4.9 
(as determined in Belfast) 
Table 3. 15 GC-MS incorporation data of (11CI ~H) alanines into selected positions of 
4-fluorothreonine 
Incubation %label in ion 218 % label in ion 236 (Positions 2,3 
time (Positions 1 and 2) and4) 
(hrs) None Single Double None Single Double Triple 
[ 1,2-13 C2]-glycine 24 87.8 3.8 8.4 48.8 14.5 33.3 3.4 
48 89.3 3.5 7.2 51.3 17.5 28.6 2.6 
r 13q 1 . ~- -a anme 24 79.2 18.0 2.8 51.6 37.0 10.6 <1.0 
48 82.6 15.2 2.2 60.3 32.7 6.7 <1.0 
[3,3,3-2H3]-alanine 24 100 <1.0 <1.0 85.4 6.6 8.0 <1.0 
48 100 <1.0 <1.0 88.7 5.3 6.0 <1.0 
[1 ,2-13C2]-glycine 24 89.5 3.6 6.9 59.4 14.6 24.3 1.7 
48 80.0 5.5 14.5 39.4 18.0 36.0 6.6 
2 13 [3,3,3- H3-3- C]- 24 73.9 21.2 4.9 51.7 26.1 12.1 10.1 
alanine* 
48 73.1 21.4 4.5 54.9 27.4 9.8 7.9 
(as determzned zn Belfast) * syntheszsed by Dr. N Chesters, Durham 
113 
Triple 
9.2 
6.4 
It is perhaps interesting to note that the level of single label detected in positions 
1 and 2 of 4-fluorothreonine after incubation with [3-13C]-alanine is three fold higher 
than that observed for [3_13C]-pyruvate (compare Tables 3.15 and 3.12). Furthermore 
incubation studies with [3,3,3-2H3]-alanine showed that one (-6%) and two (-7%) 
deuterium atoms were incorporated into the fluoromethyl moieties of each fluorinated 
metabolite. 
ytOH S. cattleya ~-> + 
NH2 
(147) 
Scheme 15 
The GC-MS data (Tables 3.14/ 3.15) indicate that the labelling pattern derived 
from [3- 13C,3,3,3-2H3]-alanine (synthesised by Dr. N. Chesters, Durham) closely 
resembles that for [3-2H3]- and [3-13C]-alanine. However the GC-MS data for 
incorporations into ion 236 do not allow a definitive assignment of the number and type 
of label present at each position (2,3 or 4) of 4-fluorothreonine. Nevertheless a much 
clearer picture again emerges with 19F eH}-NMR analysis allowing the presence of up 
to two deuterium atoms on the fluoromethyl group. The proton coupled 19F-NMR [Fig. 
3.20(a)] illustrates that each parent signal is associated with a pair of upfield shifted 
(1.24-1.28ppm) doublets (J= 167Hz) corresponding to the presence of triple label 
consisting of two deuterium and one 13C atom on the fluoromethyl positions of 
fluoroacetate and 4-fluorothreonine. Increasing the sensitivity of the 19F-NMR 
experiment by applying proton decoupling unambiguously reveals, in each case, a set of 
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13C satellites due to populations of fluorometabolite molecules with a 19F -13C-12C 
sequence [Fig. 3.20(b)]. Fluorine signals due to 19F-13C-2Hpopulations offluoroacetate 
and 4-fluorothreonine are also apparent (Scheme 16). 
0 OH 0 
,Aou + Non 
F F NH2 
D 0 / 0 OH 0 
~vOH S. cattleya o0ou + vNou > NH2 F F NH2 
(148) (149) (150) 
0 OH 0 
oVou + :Non 
F F NH2 
(151) (152) 
Scheme 16 
The incorporation of two deuterium atoms from DL-[3-13C,3,3,3-2H3]-alanine, 
albeit small, into the fluoromethyl group of both fluorometabolites suggests that 
oxidation of this group is not a necessary pre-requisite for fluorination. The similarities 
between the labelling patterns after incubations with DL-[3-13C]-serine, DL-[3-13C]-
alanine and [3- 13C]-pyruvate suggests that these compounds interconvert and have a 
close metabolic relationship in S cattleya. Of course it is well known that pyruvate can 
be derived from serine mediated by L-serine dehydratase and also from L-alanine 
through transamination during normal cell metabolism. 
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Fig. 3.20 (a) 12F-NMR spectrum (b) 12E.{.1H}-NMR spectrum of the cell supernatant 
from the [3-u.C-3.3.3-~H2]-alanine feeding experiment. 
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3. 8 Incorporation of deuterium from [2,2,3,3-6H4]-succinic and 
[2,3,3-6H3]-aspartic acids into fluoroacetate and 4-fluorothreonine. 
The relatively high incorporation of 14C-label from succinic and aspartic acids (see 
radiochemical results, Chapter 2) prompted us to investigate if the hydrogen atoms 
located at C-2 and C-3 of these metabolic acids could be incorporated intact into the 
appropriate carbon sites offluoroacetate and 4-fluorothreonine (Schemes 17 and 18). 
HO~ ox 1 
I( _)\_ -oH 
0 0 0 
(153) 
Scheme 17 
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!( nY -oH 
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It was anticipated that metabolism of the deuteriated succinic acid, through the 
TCA cycle, would generate [3-2H]-oxaloacetate and furnish fluorometabolites bearing a 
single deuterium atom bonded to the fluoromethyl carbons. The processing of the 
deuterium atoms from [2,3,3-2H3]-aspartate was predicted to occur with retention of up 
to two deuterium atoms. Thus deuterium labelled succinate and aspartate were 
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administered to resting cells of S. catt/eya at a final concentration of 1 OmM. The 
19F{ 1H}-NMR spectrum resulting from the incubation of [2,2,3,3-2H4]-succinate with 
resting cells of S. cattleya is shown in Fig. 3 .21. 
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Fig. 3.21 12E.{1H}-NMR oflyophilised cell extracts from the [2.2.3.3-£,H4]-succinate 
feeding experiment 
As predicted a single deuterium atom is retained in both fluoroacetate and 
4-fluorothreonine as seen by the presence of an upfield shifted triplet (J=6 Hz, 
(3-shift = 0.6ppm) associated with the parent (unlabelled) signals. The absence of the 
incorporation of two deuterium atoms is consistent with its in vivo conversion to 
oxaloacetate bearing one deuterium atom at C-3 (157) as outlined in Scheme 19. The 
deuterium atom retained in (157) is carried through to the fluoromethyl carbons of both 
fluorometabolites, presumably via the phosphoenolpyruvate intermediate (158). 
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Table 3.16 GC-MS incorporation data of [2.2.3.3)H4]-succinic and [2.3.3)Hl]-aspartic 
acids into fluoroacetate 
Precursor Incubation % label 
time 
(hrs) None Double Single 
Position 1 Position 2 
2 24 82.3 1.2 16.5 [2,2,3,3- ~]- -
succinate 48 79.5 <0.5 - 20.0 
[2,3,3-2II3]-aspartate 48 93.5 2.0 - 4.5 
(as determined in Belfast) 
Table 3.17 GC-MS incorporation data of [2.2.3.3)H4]-succinic and [2.3.3-2HJ]-aspartic 
acids into selected positions of 4-fluorothreonine. 
Precursor Incubatio 
n time 
(hrs) 
2 [2,2,3,3- ~]- 24 
succinate 48 
2 [2,3,3- II3]-aspartate 48 
(as determined in Belfast) 
%label in ion 218 
(Positions 1 and 2) 
None Single Double 
100 <0.5 <0.5 
99.7 <0.5 <0.5 
99.8 <0.5 <0.5 
.. 
.. 
%label in ion 236 (Positions 
2,3 and 4) 
None Single Double 
85.3 14.5 <0.5 
81.3 18.6 <0.5 
93.1 4.8 2.3 
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Fig. 3.22 Vl£{.1H}-NMR spectrum of the supernatant from resting cells of S. cattleva 
incubated with [2.3.3)H3.]-aspartate 
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The incorporation of up to two deuterium atoms from [2,3,3-2H3]-aspartate can 
be rationalised if the latter is metabolised via transamination to oxaloacetate (Scheme 
20). retaining a maximum of two deuterium atoms at C-3 (157). Decarboxylation of 
(159) would generates (160) which predominantly transfers a single deuterium to the 
terminal carbon atoms of both fluorometabolites (Scheme 20). This result is apparent 
from the 19F eH}-NMR spectrum (Fig. 3.21) which shows that the dominant unlabelled 
signal for fluoroacetate and 4-fluorothreonine has an accompanying upfield shifted 
triplet 
(~-shift = 0.6ppm). Importantly however, a low level of double labelled fluoroacetate 
and 4-fluorothreonine, is detectable by GC-MS and is also evident in 
the 19F eH}-NMR spectrum where a 19F- 12C-eH2) combination is apparent as a small 
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upfield shifted multiplet (2P-shift = 1.2ppm) associated with each parent peak (Fig. 
3.21). 
rrDD 0 HO 0°NH 2 
P=--POt 
Scheme 20 
OH 
+ 
D D 0 HONOH 
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(160) 
The transfer of deuterium label from [2,3,3-2H3]-aspartate and [2,2,3,3-2H4]-
succinate provides strong evidence for the retention of hydrogen atoms of 
phosphoenolpyruvate and supports the hypothesis that phosphoenolpyruvate is an 
intermediate between the added precursors and the organofluorine metabolites produced 
in S. cattleya. 
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3.9 The incorporation of [2-.UC]-acetate into fluoroacetate and 
4-fluorothreonine produced by resting cells of S. cattle.ya 
As acetate serves as a central branch point linking many metabolic pools in most 
organisms, it was of particular interest to determine the incorporation of acetate into the 
fluorometabolites. Accordingly, [2-13C]-acetate was administered to resting cells of 
S. cattleya at a fmal concentration of IOmM. To allow a relative comparison of the 
labelling results from feeding experiments, the feeding experiment with [2- 13]-acetate 
was carried out simultaneously with a [I ,2-13C2]-glycine control feeding experiment. 
Table 3.18 Incorporation of [2-.UC]-acetate into fluoroacetate 
Precursor (hrs) None Double Single 
Position I Position 2 
[I ,2- 13 C2]-glycine 24 47.2 39.4 8.3 5.1 
(control) 48 50.1 34.0 I 0.1 5.8 
I" [2- "'C)-acetate 24 64.5 18.1 7.8 9.6 
48 73.2 11.2 7.6 8.0 
(as determined in Belfast) 
Table 3.19 Incorporation oflabel into selected positions of 4-fluorothreonine from 
[2-.Uq -acetate 
Incubatio %label in ion 218 %label in ion 236 (Positions 2,3 
n time (Positions 1 and 2) and 4) 
(hrs) None Single Double None Single Double Triple 
[1,2- 13C2]-glycine 24 87.8 3.8 8.4 48.8 14.5 33.3 3.4 
(control) 48 89.3 3.5 7.2 51.3 17.5 28.6 2.6 
]" [2- "'C)-acetate 24 92.3 5.8 1.9 58.6 20.1 20.3 1.0 
48 94.5 4.5 1.0 68.8 17.6 13.2 <0.5 
(as determined in Belfast) 
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Fig. 3.23 12E{1H}-NMR spectrum of the supernatant from resting cells of S. cattleva 
incubated with [2-.UC]-acetate 
Direct inspection of the 19F eH}-NMR spectrum (Fig. 3.23) of the [2- 13C]-
acetate experiment reveals a similar multiplicity of the NMR signals for both 
fluorometabolites indicating that incorporations of [2-13C]-acetate into fluoroacetate 
mirror those into C-3 and C-4 of 4-fluorothreonine. It is clear from the insets of the 
NMR signals for the fluoroacetate and 4-fluorothreonine that molecules containing the 
19 13 12 19 12 13 . . . F- C- C and F- C- C combmatlons are present at a higher level than those 
containing a 19F-13C-13C combination (doublet of doublets; 18Hz, 165Hz; a.+ P-shift = 
0.09ppm). This is in good agreement with the GC-MS data for [2-13C]-acetate (compare 
single and double incorporation after 48h, Tables 3.18 and 3.19). 
The equal distribution of label in positions 1 and 2 of fluoroacetate ( -8%, Table 
3.16) can be rationalised by the pathway depicted in scheme 21 illustrating the 
conversion oflabelled acetate (161) to labelled acetyl-CoA (162) to [2-13C]-citrate (163) 
by condensation with oxaloacetate. The 13C label would then be transferred via 
123 
intermediates of the TCA cycle to C-2 of fumarate (164), a symmetrical intermediate, 
which gives rise to equivalent levels of [2-13C]- (165) and [3- 13C]-oxaloacetate (166). 
I " I " Such labelled oxaloacetates are converted to [2- -'C)-pyruvate and [3- -'C)-pyruvate 
which are respective precursors to [I-13C]-fluoroacetate and [2- 13C]-fluoroacetate. 
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Scheme 21 . Production of labelled fluorometabolites from [2-11C]-acetate 
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A significant level of recombination of isotope ( -18%) in fluoroacetate from 
[2-13C]-acetate is also apparent and is clearly illustrated by the characteristic doublet of 
doublets at 8 = -214.48ppm due to populations of [1,2-13C2]-fluoroacetate (Fig. 3.23). 
The rationale presented in scheme 21 is consistent with this observation if 
[2-13C]-oxaloacetate (165) is condensed with [2-13C]-acetyl-CoA and progressed around 
I3c the TCA cycle to generate [2,3- 2]-pyruvate. 
3.10 Summary 
The results of the 13C and 2H labelled studies on fluorometabolite biosynthesis in 
S. cattleya clearly indicate that glycine and pyruvate are efficiently incorporated into 
both fluoroacetate and 4-fluorothreonine. It is also interesting to note the mirroring of 
19F eH}-NMR peak multiplicities for fluoroacetate and C-3 and C-4 of 
4-fluorothreonine in all incubation experiments to date which suggests that fluoroacetate 
and C-3 and C-4 of 4-fluorothreonine have a common origin. The 19F-NMR data is 
consistent with the conversion of glycine to pyruvate via serine as depicted in Fig. 3.24. 
The relatively high incorporations of [2-13C]- and [3-13C]-pyruvate provides evidence 
that the a and ~ carbon atoms of pyruvate are incorporated as a unit into fluoroacetate 
and C-3 and C-4 of 4-fluorothreonine. Phosphoenolpyruvate is derived from the TCA 
cycle intermediate oxaloacetate and consistent with this the citrate related metabolites 
succinate, aspartate and acetate also labelled the fluorometabolites. The results reinforce 
the conclusion that phosphoenolpyruvate is involved. Phosphoenolpyruvate can enter 
the glycolytic pool and recently Tamura et al., 130 have shown that [2- 13C]-glycerol is 
exclusively incorporated into C-1 of fluoroacetate. Extending this study, the Durham 
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group (Dr. J. Nieschalk) have recently demonstrated the incorporation of the pro-R 
hydroxymethyl group of glycerol into the fluoromethyl groups of fluoroacetate and 
4 fl thr . 155 - uoro eorune. 
Fig. 3.24 Summary of the results from stable labelled studies with succinate. aspartate 
and acetate 
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3.11 The incorporation of [2-13C]-glycerol into fluoroacetate and 
4-fluorothreonine produced by resting cells of S. cattleva 
This particular investigation was designed to test the hypothesis that an intermediate of 
glycolysis was intimate with the fluorination event. In the only other biosynthetic study 
reported on these fluorometabolites, Tamura et al, 130 have shown that [U-14C]-glycerol 
was very efficiently incorporated into fluoroacetate by suspension cells of S. cattleya. 
Moreover they demonstrated that the label from [2-13C]-glycerol is incorporated (-40%) 
into the C-1 of fluoroacetate. These workers also noted a significant incorporation of C-
2 and C-3 from ~-hydroxypyruvate and accordingly concluded that fluoroacetate derives 
from C-1 and C-2 of glycerol via ~-hydroxypyruvate. Thus the incorporation of label 
from [2- 13C]-glycerol into the fluorometabolites was re-evaluated in resting cells of 
S. cattleya at varying concentrations of [2-13C]-glycerol over a 24h and 48h time period 
(Results shown in Tables 3.20/ 3.21). To allow a relative comparison of the labelling 
results from feeding experiments, this study was carried out simultaneously with a 
[1,2-13C2]-glycine control feeding experiment. 
Although Reid et al., 132 demonstrated a lower incorporation of [U-14C]-glycerol 
into fluoroacetate compared with [U-14C]-glycolate, the results from Tables 3.20 and 
3.21 appear to indicate a higher level of incorporation oflabel from [2-13C]-glycerol into 
both fluorometabolites. The isotope from [2-13C]-glycerol appears to be incorporated 
particularly in position 1 of fluoroacetate (-56%, compared to -40% reported by 
Tamura et al.) and positions 2,3 and 4 of 4-fluorothreonine (-60%) after 24h incubation 
with 7.5mM [2-13C]-glycerol. Such high incorporation levels from a stable labelled 
precursor have not previously been observed in this study and suggest that glycerol is 
metabolically closer to the substrate for fluorination. 
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Table 3.20 GC-MS data of isotope incorporation from vazying concentrations of 
U.:PC]-glycerol into fluoroacetate 
Incubation time % label 
Precursor (hrs) None Double Single 
Position 1 Position 2 
[ 1,2- I 3C2]-glycine 48 43.2 43.5 9.9 3.5 (10mM) 
I' [2- "'C)-glycerol 24 52.6 8.5 38.9 <0.5 
(2.5mM) 48 64.3 6.7 29.0 <0.5 
I' [2- "'C)-glycerol 24 39.2 10.4 50.4 <0.5 
(5.0mM) 48 51.0 8.5 40.6 <0.5 
J' [2- "'C)-glycerol 24 31.3 - 12.1 56.5 <0.5 
(7.5mM) 48 43.4 9.5 47.2 <0.5 
(as determined in Belfast) 
Table 3.21 GC-MS data of isotope incorporation into selected positions of 
4-fluorothreonine from [2)1C]-glycerol 
Precursor Incubation %label in ion 218 % label in ion 236 (Positions 2,3 
time (Positions 1 and 2) and4) 
(hrs) None Single Double None Single Double Triple 
[ 1,2-13C2]glycine 48 87.2 3.5 9.3 45.8 15.2 33.9 5.2 (lOmM) 
[2- I 3C]-glycerol 24 95.9 2.1 2.0 60.2 39.4 <0.5 <0.5 
(2.5mM) 48 98.2 1.8 <0.5 70.3 29.4 <0.5 <0.5 
I' [2- "'C)-glycerol 24 92.8 5.0 2.2 46.4 52.0 1.6 <0.5 
(5.0mM) 48 96.1 3.9 <0.5 57.2 41.8 1.0 <0.5 
I' [2- "'C)-glycerol 24 89.4 7.2 3.4 39.6 57.7 2.7 <0.5 
(7.5mM) 48 92.6 7.4 <0.5 49.5 48.8 1.8 1.8 
(as determined in Belfast) 
19F { 1H}-NMR data also show that the label from [2-13C]-glycerol is located 
principally on the carboxylate carbon of fluoroacetate (Fig. 3.25(a)) and demonstrate 
that label in position 3 constitutes most of the label in positions 2,3 and 4 of 4-
fluorothreonine (Fig. 3.25(b)). 
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Fig. 3.25 12E.{.1H}-NMR spectrum of the incorporation of [2-UC]-glycerol into 
(a) fluoroacetate and (b) 4-fluorothreonine produced by resting cells of S cattleva. 
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This observation is highlighted by the presence of a shifted signal (doublet, J=18Hz) 
associated with each dominant parent peak, corresponding to fluorometabolites with a 
19F- 12C- 13C combination. 
~ 
HO OH 
+ 
S. cattleya 1!0B 
F NH2 
(85) 
Scheme 22 
Additional evidence for the role of glycerol in the biosynthesis is provided by 
incorporation experiments with (25)- and (2R)-[1,1-2H2]-glycerol that have 
demonstrated the incorporation of deuterium label from only the (2R) enantiomer whilst 
the pro-S hydroxymethyl group is oxidatively cleaved during the biosynthesis. 155 This 
shows that the pro-R hydroxymethyl group of glycerol is eventually fluorinated and is 
consistent with the phosphorylation of this hydroxymethyl group by glycerol kinase. 
Indeed the predominant retention of both deuterium atoms from (2R)- [1,1-2H2]-glycerol 
provides unambiguous evidence that this carbon is not oxidised prior to fluorination. 
It is therefore possible to envisage the metabolism of pyruvate and glycerol to 
fluoroacetate and 4-fluorothreonine proceeding via an intermediate of the glycolytic 
pathway as depicted in Fig. 3.26. This Figure summarises the overall link between the 
various precursors involved in the biosynthesis of fluoroacetate and 4-fluorothreonine 
and moreover introduces glycolytic intermediates as potential candidates for the 
substrate of the fluorinating enzyme. 
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Fig. 3.26 Summarv of the incorporation results showing the relationship between 
isotopically labelled putative precursors in the biosynthesis of fluoroacetate and 
4-fluorothreonine inS. cattleva 
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2 2 2 3.12 [3--Hx]-fluoropyruvate, [3--HxJ-3-fluorolactate and [3-llxJ-3-fluoro-
propane-1,2-diol as putative precursors of fluoroacetate and 
4-fluorothreonine 
In an effort to determine the nature of the initial product of fluorination on the 
biosynthetic pathway to fluoroacetate and 4-fluorothreonine, the incorporations of 
[3-2HxJ-fluoropyruvate, [3-2Hx]-3-fluorolactate and [3-2HxJ-3-fluoropropane-1 ,2-diol. 
were investigated as putative post-fluorinated substrates. Each compound was 
synthesised carrying at least one deuterium label and their incorporations into 
fluoroacetate and 4-fluorothreonine were assessed in resting cells of S. cattleya. It is 
perhaps interesting to note that callus cultures of D. cymosum are capable of converting 
3-fluoropyruvate to fluoroacetate 120 suggesting a role for 3-fluoropyruvate as a possible 
intermediate in fluoroacetate biosynthesis in plants. 
3.12.1 Synthesis of isotopically enriched 3-fluoropyruvate and 3-fluorolactate. 
2 
3.12.1.1 Synthesis of[3-t1x]-fluoropyruvic acid 
In order to prepare a sample of [3-2Hx]-fluoropyruvate an investigation of 
deuterium exchange into unlabelled fluoropyruvate was undertaken. The presence of the 
fluorine atom, facilitates the enolisation process and has the added advantage that the 
course of the reaction can be monitored directly by 19F-NMR. 3-Fluoropyruvic acid 
gives a triplet in the 19F-NMR spectrum at -229.5ppm. When one geminal hydrogen is 
replaced by deuterium, the signal shifts to lower frequency by 0.6ppm (~-shift) and 
collapses to a doublet of triplets (dt) (Fig. 3.25(a)). Two deuterium atoms geminal to the 
fluorine shift the signal (now a pentet by virtue of the fluorine coupling to the two 
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deuterium atoms) to a lower frequency by 1.2ppm. Thus, by determining the splitting 
pattern and isotopic chemical shift value, the course of the deuterium exchange can be 
followed. 
0 0 0 2H 0/ 2~80 D~OH DnOH (you 2 4 + 
120 °C 2h 15min F 0 F 0 F 0 
(176) (177) (178) 
Scheme 23 
The sodium salt of 3-fluoropyruvic acid was dissolved in 2H20 with a minimum 
amount of 2H2S04 and heated in a sealed Carius tube at l20°C for 8h (Scheme 23). 
During the initial experiments, the 19F-NMR spectrum of the resultant mixture showed 
an array of signals which could not be interpreted. However a pentet with the correct 
chemical shift for eH2rfluoropyruvate was observable in the mixture indicating that the 
protons had exchanged fully but decomposition products dominated. This gave 
problems with isolation and purification. Nevertheless, a time course study to 
investigate the rate of exchange of hydrogen for deuterium in 3-fluoropyruvic acid was 
carried out and the results are presented in Table 3.22. After 5min no exchange is 
observed, but after 15min, a low concentration of mono-labelled material becomes 
apparent (Fig. 3.27 (a)) as indicated by the 0.6ppm upfield shifted dt in the 19F-NMR 
spectrum. 
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Table 3.22 Time course study for the exchange of:fluoropyruvate in D20/ D2S02 at 
120°C in Carius tube. 
Reaction time Concentration of Concentration of Concentration of 
starting material, mono-deuteriated di-deuteriated 
3-fluoropyruvic acid product(%) product(%) 
(%) 
5 min 100 0 0 
15min 93 7 0 
30min 60 36 4 
1.5h 7 44 49 
2h 15min 1 29 70 
3h 0 0 32 
The double labelled material (178) becomes evident after only 30 min at 120°C (Fig. 
3.27(b)), however a significant amount of unlabelled starting material persists after 1.5h 
(Fig. 3.27(c)). Nonetheless the optimum reaction time was found to be 2h 15min at 
which point the reaction mixture became pale yellow indicative of the onset of side 
products and decomposition. The optimal ratio of mono- to di- labelled sample, without 
the formation of side products, is 2.6: 1, after 2h 15mins. 
Continuous extraction of the acidic aqueous 2H20 layer into ethyl acetate 
allowed the recovery of 3-:fluoropyruvic acid which was dissolved in water, neutralised 
and freeze dried to give the corresponding sodium salt (49%). It is important to note that 
this sample contained a mixture of the mono and di deuteriated forms of 3-
2 
fluoropyruvate therefore x = 1 or 2 in [3- Hx]-fluoropyruvate. 
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3.12.1.2 Synthesis of [3-~HJ-3-fluorolactate 
2 
A mixture of the mono- and di- deuteriated [3- Hx]-fluoropyruvic acid prepared above 
was dissolved in methanol and treated with sodium borohydride to give [2Hx]-
fluorolactate (Scheme 24). The reduction is readily followed by 19F-NMR as the 
multiplicities of the fluorine signals (a triplet and doublet of triplets shown in Fig. 3.27) 
become more complex by virtue of the coupling to the new C-2 hydrogen of 
3-fluorolactate. The 19F-NMR spectrum in Fig. 3.28 clearly illustrates that the dt (o=-
230.2ppm, Fig. 3.27(c)) has been converted to a multiplet and similarly the pentet has 
been transformed to a more complex signal (doublet of pentets, dp). For the isolation of 
deuteriated [3-2Hx]-3-fluorolactate, the aqueous layer was continuously extracted into 
ethyl acetate for 24h and the free acid dissolved in water, neutralised with 1 N NaOH 
and freeze dried to afford the sodium salt of [3-2Hx]-3-fluorolactic acid (38%). 
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3.12.2 Incorporation of deuterium label from [3-tl!)-fluoropyruvate and 
2 13= tixl-3-fluorolactate into fluoroacetate and 4-fluorothreonine 
Each of the candidate precursors were incubated with resting cells of S cattleya at a 
fmal concentration 1 OmM. GC-MS analysis of the supernatants showed that 
4-fluorothreonine was not significantly labelled with deuterium (Table 3.24) but a high 
level of (-23%) [2-2H]-fluoroacetate was apparent (Table 3.23). 
Table 3.23 GC-MS data of the incorporation of deuterium from 
.Q}Hx]-fluoropyruvate and [3-~Hx]-3-fluorolactate into fluoroacetate 
(as determined in Belfast) 
Incubation % label 
time 
Precursor (hrs) None Double Single 
(Position 2) 
[3-2H,J-3-fluoropyruvate 0 55.2 19.6 25.3 
control (no cells) 24 56.0 19.2 24.9 
(10mM) 48 52.7 21.1 26.2 
[3-2H,J-3-fluoropyruvate 24 56.9 19.9 23.2 
(10mM) 48 75.5 11.6 13.0 
[3-2H,J-3-fluorolactate 24 97.6 <0.5 2.4 
(lOmM) 48 94.5 3.8 1.7 
x=lor2 
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Table 3.24 GC-MS data for the incorporation of deuterium from [33H20J-fluoropyruvate 
and [3-~H20J-3-fluorolactate into positions 2.3 and 4 of 4-fluorothreonine 
(as determined in Belfast) 
Precursor Incubation %label in ion 236 (Positions 2,3 and 4) 
time 
(hrs) None Single Double 
[3-2HJ-3-fluoropyruvate 24 96.5 2.5 1.0 
(lOmM) 48 98.3 1.5 <0.5 
[3-2HJ-3-flu oro lactate 24 100 <0.5 <0.5 
(lOmM) 48 99.6 <0.5 <0.5 
x =I or 2 
However, comparable levels of single and double labelled fluoroacetate were detected in 
control samples (lOmM [3-2Hx]-fluoropyruvate, no cells, in MES buffer only) indicating 
that deuterium labelled fluoroacetate is not formed through biotransformation of 
[3-2Hx]-fluoropyruvate but is rather produced from the oxidative decarboxylation of 
[3-2Hx]-fluoropyruvate, thus accounting for the high concentrations of [2-2H]- and 
[2,2-2H2]- fluoroacetate present in the supernatant. It is perhaps interesting to note that 
the ratio of label in the fluoroacetate (Table 3.23) from the 48h supernatant sample is 
different to that of the 48h control sample suggesting that [3-2Hx]-fluoropyruvate is 
defluorinated and the fluoride is reincorporated for the de novo synthesis of 
fluoroacetate. Despite the anomalous fluoroacetate incorporation result, it has been 
suggested earlier in this thesis that the labelling pattern for the incorporation into C-1 
and C-2 of fluoroacetate mirror those into positions 3 and 4 of 4-fluorothreonine. Hence 
GC-MS data for the incorporation into 4-fluorothreonine (Table 3.24) clearly show that 
single and double label in C-3 and C-4 are present at a low level and that this should 
also be reflected in fluoroacetate. These results are inconsistent with 3-fluoropyruvate or 
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3-fluorolactate as post fluorinated intermediates in fluorometabolite biosynthesis in 
S. catt/eya. 
2 
3.12.3 Synthesis of [3-llx]-3-fluoropropane-1.2-diol 
2 
It was judged appropriate to prepare [3- HxJ-3-fluoropropane-1,2-diol, to test the 
hypothesis that sn-glycerol-3-phosphate is the substrate for fluorination. If fluoride ion 
displaced the phosphate group then 3-fluoropropane-1,2-diol would be the 
post-fluorinated product and should become incorporated into the fluorometabolites. 
Accordingly [3-2HxJ-3-fluoropropane-1 ,2-diol was prepared by treating [3-2HxJ-
fluoropyruvate with lithium aluminium hydride (Scheme 25) to produce a viscous 
2 
mixture of [3- HxJ-3-fluoropropane-1 ,2-diol. 
0 DnOH 
F 0 
(178) 
Scheme 25 
(181) 
2 
3.12.4 Incorporation of deuterium label from [3-llxJ-3-fluoropropane-1.2-diol 
into fluoroacetate and 4-fluorothreonine 
2 [3- Hx]-3-Fluoropropane-1,2-diol was incubated with resting cells of S. cattleya at a 
final concentration of 10mM. It is clear from the GC-MS results shown in Tables 3.25 
and 3.26 that there is a very low incorporation of deuterium label into both of the 
fluorometabolites. Approximately 95% of the 4-fluorothreonine molecules produced by 
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the resting cells remain unlabelled after a 48h incubation. A similar situation is apparent 
in fluoroacetate where the data indicate a very low level of label at its terminal carbon 
atom. These results are consistent with the 19F {'H}-NMR (not shown) spectra of the 
fluorometabolites. 
2 
Table 3.25 GC-MS data for the incorporation of [3-rfx]-3-fluoropropane-1.2-diol into 
position 2 of fluoroacetate 
Precursor Incubation time % label 
(hrs) None Double Single 
Position 1 Position 2 
2 [3- HJ-3-fluoro-
propane-1,2-diol 48 96.9 3.1 ---- <0.5 
(as determined in Belfast) 
2 
Table 3.26 GC-MS data for the incorporation of [3-rfxJ-3-fluoropropane-1.2-diol into 
selected positions of 4-fluorothreonine 
Precursor Incubation %label in ion 218 % label in ion 236 (Positions 
time (Positions 1 and 2) 2,3 and 4) 
(hrs) None Single Double None Single Double 
[3,3-2Hx]-3-fluoro-
propane-1 ,2-diol 48 94.0 1.4 1.8 97.2 1.9 0.9 
(as determined in Belfast) 
A clear conclusion to emerge from this analysis is that the deuterium atoms from 
2 [3- Hx]-3-fluoropropane-1,2-diol are not incorporated into the fluorometabolites giving 
no support to the hypothesis that sn-glycerol-3-phosphate is the substrate for the 
fluorination enzyme. 
OH OH 
H~OP H~F 
.... 
~ 
F 
Fig. 3. 29 
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3.13 Discussion and Conclusion 
It has been clearly established, from isotopic incorporations that the a-carbon atom of 
glycine, through an efficient recycling process, contributes to the construction of 
fluoroacetate and C-3 and C-4 of 4-fluorothreonine. However the carboxylate carbon of 
glycine is not retained to any significant extent in either fluorometabolite. GC-MS and 
19F eH}-NMR data for the incorporation of labelled serine, alanine and pyruvate is 
consistent with the conversion of glycine to pyruvate via serine. Pyruvate then donates 
its a and p carbon atoms as an intact unit to form the carbon skeleton of fluoroacetate 
plus the corresponding C-3 and C-4 sites of 4-fluorothreonine. The incorporation of a 
single deuterium atom from [2,2,3,3-2H4]-succinate and up to two deuterium atoms from 
[2,3,3-2H3]-aspartate into the fluorometabolites can be rationalised via the intermediacy 
of oxaloacetate/ phosphoenol pyruvate. 
The highest incorporation of label into fluoroacetate and positions 3 and 4 of 4-
fluorothreonine was achieved using [2-13C]-glycerol and the stereochemical labelling is 
consistent with glycerol entering the glycolytic pathway by the action of glycerol 
kinase. Tamura et al., 130 after demonstrating the high incorporation of glycerol, 
concluded that C-1 and C-2 of fluoroacetate were derived from C-1 and C-2 of glycerol 
via P-hydroxypyruvate. They suggested that fluoroacetate could either be formed from 
the decarboxylation of P-hydroxypyruvate producing glycolate, the hydroxyl group of 
which, could be substituted by fluoride. Conversely, fluoroacetate could be formed by 
the initial displacement of the hydroxyl moiety of P-hydroxypyruvate by fluoride 
followed by decarboxylation. However, this investigation has demonstrated only a very 
poor incorporation of [U-14C]- and [2--13C]- glycolate into fluoroacetate. Furthermore 
the failure to detect incorporation of isotope from deuterium labelled P-fluoropyruvate 
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into the fluorometabolites does not support the intermediacy of ~-fluoropyruvate. Our 
data force the conclusion that a presently unknown intermediate on the glycolytic 
pathway is the substrate for fluorination. 
If sn-glycerol-3-phosphate was the substrate then deuterium atoms from [3_2Hx]-
3-fluoropropane-1 ,2-diol should have been incorporated into the fluorometabolites. 
However the very poor incorporation of deuterium label from [3-2Hx]-3-fluoropropane-
1,2-diol did not lend support to this notion. Similarly other isotopically labelled post-
fluorinated substrates, namely [3-2Hx]-3-fluoropyruvate and [3-2HJ-3-fluorolactate 
were poorly incorporated and these too are discounted as the initial products of the 
fluorination event. The other candidate glycolytic intermediates are dihydroxyacetone-
phosphate and glyceraldehyde-3-phosphate, however the incorporation of the putative 
post-fluorinated metabolites of both of these compounds remains to be investigated. 
The similarity in the labelling patterns observed for fluoroacetate and positions 3 
and 4 of 4-fluorothreonine in all of the experiments indicate a single fluorinating 
d · · fi th · · ISO enzyme an a common ongm or ese mOieties. 
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Biosvnthesis o.f.fluoroacetate and 4-jluorothreonine in S. cattleya 
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Chapter 4 
4. Total Synthesis of the natural product 4-fluorothreonine 
4.1 Introduction 
The pnmary objective of the synthetic chemistry was to establish the absolute 
stereochemistry of the natural product 4-fluorothreonine. An additional objective was to 
prepare a sample of deuterium labelled 4-fluorothreonine to investigate if 
4-fluorothreonine is converted to fluoroacetate by resting cells of S. cattleya. An 
efficient route to isotopically labelled threonines was also developed during this work. 
Optically active fluorinated threonines have attracted much interest due to their 
reported anti-tumour activities. 156 4-(2S,JS)-Fluorothreonine has been prepared 
synthetically by Scolastico and co-workers in 1985 157 before the natural product was 
identified. More recently Shimizu et a/., 158 prepared the same stereoisomer using a 
lipase enzyme in the key resolution step. For each case, the optical rotation value of the 
synthetic material was very close to that of the natural product ([a ]0 = -18°) however 
the relative or absolute stereochemistry of the natural product has never been 
unambiguously established. In this investigation, the synthetic 4-fluorothreonine was 
co-analysed with the naturally produced 4-fluorothreonine, for the first time. 
Seebach's imidazolidinone methodology emerged as an attractive and efficient 
route to a-amino-P-hydroxy acids. 154 The route involves the stereoselective alkylation 
of the enolate of 1-benzoyl-2-tert-butyl-3-methylimidazolidin-4-one (144, R=H) to 
generate products (144a) of electrophile approach anti to the tert-butyl moiety (Scheme 
26). Subsequent hydrolysis of the alkylation product under acidic conditions affords the 
appropriate amino acid in enantiomerically pure form. 
144 
~~](' 
N R 
Bz 
(144, R=H) ~ 
Jl 
R' H 
Me 0 7-(:(,. 
Bz R 
(144a) 
(144b) 
Interestingly the condensation of (144, R=H) with aldehydes generates an 
additional stereocentre and moreover proceeds with high stereoselectivity affording a 
single major diastereoisomer (144b) (Scheme 26). Hydrolysis of this diastereoisomer 
produces the desired threo amino acid. In the case of using acetaldehyde, the 
condensation product (186) is generated which can be hydrolysed to give 
(2S,3R)-threonine (187) (Scheme 27). 
Me ~e 0 OH 0 
-1-(:( ii uHou 
-1-<NX,(" Bz Bz NH2 
(144) (186) (187) 
Scheme 27 (I) LDA/ CH3CHO/ -100°C (ii) ION HCI/ 100°C/ 72h 
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It is the tert-butyl group at the C-2 stereogenic centre that induces facial 
selectivity to the enolate carbon 5 during reactions with electrophiles to set the anti-(S) 
absolute stereochemistry at the a-carbon. Fig. 4.1 shows the three staggered approaches 
of acetaldehyde to the enolate. The addition is thought to occur via the transition state 
(188) as this is consistent with the observed stereocontrol at the ~-centre generating the 
threo product. The transition state orientation in (188) is more favoured as the double 
bonds of the donor and the acceptor carbonyl are synclinal and not anti peri planar as in 
(190)159'160, preventing the separation of opposite developing charges and still allowing 
for the 0-Li-----0 chelation (twist-boat arrangement). Furthermore the methyl group is 
not over the face of the ring as in (189) plus there is maximum overlap of the donor and 
n-systems in (188). 
(188) (189) 
F. a 4 1154 Ito. . 
(190) 
This methodology therefore offered potentially a more direct and convenient route for 
the preparation of 4-(2S,3S)-fluorothreonine. 
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4.2 Synthesis of (2S.3R)-threonine 
4.2.1 Synthesis ofDL-1-benzoyl-2-(tert-butyl)-3-methyl-imidazolidinone (144) ill 
The racemic form of the imidazolidinone (185) was prepared from glycine methyl ester 
hydrochloride by its initial conversion to the corresponding N-methylamide161 (183). 
The Schiff base (184) that is generated on reaction with pivalaldehyde was cyclised 
using methanolic HCl for 12h producing 2-(tert-butyl)-3-methyl-imidazolidinone (185) 
as outlined in Scheme 28. 
0 
- ~ II OH3~0Me 
(182) 
-rlJO 
N 
H 
(:!:) 
(185) 
iii 
Scheme 28 (I) 8M CH3NH2 I DCMI 25°CI ISh 
(iii) acidic methanol/25°C/ 3h 
(183) 
ii 
• 
0 ~I N II ~~NMe 
H 
(184) 
(ii) Pivalaldehyde/ Et3N/ reflux I Oh 
The imidazolidinone (185) can at this point be resolved by crystallisation of the 
mandelate salts 161 and the desired imidazolidinone with (R) or (S) configuration may be 
147 
isolated. Subsequent treatment of (185) with benzoyl chloride generates 1-benzoyl-2-
(tert-butyl)-3-methyl-imidazolidinone (144) (Scheme 29). 
Me 0 7-(1 
N 
0~ 
(185) (144) 
Scheme 29 (I) Benzoyl chloride/ IN Na0H/25°C/ 8h 
Treatment of (S)-(144) with LDA/ THF at -78°C and then acetaldehyde at -100°C 
generated (186a), one of the four possible diastereoisomers, usually to the extent of 85% 
d. e. 
4.2.2. Hydrolysis of the alkylated imidazolidinone adduct 
OH 0 
«OH 
NH2 
(186a) (187) (86% d.e.) 
Scheme 30 (I) ION HCl/ 100°C/ 72h 
Although Seebach and co-workers have reported the hydrolysis of hydroxyalkylated 
imidazolidinones to be more facile than those derivatives geminally disubstituted in the 
C-5 position, in the event it proved difficult to drive the hydrolysis to completion using 
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the suggested conditions160 (6N HCll 100°C/ 8h). Instead, such conditions generated the 
partially hydrolysed N-methyl amide. Hydrolysis was also attempted in a Carius tube 
under high pressure and temperature but these conditions were too vigorous yielding 
only decomposition products. However, heating the adduct continuously in 1 ON HCl/ 
100°C for 72h allowed complete cleavage of the N,N acetal moiety generating (2S,3R)-
threonine with no traces of the N-methylamide contaminant. The amino acid was 
purified by ion-exchange chromatography and recrystallised from ethanol to afford 
(187). 
A similar protocol was used for the preparation of [3,4,4,4_2H4]-threonine, 
employing eH4]-acetaldehyde (Scheme 31 ). The singlet at 1.20 ppm and the singlet at 
4.10 ppm in the 2H-NMR spectrum of [3,4,4,4JH4]-threonine (192) clearly illustrates 
the expected 3: 1 ratio of the signals corresponding to the CD3 and CD peaks 
respectively (Fig. 4.2). The minor allo diastereoisomer is evident at 4.2ppm, illustrating 
the moderate diastereoselectivity of the synthetic process. 
r::( ~e 0 OH 0 
-1-<NXJ(oBz ii D:J~OH 
Bz 
H D CD 
NH2 
(-:;:) (-:;:) 3 (-:;:) 
(144) (191) (192) 
Scheme 31 (ii) 1 ON HCl/ 1 00°C/ 72h 
Resting cells of S. cattleya were incubated with DL-[3,4,4,4JH4]-threonine to determine 
the incorporation of deuterium isotope into fluoroacetate and 4-fluorothreonine. In the 
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event the isotope was not incorporated into the fluoromethyl carbons of fluoroacetate or 
the terminal carbons of 4-fluorothreonine. 
lT-
~._ ___ _ 
·-lf ... 
' 0 
' ' 
• 0 
) ' ) 0 I o 
' ' ' 0 
Fig. 4.? 1H-NMR spectrum of [3.4.4.4)H1]-threonine (192) 
4.3 Synthesis of 4-(2S.3S)-fluorothreonine 
P . 1 . dio7I~7Iss . I . d f h. 4(2S3S)f1 h . revwus y Cite · · · optica rotation ata o synt etic - , - uorot reomne 
appear to be consistent with that for the corresponding natural compound suggesting 
that the natural product also possesses a (2S,3S) threo-configuration. The Seebach 
methodology yields threo a-amino-~-hydroxy acids. However a straightforward 
!50 
condensation of the imidazolidinone (144) and fluoroacetaldehyde is not possible due to 
the lack of availability of fluoroacetaldehyde in a non-aqueous form. We thus 
considered fluoroacetyl chloride as an alternative electrophilic substrate to explore the 
possibility of generating a J3-ketone (193). The ketone may then be reduced and 
hydrolysed to give 4-(2S,3S)-fluorothreonine. 
4. 3.1 Synthesis of the fluorinated '(3-ketone' (193) 
(144) (193) 
Scheme 3 2 (I) LDA/ FCH2COCV -1 oooc 
Accordingly, the treatment of sodium fluoroacetate with phthaloyl chloride generated 
fluoroacetyl chloride in excellent yield. 162 The imidazolidinone adduct (193) which was 
generated after treatment of the enolate of (144) with fluoroacetyl chloride proved to be 
stable at room temperature. The yield of this condensation step was initially low (32%) 
due to the formation of (196), an adduct formed between diisopropylamine and 
fluoroacetyl chloride. 
0 
+ (a 
F 
(194) (195) (196) 
Scheme 33 
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In an attempt to increase the yield of this condensation step, various 
modifications were investigated, i.e. the reaction was quenched at -78°C, -50°C, -25°C, 
0°C and 25°C but this did not improve the product profile. In an effort to suppress the 
side reaction (Scheme 33) experiments were conducted with n-butyllithium alone. 
However these conditions furnished many new unidentified side products which 
consequently led to poorer yields of (193) (See Table 4.1 ). Lithium 
hexamethyldisilazide (LHMDS) was then explored as an alternative base to LDA but 
only a minimal conversion to the product was achieved since the yield of the competing 
amide formation (Scheme 33) was even greater in this case. 
Table 4.1 
Reaction Yield of 'f)-ketone' (193) 
LDA I fluoroacetyl chloride 32% 
BuLi I fluoroacetyl chloride 14% 
Hexamethyldisilazide I II < 10% 
Due to the high reactivity of fluoroacetyl chloride attention was focused on a 
milder electrophilic substrate, namely ethyl fluoroacetate. Deprotonation of the 
imidazolidinone (144) was achieved using LDA to generate the characteristic red 
coloured anion which was quenched with ethyl fluoroacetate. In the event, tic results 
showed very little conversion of starting material (144) to product (193). 
n-Butylilthium, LDA and hexamethyldisilazide were all explored as bases for reaction 
with ethyl fluoroacetate, but no notable increase in the yield of the product (193) 
(<10%) was observed (See Table 4.2). 
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Table 4.2 
Reaction Yield of 'f)-ketone' (183) 
LDA I Ethyl fluoroacetate <10% 
BuLi I Ethyl fluoroacetate <10% 
Hexamethyldisilazide I " 0% 
Optimisation (1: 1 ratio of LDA to starting imidazolidinone, stirred at -78°C for 
30min followed by reaction with 10 equivalents of fluoroacetyl chloride at -1 00°C for 
5min) of the LDA/ fluoroacetyl chloride mediated reaction increased the yield from 
32% to 57%, after recrystallisation from ethanol, and 19F, 13C, 1H NMR spectra all 
indicated the presence of a single diastereoisomer. A suitable crystal of (195) was 
submitted for X-ray analysis and the crystal structure is shown in Fig. 4.2. The most 
interesting feature of the structure is that the geometry of the stereo genic carbon centre 
at C-5 is tetrahedral indicating that the sterically bulky tert-butyl moiety occupies a 
position anti to the fluoroacetyl fragment. This is an important observation, as the 
tetrahedral geometry renders the ~-ketone (193) resistant to epimerisation, and sets the 
desired stereogenic centre at C-5. It is interesting to note that the bond angles at C-5 of 
(193) are close to that of an ideal tetrahedral centre (Fig. 4.3). This tetrahedral character 
of the C-5 centre is further reinforced by the X-ray crystal structure of the acylated 
imidazolidinone derivative (206, see page 168, Appendix A4) derived from acetyl 
chloride rather than fluoroacetyl chloride. 
*X-Ray crystallography performed by Dr. A. Batsanov and Miss J. Moloney. 
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Fig. 4.3 
Fig. 4.4 Crystal structure of(J93) showing tetrahedral geometry at C(5). 
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4.3.2 Reduction of the '6-ketone' intermediate (193) to (197) 
(193) (197) 
Scheme 34 (I) NaB~/ MeOH/ Smin 
The key issue now was whether the reduction of the ~-ketone would be stereoselective 
and deliver the desired threo product, however in the event this proved to be the case. 
Reduction of (193) with sodiwn borohydride (excess) generated the ester (197) rather 
than the hydroxyamide (197a) due to a facile transesterification process. This 
phenomenon had previously been observed by Seebach. 154 
An optimwn reaction time of 5min proved crucial in isolating the correct 
product and generated (197) as a single diastereoisomer, as determined by 19F, 1H, and 
13C NMR spectroscopy, clearly demonstrating the high stereoselectivity of the reduction 
step. Reaction times >5min for the reduction step resulted in the isolation of an 
additional product. This was obvious from mass spectroscopy data which showed a 
fragmentation pattern attributable to (198). It was found that the aqueous extract from 
the sodiwn borohydride workup developed crystals which were identified as the sodium 
salt of benzoic acid (199). The highly basic conditions of the reduction almost certainly 
promoted the hydrolysis of the ester group as depicted in scheme 35. 
155 
(197a) OH 
1 
+ 
(199) (198) 
Scheme 35 
This ester hydrolysis was arrested by neutralising the methanolic solution with IN HCL 
Tic and IH-NMR analysis of the crude reaction mixture also revealed the presence of 
the starting imidazolidinone (144) (13%) if the reaction time is extended. This is 
presumably due to a 'retro-aldol' reaction occurring during the reduction process as 
outlined below (Fig. 4.5). 
Me Na 
-r<=rf~ 
Bz F 
0 
~OM• 
F 
Retro-aldol 
+ 
(200) (144) (201) 
Fig. 4.5 
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It would appear that the hydride delivery is to the re face of the carbonyl group. 
This face is the more exposed of the two as theN-benzoyl aromatic ring hinders access 
to the si face. Additionally the imidazolidinone ring carbonyl may co-ordinate boron 
and direct hydride to the more open re face of (193) (Fig. 4.6). The crystal structure 
indicates that the N-benzoyl centre is relatively more planar than the other nitrogen 
centre of (193) and allows the phenyl group to occupy a position as depicted below. 
This attack of the hydride sets the desired (S) stereochemistry at the stereogenic centre 
C-1 '. 
Fig. 4.6 
4.3.3 Hydrolysis of (2S.5S.l 'R)-5-(1 '-benzoyloxy-2 '-fluoroethyl)-2-(tert-
butyl)-3-metbylimidazolidin-4-one (197) 
(197) (202) 
Scheme 36 (I) 1 ON HCI/ 1 oooc; 72h 
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Hydrolysis of (197) was achieved under vigorous acid conditions, 1 ON HCl I 
100°C for 72h. The 4-(2S,3S)-fluorothreonine generated was recovered by ion-exchange 
chromatography and purified by recrystallisation from methanol/ water (9: 1 ). The 
optical rotation of the synthetic material ([a]0 25 = -20°, c=5, H20) compared very well 
with that reported by the groups of Scolastico157 ( [a]0 25 = -18.4°, c=1, H20) and 
Shimizu158 ([a]0 25=-20°, c=0.065, H20), clearly indicating that 4-(2S,3S)-
fluorothreonine had been isolated. The relative stereochemistry of the fluorinated amino 
acid (202) was shown to be threo by X-ray analysis (Fig. 4.7, Appendix A2). Note that 
the CH2F group is rotationally disordered over two positions due to the similar steric 
demands of fluorine and hydrogen which allows hydrogen to be replaced by fluorine in 
the solid state. The (2S,3S) absolute stereochemistry follows from the known absolute 
stereochemistry ofthe ~-ketone (194). Fig. A3 (Appendix A3) shows the 3-D network 
of hydrogen bonding interactions between molecules of 4-(2S,3S)-fluorothreonine in the 
crystal lattice. The shortest F-H interactions are typically 2.29 A, 2.55 A and will be 
weak interactions. 
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4.4 Comparison of natural and synthetic 4-fluorothreonine. 
The natural 4-fluorothreonine was isolated from cultures of S. cattleya and supplied by 
Harper and co-workers at the Queen's University in Belfast. To determine if the 
synthetic (2S,3S) isomer was identical to the natural 4-fluorothreonine, an "add-mix" 
experiment was conducted. Addition of the synthetic 4-fluorothreonine (5mg/ml) to the 
natural material (2mg/ml) was carefully monitored by 19F-NMR spectroscopy. No 
change was observed in the 19F-NMR and furthermore the 1H-NMR of the mixed 
sample revealed an identical set of signals signifying that the synthetic and the natural 
4-fluorothreonine were in fact the same stereoisomer. It must be added that care was 
taken to ensure that no overdosing had occurred. The [a ]0 of the natural product 
reported by Sanada et al., 107 (-18°, c=l, H20) differs slightly from our value of -20° 
( c=5, H20). However this difference, in the optical readings, may be due to temperature 
and concentration effects. Moreover identical GC-MS, HPLC and 13C-NMR data of the 
natural and synthetic forms of 4-fluorothreonine give reassurance that both compounds 
are identical (Fig. 4.8 and 4.9). 
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H(1AJ 
HOCJ 
0(2) 
Fig. 4.7 Crystal structure of 4-(2S,3S)-jluorothreonine (202) 
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Fig. 4.8 GC-MS trace of 4-.fluorothreonine isolated from S. cattleya 
161 
TIC: RUHUL4.0 
1400000 
IZ00000 
1000000 
800000 
600000 
400000 
Z00000 
0 
il'le--> 5. 10.00 15.00 Z0.00 ZS.00 
Abundance Scan 589 <8.471 l'lin>: RUHUL4.0 
z 8 
300000 
Z50000 73 
200000 
Z36 
150000 
100000 
50000 100 
1Z8 147 
17? 45 
0 J. I ~l\ J, ht. ,nl 172 190 hz4s 290 310 3~8 I I. 
f!/z--) s0 H~ t50 zoo ZS0 300 
Fig. 4.9 GC-MS trace of synthetic (2S,3S)-4-jluorothreonine (202) 
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Interestingly, Table 4.3 below shows the relationship of the optical rotation 
values between the various forms of threonine (Ref Aldrich Chemicals Cat.) 
Table 4.3 
Threonine [a]D (c=l, H20) at 25°C 
D- threonine +270 
D-al/o-threonine - 8.8° 
L-threonine - 27.4° 
L-a//o-threonine +90 
Note the marked difference in optical rotation values for allo-threonine and the Ll D 
forms. It is therefore anticipated that L-al/o-4-fluorothreonine would give a significantly 
different optical rotation value from L-4-fluorothreonine. These data provide further, 
albeit circumstantial, evidence that the stereochemistry at positions C-2 and C-3 of the 
natural4-fluorothreonine is (2S,3S). Fig. 4.10 shows a 400MHz 19F-NMR of the mixed 
sample of natural and synthetic 4-fluorothreonine indicating the presence of only a 
single diastereoisomer. 
It is perhaps important to note that HPLC analysis of L-allo- and a synthesised 
sample of L-threonine showed different elution times whereas the natural and synthetic 
4-fluorothreonines showed identical elution times [Fig. 4.11(a), (b)]. (N.B. the dominant 
peak at 11.3min on the chromatogram of the natural compound [4.ll(b)] is due to 
tyrosine which was used as an internal standard). 
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-227 -228 -229 -230 -231 -232 ppr. 
Fig. 4.10 400MHz 12F -NMR spectrum of a mixed sample of natural and svnthetic 
4-fluorothreonine (2mg: Smg) 
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Fig. 4.11 Liquid chromatogram of (a) synthetic 4-(2S. 3~)-fl.uorothreonine (b) natural 
4-fluorothreonine 
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4.5 Synthesis of [3-1H]-4-fluorotbreonine (204) 
ii 
(193) (203) (204) 
Scheme 37 (I) NaBD4 (77%) (ii) ION HCll 100°C/ 72h (67%) 
The route to 4-(2S,3S)-fluorothreonine is amenable to isotope labelling and a deuterium 
label was introduced at C-3 of 4-fluorothreonine by treating (193) with NaBD4 to 
generate (203). Acid hydrolysis of (203) followed by isolation using ion-exchange 
chromatography allowed recovery of [3-2H]-4-fluorothreonine (204) in satisfactory 
yield. 
4.6 Synthesis ofDL-[4.4.4-1H3]-tbreonine (208) 
In the initial stages of the project, it was judged important to prepare 
DL-[4,4,4-2H3]-threonine to determine the incorporation of deuterium into fluoroacetate 
and 4-fluorothreonine. Thus acetyl chloride was investigated in place of acetaldehyde as 
the electrophile in Seebach's route to L-threonine. 
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4.6.1 Synthesis of (2S. 3R)-threonine (187) using acetyl chloride as the electrophile 
(144) (205) 
OH 0 
~OH iii 
NH2 
(187) (186a) 
Scheme 38 (I) LDA/ CH3COCI/ -100°C (40%) (ii) NaB~/ Me0H/5min (69%) 
(iii) ION HCl/ l00°C/ 72h (69%) 
Coupling of the chiral imidazolidinone (144) with acetyl chloride generated the ketone 
(205) as a single diastereoisomer. X-ray analysis of a suitable crystal of the ketone (205) 
showed that the acetyl moiety occupies a site anti to the tert-butyl group (Fig. 4.12, for 
crystal data see Appendix A4). The tetrahedral geometry of the stereogenic centre at C-5 
of (206) again indicates that this centre is resistant to epimerisation. Thus the structures 
of (193) and (205) show very similar characteristics. 
Reduction of (205) generated the secondary alcohol which rearranged to the 
ester (186a) in an analogous manner to that of the fluorinated intermediate (193, see 
page 155). 
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Fig. 4.12 Crystal structure of 5 -(2S. 5S) - (1 ' - carbonyl- 2' - methyl ) - 2 - ( tert-
butyl) -3-methylimidazolidin-4-one (205) 
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The optical rotation value for (186a) ([a]0 = +90°) and of (184a) was similar to that 
([a.]0 = +85.7°)154 reported for the aldehyde derived benzoyl ester (186a). 
Hydrolysis under acidic conditions liberated (2S,3R)-threonine [(187), scheme 
38] which was purified by ion-exchange chromatography. Comparison of the 1H-NMR 
of the synthesised threonine and a reference sample of L-threonine and allo-threonine 
demonstrated that the route yielded the desired diastereoisomer. The 1H-NMR spectra 
(Fig. 4.13(a), (b), (c)) clearly show that these two diastereoisomers are easily 
distinguished. The presence of only a single diastereoisomer, indicated again that the 
reduction takes place with a high level of stereoselectivity. Furthermore the optical 
rotation value of the prepared L-threonine ([a]0 = -24°, c=l, H20) was close to the 
literature value ([a]0 = -27.4°, c=l, H20). 154 
With the synthesis of threonine in place, the route was modified to prepare 
[ 4,4,4-2H3]-threonine. The coupling between [2,2,2-2H3]-acetyl chloride and the 
imidazolidinone enolate produced the corresponding deuteriated ketone (206) 
(Scheme 39). Reduction of this ketone with NaBH4 followed by acid hydrolysis 
generated [4,4,4-2H3]-threonine (208) (24% overall yield) in a straightforward manner. 
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Scheme 39 (I) LDA/ CD3COCl/ -100°C (ii) NaBf4/ MeOH/Smin 
(iii) 1 ON HCl/ 1 00°C/ 72h 
With the racemic [ 4,4,4-2H3]-threonine in hand, its incorporation into the 
fluorometabolites in resting cells of S. cattleya was studied. The GC-MS data indicated 
that the isotope is not significantly incorporated (-0.1%) into C-2 of fluoroacetate or 
C-3 and C-4 of 4-fluorothreonine (results not shown). From this study, it is evident that 
threonine is clearly not a precursor to the fluorometabolites. However, given the 
efficient serine hydroxymethyl transferase activity catalysing the interconversion of 
serine and glycine, it is possible to envisage this enzyme mediating the cleavage of 
threonine to acetaldehyde and glycine. The carbon atoms of glycine thus produced may 
be efficiently incorporated into the fluorometabolites, accounting for the relatively high 
incorporation level of [U-14C]-threonine (see Chapter 2, Table 2.2, p 64). 
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4.7 Summary 
A novel approach to the synthesis of threonines has been developed where acetyl 
chloride can be used as a good substitute for acetaldehyde in the diastereoselective 
acylation of a chiral imidazolidinone enolate, thus providing an alternative route to 
threo-amino acids such as L-threonine. This modification has the advantage of using 
acid chlorides in place of aldehydes when the requisite aldehyde is unavailable. The 
stereospecific synthesis of 4-(2S,3S)-fluorothreonine, using this modified procedure, has 
allowed the absolute stereochemistry of the n~tural product to be assigned. 
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4.8 Towards a synthesis of 4-chlorothreonine (67) 
Yoshida et al., 163 in 1994 have reported 4-chlorothreonine (67) as a microbial 
metabolite produced by Streptomyces sp. OH-5093. 4-Chlorothreonine is also a 
constituent of the naturally occurring syringostatins and syringomycin metabolites of 
Pseudomonas syringae. 164' 165 The methodology developed in this thesis for the 
preparation of 4-fluorothreonine was explored towards the synthesis of 
4-chlorothreonine. 
Me 0 
-KX,7° 
Bz \ 
~a 
(144) (209) 
Scheme 40 (i) LOA/ ClCH2COCl/ -1 oooc 
Deprotonation of the imidazolidinone was achieved with LDA. This was 
followed by acylation using chloroacetyl chloride which generated the chloroketone 
(209). This compound proved difficult to purify by flash chromatography therefore the 
partially purified chloroketone was reduced directly with sodium borohydride. 
(209) 
Scheme 41 (i) NaB~/ MeOH/5min (12%) 
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~e 0 
r<NX OBz 
H '''( 
C~CI 
(210) 
The reduction (Scheme 41) was neutralised after 5min and subsequent 
purification of the resultant product over silica afforded the chlorinated ester (210) 
which was isolated as a yellow oil (12% from (144)) and was fully characterised. 
Hydrolysis of (210) using ION HCl at 100°C for 72h generated a complex mixture of 
products which could not be characterised. 1H-NMR spectra of the hydrolysis products 
showed no obvious signals that could be attributed to 4-chlorothreonine. As a result of 
the labile C-Cl bond in (210), efforts to synthesise 4-chlorothreonine using this route 
were discontinued. 
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Biosynthesis qffluoroacetate and 4-fluorothreonine bv S. cattleya 
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5. Experimental 
(Part I) 
General: 
Flash column chromatography was performed with (FC) Fluka silica gel-60 (35-70!J.m) 
or Sorbsil-C60-M (40-60!J.m). Infra red spectra were recorded on a Perkin-Elmer F.T. 
1600 or 1720X spectrometer 1H-NMR spectra were recorded on a Varian Gemini 
200MHz (199.977MHz), Varian XL-200 (200.057MHz), Varian VXR-400S (399.952) 
and Broker AC-250 (250.133MHz) spectrometers. BC-NMR were obtained using 
Varian Gemini 200MHz (50.30MHz), Bruker AC-250 (62.257MHz) and Varian VXR-
400S (100.577MHz) spectrometers. 2H-NMR were recorded on a Bruker AMX-
500MHz (76.775MHz) spectrometer. 19F-NMR were recorded on a Bruker AC-250 
(235.34MHz), Varian VXR-400S (376.289MHz) and a Bruker Spectrospin AMX-
500MHz (471.54MHz) spectrometers. Chemical shifts (8) are quoted in ppm relative to 
TMS for 1H and 13C-NMR and fluoride was used as a reference for 19F { 1H}-NMR 
spectra. Coupling constants, J, are quoted in Hz. Radioactive analysis was performed on 
a Packard 200CA scintillation analyser in Ecoscint A fluid. Mass spectra were recorded 
on a VG analytical 7070E mass spectrometer. Melting points were performed on a 
Gallenkarnp apparatus and are not corrected. 
Note: Sodium jluoroacetate and jluoroacetyl chloride are both toxic compounds and 
must be handled with great caution. 
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5.1 Preparation of N-(2.2-Dimethylpropylidene)-glycine-(N-metbylamide) (184) 161 
Glycine methyl ester hydrochloride (182) (12.56g, 0.10mol) was added slowly to cooled 
8M ethanolic methylamine (37.5ml), with stirring at room temperature (-15h). After 
concentration of the suspension in vacuo, CH2Cl2 (20ml) was added to the resulting 
viscous material and the solution concentrated in vacuo. This residue, pivalaldehyde 
(23.5ml, 0.15mol) and triethylamine (20.9ml, 0.15mol) in CH2Cl2 (lOOml) was heated 
under reflux for 1 Oh. The cooled mixture was filtered and the filter cake washed with 
diethyl ether (50ml). The resulting white foamy filtrate was again filtered off and 
concentration of the filtrate gave N-(2,2-dimethylpropylidene )-glycine-(N-methylamide) 
(184) as a yellow oil (11.8g, 76%) B.p. 120°C I 0.1 Torr, lit. b.p. l19°C/ 0.1 Torr. 161 IR 
(CHC13): 3315m (br.), 2960s, 1660s, 1525s, 1405m. 1H-NMR (CDC13): 7.60 (lH, s, H-
C=N), 7.00 (lH, s, br, NH), 3.98 (2H, s, Hz-C(2)), 2.83 (3H, d, 1=3.0, Me-N), 0.95 (9H, 
s, (t-Bu)). 13C-NMR (CDC13): 172.5 (C-4), 115.0 (C-2), 46.1 (C-5), 39.4 (-CMe3), 27.0 
(N-Me), 21.4 (t-Bu). MS: (EI); 157 (M+ +1, 12%), 141 (2%), 113 (2%), 99 (86%), 73 
(100%), 72 (23%), 41 (35%), 30 (48%). 
5.2 Preparation of 2-(tert)-butyl-3-metbyl-imidazolidin-4-one (185) 161 
A solution of (184) in methanol (30ml) was treated with a saturated solution of 
methanolic HCl at 0°C. After stirring (30min) at 0 oC the mixture was left to stir at room 
temperature for 3-4h. The resultant solution was concentrated to a syrup under reduced 
pressure, dissolved in CH2Cl2 (80ml), and washed with 3M aqueous NaOH (67ml). The 
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organic extract was dried (MgSO 4) and the solvent evaporated to afford the product 
(185) as a yellow oil. (10.7g; 69%). B.p. 128°C/ 0.05 Torr, lit. b.p. 130°C/ 0.05 Torr. 161 
IR (CHC13): 3378m (br), 2963s, 1675s, 1400m, I 319m, 1110m. 1H-NMR (CDC13): 4.13 
(1H, s, H-C(2)). 3.43 (1H, s, H-C(5)), 2.92 (3H, s, Me-N), 2.36 (IH, s, br, NH), 0.97 
(9H, s, (Me)3C). 13C-NMR (CDC13): 174.5 (C-4), 85.0 (C-2), 49.1 (C-5), 37.4 (-CMe3), 
31.0 (N-Me), 25.4 (t-Bu). MS: (CI); 157 (M+ +1, 2%), 141 (2%), 113 (2%), 99 (96%), 
73 (100%), 42 (31%), 41 (32%), 30 (47%). Found 157.13392, C8H17N20 (M++l) 
requires 157.13408. 
5.3 Preparation of DL-1-benzoyl-2-(tert)-butyl-3-methylimidazolidin-4-one (144)161 
Benzoyl chloride (0.89g, 0.73ml) and IM NaOH (3.9ml) was added to a stirred solution 
of 2-(tert)-butyl-3-methylimidazolidin-4-one (185) (l.OOg, 6.4mmol) in CH2Cl2 (lOml) 
with ice-cooling. The reaction was monitored by t.l.c. and when judged complete, the 
solvent was removed under reduced pressure to afford a yellow oil which was dissolved 
in diethyl ether (25ml) and washed with IM NaOH. The organic layer was separarted 
and dried (MgS04). Removal of the solvent left an off-white solid which was 
recrystallised from a minimum amount of hot ethanol to give (144) in 85% yield. M.p. 
142-143°C lit. 143-144°C. 161 IR (KBr): 3509m (br), 3390m (br), 2982s, 2879m, 1700s, 
1646s, 1483m, 1378s, 1304s, 1253s, 1115m, 884m, 790m, 121m, 596m. 
1 H-NMR (CDCl3): 7.48 (5H, m, arom), 5.68 (1H, s, H-C(2)), 4.11 (2H, d, Joem = 15.2, 
" 
HrC(5)), 3.81 (2H, d, Jgem = 15.2, H2-C(5)), 2.99 (3H, s, N-Me), 1.10 (9H, s, t-Bu). 
13 C-NMR (D20): 171.5 (C-OPh), 164.2 (C-4), 134.2 (arom), 131.5 (arom), 128.5 
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(arom), 127.9 (arom), 80.7 (C-2), 66.9 (C-5), 39.7 (-C(Me)3), 31.5 (N-Me), 25.9 
((Me)3). MS: (CI); 261 (M++1, 100%). 
5.4 Preparation of DL-1-benzoyl-2-(tert-butyl)-5-(1-hydroxy-ethyl)-3-
methylimidazolidin-4-one (186) 154 
A solution of(144) (0.65g, 2.5mmol) in THF (15ml) was added slowly (via cannula) to 
a solution of diisopropylamine (0.35ml, 2.5mmol) and 1.6M butyllithium (1.87ml, 
1.2equiv.) in THF (25ml) at -78 °C and left to stir at -78 °C for 15min. The temperature 
was lowered to -100 °C (liquid nitrogen/ diethylether) for 30 min and acetaldehyde 
(0.70ml, 12.5mmol) was added by syringe to the mixture which rapidly deolourized. 
After 1 min the reaction was quenched with saturated aqueous NH4Cl (25ml) and Et20 
(25ml) and after warming to room temperature, the two phases were separated and the 
aqueous layer extracted into Et20 (3 x 25ml). The combined organic extracts were 
washed with H20 (20ml), dried (MgS04) and concentrated to afford a white solid. 
Crystallization from ethyl acetate/ petroleum ether (b.p. 60-80°C) (2:3) gave DL-1-
benzoyl-2-(tert-butyl)-5-(1-hydroxy-ethyl)-3-methylimidazolidin-4-one (186) (0.23g, 
30%). M.p. 165-166°C lit. 165.9-166.8°C.154 IR (CHC13): 3420m (br), 2973s, 1681s, 
1637s, 1377s, 1258m, 1126m, 1090s, 872m, 762m, 724s, 698s, 538m. 1H-NMR 
(CDC13): 7.98-7.95 7.54-7.39 (5H, m, arom), 5.38 (1H, dq, J=6.5, 4.3, H-C(l.)), 4.21 
(1H, d, J=2.0, H-C(2)), 3.73 (1H, m, H-C(5)), 2.93 (3H, s, Me-N), 1.48 (3H, d, J=6.5, 
• 13 
CH3C(l )), 0.99 (9H, s, (t-Bu)). C-NMR (CDC13): 172.3 (C-OPh), 162.8 (C-4), 136.2 
(arom), 132.0 (arom), 128.5 (arom), 126.2 (arom), 81.7 (C-2), 65.7 (C-1 '), 61.2 (C-5), 
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38.1 (-C(Me)3), 31.5 (N-Me), 25.9 ((Me)3), 19.3 (C-2'). MS (EI): 247 (M+ -57, 25%), 
203 (11%), 125 (49%), 105 (100%), 77 (36%). 
5.5 Preparation of DL-threonine~ 
A mixture of (186) (0.304g, 1mmol) and ION HCl (15ml) was heated under reflux at 
100°C for 72h. The cooled solution was extracted into Et20 (3x10ml) and the aqueous 
phase evaporated to leave a residue which was adsorbed onto Dowex-50-W X8 ion-
exchange resin (30g). The ion-exchange resin was primed by initially washing it until it 
was neutral, followed by acidification with dil. HCl and then the amino acid was eluted 
with 1.5M aqueous NH40H solution (250ml). Concentration of the aqueous ammonia 
solution under reduced pressure afforded DL-threonine as an amorphous white solid 
which was recrystallised from EtOH/ H20 (0.085g, 71 %). M.p. 241-244°C (dec.), lit. 
242-245 °C (dec.). 154 IR (KBr): 3168s (br), 2975s (br), 2712m (br), 2049w, 1626s, 
1456s, 1346s, 1112s, 1040s, 935s, 560s. IH-NMR (D20): 4.13 (1H, dq, 1=6.3, 4.5, H-
C(3), 3.45 (1H, d, 1=4.5, H-C(2)), 1.23 (3H, d, 1=6.2, Me-C(3). 13C-NMR (D20): 181.4 
(C-1), 70.1 (C-3), 62.7 (C-2), 20.0 (C-4). MS: (EI); 75 (M+-44, 92%), 74 (23%), 57 
(89%), 56 (29%), 45 (42%), 44 (100%), 42 (40%), 41 (16%). 
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5.6 Preparation ofDL-[3.4,4.4-1H4)-threonine (192) 
A solution of (144) (0.65g, 2.5mmol) in THF (15ml) was added slowly (via cannula) to 
a solution of diisopropylamine (0.35ml, 2.5mmol) and 1.6M butyllithiurn (1.87ml, 
1.2equiv.) in THF (25ml) at -78 oc and left to stir at -78 oc for 15min. The temperature 
was then lowered to -100°C for 30min and [1,2,2,2-2H4]-acetaldehyde (0.70ml, 
12.5mmol) was added by syringe to the mixture. After lmin the reaction was quenched 
with sat. aqueous NH4Cl (25ml) and Et20 (25ml). The aqueous layer was extracted into 
Et20 (3 x 25ml) and the combined organic extracts were washed with H20 (20ml), dried 
(MgSO 4) and concentrated to afford an off-white solid. This material was not 
characterised but directly dissolved in ION HCl (lOml) and heated under reflux at 100° 
C for 72h. The cooled solution was extracted into Et20 (3x10ml) and the aqueous phase 
evaporated to leave a residue which was adsorbed onto Dowex-50-W X8 ion-exchange 
resin (30g). The product was eluted with 1.5M aqueous NH40H solution (250ml) and 
removal of the solvent in vacuo afforded DL-[3,4,4,4-2H4]-threonine (0.04g, 14% from 
starting material (144)). M.p. 235-239°C (dec.). IR (KBr): 3154s (br), 2971s (br), 
2667m (br), 1619s, 1417s, 1040s, 701s, 563m. 1H-NMR (D20): 3.45 (lH, d, J=4.5, H-
C(2)). 2H-NMR (H20): 4.20 (lD, s, minor diastereoisomer), 4.10 (lD, s, D-C(3)), 1.23 
(3D, s, (CD3)). MS: (CI); 137 (M(NH4t -2D, 7.9%), 105 (23.9%), 88 (41.6%), 78 
(77.2%), 60 (20.7%), 49 (10.1%). 
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5. 7 Preparation of 5-(2S.5S)-(1' - carbonyl - 2' - methyl ) - 2 - ( tert- butyl) -3-
methylimidazolidin-4-one (205) 
A solution of (144) (0.50g, 1.9mmol) in THF was added slowly (via cannula) to a 
solution of diisopropylamine (0.26ml, 1.9mmol) and 1.6M n-butyllithium (1.42ml, 
1.2equiv.) in THF (15ml) at -78 oc and left to stir at -78 oc for 15min. The temperature 
was then lowered to -100 °C for 30 minutes and acetyl chloride (1.2ml, 15mmol) was 
added. After 3min the reaction was quenched with sat. aqueous NH4Cl (25ml) and Et20 
(25ml) and left to warm to room temperature. The two phases were separated, the 
aqueous layer extracted into Et20 (3 x 25ml) and the combined organic extracts were 
washed with H20 (20ml), dried (MgS04) and evaporated to afford an off-white solid 
which was purified by recrystallisation from ethanol to afford (205) (200mg, 40%). M.p. 
25 188-189°C (dec). [a]0 = + 120° (c=O.Ol, CHC13). IR (KBr): 2984s (br), 2940s (br), 
22870s (br), 1732s, 1700s, 1397s, 1374m, 1152, 727s, 700m. 1H-NMR (CDC13): 7.60-
7.23 (5H, m, arom), 5.64 (lH, s, H-C(2)), 5.11 (lH, s, H-C(5)), 3.00 (3H, s, Me-N), 1.82 
(3H, s, CH3CO), 0.99 (9H, s, t-Bu), 13C-NMR (CDC13): 199.7 (C-1 '), 171.3 (C-OPh), 
165.3 (C-4), 136.3 (arom), 131.3 (arom), 128.6 (arom), 127.7 (arom), 79.9 (C-2), 70.5 
(C-5), 40.3 (-.C(Me)3), 32.1 (N-Me), 28.7 (-C-2'), 26.1 ((Me)3). MS: (EI); 245 (M+ -57, 
37%), 204 (9%), 125 (51%), 105 (100%), 77 (36%) 43 (11%). CHN found C 56.18% 
H 72.73% N 9.21% C17H22N20 3 requires C 56.29% H 72.85% N 9.27%. 
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5.8 Preparation of5 -( 2S. SS )- ( 1'- benzoyloxy)- 2'- methyl)- 2- ( tert -butyl)-
3 - methylimidazolidin - 4 - one (186a) 
A solution of (205) (200mg, 0.65mmol) in methanol (60ml) was treated with sodium 
borohydride (24mg, 1 equiv.). After 5min the reaction was quenched to neutral pH by 
the addition of IN HCI. The aqueous methanolic mixture was removed under reduced 
pressure to leave a dry white residue which was suspended in H20 (15ml) and extracted 
into Et20 (3x15ml). Removal of the solvent left a yellow gum (-300mg) which was 
purified by chromatography to afford (186a) as a white solid (136mg, 69%). M.p. 165-
1660C, lit. 165.9-166.8°C.154 [a]0 25= +82° (c=0.01, CHC13), lit. [a]0 = +85.7° (c=l.03, 
CHC13).
154 IR (CHC13): 3420m (br), 2973s, 1681s, 1637s, 1377s, 1258m, 1126m, 1090s, 
872m, 762m, 724s, 698s, 538m. 1H-NMR (CDC13): 7.98-7.95 and 7.54-7.39 (5H, m, 
, 
arom), 5.36 (1H, dq, J=6.5, 4.3, H-C(1 )), 4.20 (1H, d, J=2.0, H-C(2)), 3.73 (1H, m, H-
, 13 C(5)), 2.95 (3H, s, Me-N), 1.47 (3H, d, J=6.5, CH3C(l )), 0.99 (9H, s, t-Bu). C-NMR 
(CDC13): 173.3 (C-OPh), 164.2 (C-4), 133.2 (arom), 131.4 (arom), 128.1 (arom), 126.6 
(arom), 82.4 (C-2), 67.3 (C-1 '), 61.4 (C-5), 40.1 (-.C(Me)3), 33.7 (N-Me), 26.7 ((Me)3), 
21.3 (C-2'). MS: (EI); 245 (M+ -57, 34%), 204 (19%), 125 (45%), 105 (100%), 77 
(28%) 43 (9%). CHN found C 56.28% H 72.98% N 9.16% C17H24N20 3 requires 
C 56.29% H 72.85% N 9.27%. 
5.9 Preparation of (2S.3R)-threonine (187) 
A mixture of (186a) (0.300g, lmmol) and ION HCI (15ml) was heated under reflux at 
100°C for 72h. The cooled solution was extracted into Et20 (3x10ml) and the aqueous 
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phase evaporated to leave a residue which was adsorbed onto Dowex-50-W X8 ion-
exchange resin. The amino acid was eluted with 1.5M aqueous ammonia solution 
(250ml). Evaporation of the aqueous ammonia solution under reduced pressure afforded 
L-threonine which was recrystallised from EtOH/ H20 (0.073g, 69.4%). M.p. 240-244° 
C (dec.), lit. 242-245 oc (dec.). [a]0 25= -25° (c=l, H20), lit. [a]0 25= -27.9° (c=l.02, 
H20). 154 IR (KBr): 3143s (br), 2971s (br), 2712m (br), 1635s, 1450s, 1246s, 1102s, 
1040s, 915s. 1H-NMR (D20): 4.11 (lH, dq, J=6.3, 4.5, H-C(3)), 3.48 (lH, d., J=4.5, H-
C(2)), 1.20 (3H, d, J=6.2, Me-C(3)). 13C-NMR (D20): 183.1 (C-1), 72.1 (C-3), 60.7 (C-
2), 23.0 (C-4). MS: (EI); 75 (M+-44, 92%), 74 (21%), 57 (75%), 56 (32%), 45 (45%), 44 
(100%), 41 (16%). CHN found C 40.49% H 7.63% N 11.74% C4~N03 requires 
C 40.34% H 7.56% N 11.76%%. 
5.10 Preparation ofDL-[4.4.4-lHJ.)-threonine (208) 
DL-1-Methyl-2-tert-butyl-3-methyl-imidazolidinone (144) (0.65g, 2.5mmol) was slowly 
added (via cannula) to a solution of diisopropylamine (0.35ml, 2.5mmol) and 1.6M 
butyllithium (1.87ml,l.2equiv.) in THF (25ml) at -78 °C and left to stir at -78 °C for 
15min. The reaction mixture went a deep red colour. The temperature was then lowered 
to -100 °C for 30 minutes and then [2,2,2-2H3]-acetyl chloride (1.4ml, 17.17mmol) was 
added. After 3min the reaction was quenched with saturated NH4Cl (25ml) and ether 
(25ml) and left to warm to room temperature. The two phases were separated and the 
aqueous layer was extracted into Et20 (3 x 25ml). The combined organic extracts were 
washed with H20 (20ml), dried (MgS04) and evaporated to afford an off-white solid 
(-300mg) which was directly dissolved in methanol (60ml) and sodium borohydride 
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(0.20g, 1 equiv.) added. The mixture was left to stir for lh and then the reaction was 
subsequently quenched with H20 (10-15ml). The aqueous methanolic mixture was 
removed under reduced pressure to a leave a residue which was suspended in H20 (10-
,, 
15m1) and extracted into Et20 (3x15ml). After removal of the solvent, the solid 
(-295mg) was dissolved in ION HCl (lOml) and heated under reflux at 100°C for 72h, 
and then treated with acidic Dowex to afford DL-[4,4,4-2H3]-threonine (0.070g, 24% 
from starting material (144)). M.p. 238-241 °C (dec). IR (KBr): 3023s (br), 2975s (br), 
2515s (br), 1625s, 1417s, 1108s, 926s, 768m. 1H-NMR (D20): 3.90 (IH, d, J=5.2 H-
13 C(3)), 3.25 (IH, d, J=5.2 H-C(2)). C-NMR (D20): 179.3 (C-1), 70.1 (C-3), 62.9 (C-2), 
14.3 (septet, J=18.2, C-4). MS: (CI); 137 (M(NH4t -2D, 3.4%), 105 (15.1%), 89 
(49.9%), 77 (11.3%), 42 (11.7%) 
5.11 Preparation of ammonium [2..1H]-glycolate (106) 
Sodium borohydride (0.5g, 13.8mmol) was added to a solution of glyoxylic acid (l.Og, 
10.8mmol) in methanol (30ml) and left to stir at room temperature for 2h. The reaction 
was acidified to pH 1 (IN HCl) and then another equiv. of sodium borohydride was 
again added and left to stir for another 2h at room temperature. The reaction was 
quenched with H20 (2-3ml) and the solvent removed under reduced pressure to leave a 
residue which was dissolved in H20 (30ml) washed with Et20 (3x20ml) and then 
adsorbed onto basic Dowex JX8-50 ion-exchange resin (25g). The product was eluted 
with l.SM aqueous ammonia solution which, after removal, afforded ammonium [2-
2H]-glycolate, as a white solid (880mg, 93%). M.p. 278-284°C (dec). IR (KBr): 3143s 
(br), 2780s (br), 2003m (br), 1740m, 1401s, 1101m (br). 1H-NMR (D20): 3.9 (lH, s, H-
185 
C(2)). 13C-NMR (D20): 182.4 (C-1), 163.5 (t, J=21.5, C-2). MS: (FAB+); 223 
(M(glyceroit -63, 42%), 154 (0.84%), 131 (34.5%), 57 (27.5%). 
5.12 Preparation of calcium glycolate (211l49 
0 (loH 
OH 
(211) 
· Trifluoroacetic anhydride (17.5g, 87.5mmol) was added to acetic acid (5g, 83mmol) at 
0°C over 1 Omin. After 25min of stirring, red phosphorus (75mg, 2.5mmol) was added. 
The mixture was heated to 60°C and stirred for 1 Omin followed by addition of bromine 
(11.9g, 75mmol) with continuous stirring for 4h. The volatiles were removed directly by 
evaporation under reduced pressure, and on cooling bromoacetic acid solidified. The 
solid was broken up and dissolved in Et20 (30ml) and filtered. The solvent was then 
removed under reduced pressure and then dried. A solution of the crude bromoacetic 
acid (1.39g, 1 Ommol) was then directly dissolved in water (20ml) and heated with 
calcium carbonate (4.5g, 45mmol) at 90°C for 60h. The reaction mixture was filtered 
hot and the filtrate (without the washings) was stored at -10°C for 24h. The crystalline 
calcium glycolate (412mg, 75%) was collected, washed with ethanol (30ml) and dried 
under vacuum. M.p. 293-297°C (dec). IR (KBr): 3226m (br), 2960s, 2873s, 2529s, 
1731 s, (br), 1462s, 10 17m. 1H-NMR (D20): 3.9 (2H, s, H2-C(2)). 13C-NMR (D20): 
175.5 (C-1), 88.4 (C-1). 
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5.13 Preparation of calcium [2,2-1H2)-glycolate (110) 
Trifluoroacetic anhydride (9.0g, 44mmol) was added to [2-2H3]-acetic acid (108) (2.5g, 
41mmol) at 0°C over 10min. After 15min of stirring, red phosphorus (37.5mg, 
1.25mmol) was added. The mixture was heated to 60°C and stirred for 10min after 
which bromine (6.0g, 38.5mmol) was added and stirring continued for 4h. The volatiles 
were removed by evaporation under reduced pressure, and on cooling a brown solid was 
evident. The solid was broken up and dissolved in methanol/ Et20 (30ml) and filtered. 
The solvent was removed under reduced pressure to leave a [2_2H2]-bromoacetic acid 
(109) as a brown oil that solidified on cooling. A solution of this crude solid (0.70g) in 
water (20ml) was treated slowly with calcium carbonate (3.5g, 35mmol) and the mixture 
heated at 90°C for 60h. The reaction mixture was filtered while hot and the filtrate 
(without washings) kept at -10°C for 24h. The crystallised product was collected, 
washed with ethanol (30ml) and dried under vacuum to afford calcium [2,2-2H2]-
glycolate as a soild (300mg, 76%). M.p. 290-294°C (dec). IR (KBr): 3224m (br), 2960s, 
13 2865s, 1726s (br), 1471s, 998m. C-NMR (D20): 182.7 (C-1), 63.5 (p, 1=6.7, C-2). 
MS: (FAB-); 219 (M(glycerolt-67, 21.1%), 127 (100%), 129 (33.2%), 35 (50.8%). 
5.14 Preparation of sodium [2-llC)-glycolate (102)130 
Trifluoroacetic anhydride (9.0g, 44mmol) was added to [2-BC]-acetic acid (2.5g, 
41mmol) at ooc over 10min. After 15min of stirring, red phosphorus (37.5mg, 
1.25mmol) was added. The mixture was heated to 60°C and stirred for 1 Omin after 
which bromine (6.0g, 38.5mmol) was added and stirring continued for 4h. The volatiles 
were removed directly by evaporation under reduced pressure, and on cooling a brown 
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solid was evident. The solid was broken up and dissolved in methanol I Et20 (30ml) and 
filtered. The solvent was removed under reduced pressure to leave a brown oil, [2-13C]-
bromoacetic acid (101) which solidified on cooling. A solution of the crude solid (l.Og) 
and potassium hydroxide (580mg, 14.5mmol) in water (10ml) was heated in a sealed 
Carius tube at l20°C for 3h. The solution was concentrated (3ml) and the pH adjusted to 
pH 2 (lN HCl) and loaded onto an Extrelute column. The product (102) was eluted with 
Et20 (1 OOml) which was removed under reduced pressure affording [2-BC]-glycolic 
acid. The solution was neutralised (IN NaOH) and then freeze dried to afford the 
sodium salt of [2-BC]-glycolic acid as a white powder (224mg, 40%). M.p. 291-294°C 
(dec). IR (KBr): 3140s (br), 2710s (br), 1738m, 1391m, 1037m, 810m. 1H-NMR (D20): 
3.68 (2H, d, J!3c-IF132.3). 13C-NMR (D20): 173.8 (d, 1=58.6, C-1), 62.0 (C-2). MS: 206 
(M+(MSTFA), 16.07%), 178 (14.3%), 162 (7.1%), 147 (85.7%), 73 (100%), 45 
(17.3%). 
5.15 Preparation of sodium [1.2-llC6]-glycolate (104)
130 
Trifluoroacetic anhydride (9.0g, 44mmol) was added to [1,2-13C2]-acetic acid (2.5g, 
41mmol) at 0°C over 10min. After 15min of stirring, red phosphorus (37.5mg, 
1.25mmol) was added. The mixture was heated to 60°C and stirred for 1 Omin after 
which time elemental bromine (6.0g, 38.5mmol) was added and stirring was continued 
for 4h. The volatiles were removed directly by evaporation under reduced pressure, and 
on cooling a brown solid was evident. The solid was broken up and dissolved in 
methanol I Et20 (30ml) and filtered. The solvent was removed under reduced pressure 
to afford [1,2-13C2]-bromoacetic acid (103) as a brown oil which solidified on cooling, 
A solution of the crude [1,2-13C2]-bromoacetic acid (l.Og, 7.1mmol) and potassium 
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hydroxide (580mg, 14.5mmol) in water (10ml) was heated in a sealed Carius tube at 120 
°C for 3h. The solution was concentrated to 3ml and the pH adjusted to pH 2 (IN HCl) 
and then loaded onto an Extrelute column. [1,2-l3C2]-Glycolic acid (104) was eluted 
with Et20 (100ml) which was removed under reduced pressure. The solution was 
neutralised (IN NaOH) and then freeze dried to afford the sodium salt of [1,2-BC~-
glycolic acid as an amorphous white powder (201mg, 35%). M.p. 289-294°C. IR (KBr): 
3130s (br), 2710s (br), 1748m, 1406m, 1011m, 810m. 1H-NMR (D20): 3.68 (2H, d, ]13c. 
H=l34.3). l3C-NMR (D20): 175.8 (d, J=58.3, C-1). 64.0 (d, J=58.3, C-2). MS: 206 (M 
(MSTFAt- 1, 20.1%), 178 (11.1%), 148 (42.1%), 73 (100.0%), 45 (8.1%). 
5.16 Preparation of DL-1-benzoyl-2-tert-butyl-3.5-dimethyl-imidazolidinone 
.am154 
Me 
-r<:x: 
Bz 3 
(212) 
DL-1-Benzoyl-2-(tert)-butyl-3-methylimidazolidin-4-one (144) (1.3g, 5.0mmol) was 
slowly added (via cannula) to a solution of diisopropylamine (0.70ml, 5.0mmol) and 
1.6M n-butyllithium (3.8ml, 5.0mmol) in THF (25ml) at -78°C and left to stir at -78°C 
for 45min. Methyliodide (0.31ml, 2.5mmol) was slowly added and after 1h at -78 °C, 
the temperature was allowed to rise to 0°C. The reaction was quenched with sat. NH4Cl 
(25ml) and Et20 (25ml) and after warming to room temperature, the aqueous phase was 
extracted into Et20 (3x20ml). The combined organic extracts were washed with brine 
(30ml), water (30ml) and dried (MgS04) and the solution was filtered and the solvent 
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removed under reduced pressure to afford DL-1-benzoyl-2-tert-butyl-3,5-dimethyl-
imidazolidinone (212) as an amorphous white solid (1.25g, 90%). M.p. 145-146°C lit. 
145.5-146.5°C.154 IR (K.Br): 3342m (br), 2947s, 2865s, 1718s, 1615s, 1225m, 936m. 
IH-NMR (CDC13): 7.50-8.10 (5H, m, arom), 5.68 (IH, s, H-C(2)), 4.23 (1H, q, J=6.8, 
H-C(5)), 2.99 (3H, s, Me-N) 1.09 (9H, s, (t-Bu)), 0.97 (3H, d, J=6.8, H3-C(l ')). 13C-
NMR (CDC13): 172.3 (C-OPh), 169.2 (C-4), 136.2 (arom), 131.6 (arom), 128.7 (arom), 
127.6 (arom), 80.4 (C-2), 57.3 (C-5), 40.1 (-C(Me)3), 32.8 (N-Me), 26.3 ((Me)3), 19.3 
(C-1 '). MS: (EI); 217 (M+-57, 100), 106 (77). 105 (89), 85 (17), 77 (73). CHN found C 
69.95% H 8.11% N 10.24% C16H22N20 2 requires C 70.07% H 8.02% N 10.22%. 
5.17 Preparation of DL-1-benzoyl-2-(tert-butyl)-3-[5-~H~]-methyl)-imidazolidin-4-
one (145) 
DL-1-Benzoyl-2-(tert)-butyl-3-methylimidazolidin-4-one (144) (1.3g, 5.0mmol) was 
slowly added (via cannula) to a solution of diisopropylamine (0.70ml, 5.0mmol) and 
1.6M n-butyllithium (3.8ml, 5.0mmol) in THF (25ml) at -78°C and left to stir at -78°C 
for 45min. eH3]-Methyliodide (0.31ml, 2.5mmol) was slowly added with no immediate 
colour change, and after 1h at -78 °C, the temperature was allowed to rise to 0°C. The 
reaction was quenched with sat. NH4Cl (25ml) and Et20 (25ml) and after warming to 
room temperature, the product was extracted into Et20 (3x20ml). The combined organic 
phases were washed with brine (30ml), water (30ml) and dried (MgS04), the solution 
was filtered and the solvent removed under reduced pressure to give an amorphous 
white solid (1.20g, 88%). M.p. 144-147°C. IR (K.Br): 3004s, 2913s, 1710s, 1622s, 
1375m, 1184s, 799m. 1H-NMR (CDC13): 7.50-8.10 (m, arom), 5.68s (1H, s, H-C(2)), 
190 
3.82 (IH, s, H-C(5)), 3.05 (3H, s, Me-N) 1.09 (9H, s, (t-Bu)). BC-NMR (CDC13): 172.4 
(C-OPh), 171.2 (C-4), 137.2 (arom), 131.9 (arom), 128.4 (arom), 127.4 (arom), 80.1 (C-
2), 57.7 (C-5), 41.4 (-.C(Me)3), 32.4 (N-Me), 26.1 ((Me)3), 13.3 (septet, J13c.2H = 19.0,-
CD3, (C-1 '). MS: (EI); 220 (M+-57, 100), 109 (57). 105 (95), 85 (19), 77 (92). CHN 
found C 69.51% H 9.19% N 10.13% C16H19N20/H3 requires C 69.31% H 9.13% N 
10.11%. 
5.18 Preparation ofDL-alanine (213l54 
A mixture of DL-1-benzoyl-2-tert-butyl-3,5-dimethyl-imidazolidinone (212) (427mg, 
1.54mmol) and ION HCl (15ml) was heated in a sealed tube at 100°C for 24h. The 
cooled solution was extracted with Et20 (3x20ml) and the aqueous phase evaporated to 
a residue which was adsorbed onto Dowex-50-W XB ion-exchange resin (50g). The ion-
exchange resin was primed by initially washing till neutral, then acidifying with dil. HCl 
and then the product eluted with 1.5M ammonia solution (250ml). Evaporation of the 
solvent under reduced pressure afforded the free amino acid, DL-alanine (213) as an 
amorphous white solid. (95mg, 66%). M.p. 293-294°C (dec.), lit. 295-296°C (dec). IR 
(KBr): 3400s (br), 3101s (br), 2750s, 2299s, 2165s, 1586s, 1397s, 1335m, 1123m. IH-
NMR (D20): 5.40 (IH, q, J=7.3, H-C(2)), 1.31 (3H, d, J=7.3, HrC(3)). 13C-NMR 
(D20): 178.3 (C-1), 54.0 (C-2), 19.9 (C-3). MS: (CI); 90 (M++l, 13.3%). 
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5.19 Preparation ofDL-[3.3,3-1H3)-alanine (146) 
A mixture of 1-benzoyl-2-tert-butyl-3-[5-2Hrmethyl]-imidazolidin-4-one (144) ( 427mg, 
1.54mmol) and 6N HCl (15ml) was heated in a sealed tube at 1 00°C for 24h. The 
cooled solution was extracted with Et20 (3x20rnl) and the aqueous phase evaporated to 
a residue which was adsorbed onto Dowex-50-W X8 ion-exchange resin. The ion-
exchange resin was primed by initially washing till neutral, then acidifying with dil. HCl 
and then the product was eluted with 1.5M ammonia solution (250ml). Evaporation of 
the solvent under reduced pressure afforded the free amino acid, [3,3,3_2H3]-alanine 
(303mg, 71%). M.p. 289-291°C (dec). IR (KBr): 3400s (br), 3119s (br), 2719s, 2310s, 
2133s, 1545s, 1407s, 1315m. 1H-NMR (D20): 4.92 (IH, s, H-C(2)). 13C-NMR (D20): 
178.3 (C-1), 53.5 (C-2), 17.9 (3D, septet, J13c.2w17.0, DrC(3)). MS: (CI); 90 (M+-ID, 
23.9%). CHN found C 39.02% H 10.72% N 15.34% requires C3H4NO/H3 C 39.13% 
H 10.87% N 15.41%. 
5.20 Preparation of [3-ZHx)-fluoropyruvate (177.178) 
A solution of the sodium salt of 3-fluoropyruvic acid (176) (l.Og, 7.8mmol) in D20 
( 1 Oml) was acidified with a few drops of D2 SO 4. and heated in a Carius tube at 120°C 
for 2h 15min. The cooled reaction mixture was continuously extracted into ethyl acetate 
for 24h. The organic layer was collected, dried (MgS04) and the solvent removed under 
reduced pressure to afford a mixture of the mono-deutero and di-deutero forms of 
fluoropyruvic acid (1 :2 respectively). The free acid was dissolved in water (5ml), 
neutralised with IN NaOH and freeze dried to yield the corresponding sodium salt 
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(500mg, 50%) as a white amorphous solid. M.p. 287-293°C (dec). IR (K.Br): 3427m 
1 (br), 3022s (br), 3022s (br), 2743m, 2656m, 2274m, 1615s, 1392s, 1140s. H-NMR 
(D20): 4.15 (1H, d, 1=46.3, HrC(3)). 13C-NMR (D20): 215.7 (m, C-2), 163.5 (C-1), 
115.2 (m, C-3). 19F-NMR (D20): -230.75 (t, 1=46.3, F-CHD), -231.31 (p, 1=6.3, F-CD-
2). MS: (CI); 126 (M(NH4t, 3.73%), 88 (21.0%), 74 (9.1%), 52 (15.0%), 44 (8.3%). 
5.21 Preparation of [3)Hx)-3-fluorolactate (179.180) 
A solution of the mono-deutero and di-deutero (1 :2 respectively) forms of 
3-fluoropyruvic acid (177,178) (450mg, 4.2mmol) in methanol (30ml) was treated with 
sodium borohydride (I equiv.) and the reaction was left to stir at room temperature for 
lh, when the volatiles were removed under reduced pressure. Water (20ml) was added 
to the residue and the aqueous layer extracted into ethyl acetate (3x25ml). The solvent 
was removed under reduced pressure to afford a residue which was further treated with 
water (5rnl), neutralised with IN NaOH and freeze dried to yield sodium [3-2HJ-3-
fluorolactate as a white amorphous solid (390mg, 39%). M.p. 278-287°C (dec). IR 
(KBr): 3141m (br), 2929s (br), 2741s (br), 2645s (br), 1617s, 1317s. 1H-NMR (D20): 
4.43 (1H, d, 1=25, H-C(2)). I3C-NMR (D20): 161.1 (C-1), 110.5 (m, C-3, D2CF), 64.8 
(m, C-2). I9f-NMR (D20): -228.3 (dt, J= 46.3, 31.5, H2C-F), -229.41 (m, HDC-F), 
-229.99 (m, D2C-F). MS: (CI); 127 (M(NH4)+, 0.5%), 83 (42.1 %), 69 (50.0%), 57 
(92.1 %), 44 (100%). 
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5.22 Preparation of [3-lHx)-3-fluoro-propan-1,2-diol (181) 
A solution of [3-2Hx]-fluoropyruvic acid (177,178) (0.50g, 6.9mmol) in ether (15ml) 
was added dropwise to an ethereal solution of lithium aluminium hydride (0. 79g, 
21mmol) at a rate to maintain reflux. The reaction mixture was heated under reflux for a 
further 3h and then the contents allowed to cool. Quenching by dropwise addition of 
ethyl acetate (excess) and then addition of 10-15ml EtOH/ H20 (50:50) generated a 
white residue. This residue was filtered and the volatiles were evaporated under reduced 
pressure to afford the title compound as a viscous oil (lOOmg, 20%). IR (KBr): 3110s 
I (br), 2970s (br), 2721s (br), 1120m. H-NMR (D
2
0): 3.72 (1H, m, HC-2), 3.55-3.25 
(2H, m, H2-C-OH). 13C-NMR (D20): 86.5 (m, C-3, F(D2)-C), 64.8 (C-2), 58.3 (C-1). 
19 + F-NMR (D20): -233.41 (m, D-CH-F), -234.04 (m, D2C-F). GC-MS: (CI); 96 (M + 
2D, 100%), 95 (M++ D, 31.6%), 94 (M+, 3.6%), 76 (1.5%), 61 (14.3%), 60 (10.4%). 
5.23 Preparation offluoroacetyl chloride (214)169 
*** Fluoroacetyl chloride is toxic and must be handled with great caution. 
0 (lei 
F 
(214) 
Sodium fluoroacetate (1.67g, 16.7mmol) and phthaloyl chloride (3.75g, 16.8mmol) 
were thoroughly mixed and gently heated to reflux. All the distillate of b.p. up to 90°C 
was collected and redistilled to yield fluoroacetyl chloride (1.38g, 95%) B.p. 70-71 °C. 
IR (CHC13): 1830s. 1H-NMR (CDC13): 5.1 (d, 1=46.5). 13C-NMR (CDC13): 169.4 (d, 
1=22.6, C-1), 82.6 (d, 1=185.2, C-2). 19F-NMR (CDC13): -210.32 (t, 1=47.5). 
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5.24 Preparation of 5-(2S.5S)-(2 '-fluoroacet-1 '-one)-2-(tert-butyl)-3-
methylimidazolidin-4-one (193) 
A solution of (144) (1.3g, 5mmol) in THF (25ml) was slowly added (via cannula) to a 
solution of diisopropylamine (0.70ml, 5mmol) and 1.6M butyllithium (3.87ml, 5mmol) 
at -78°C and left to stir at -78°C for 15min. The reaction mixture immediately went red. 
The temperature was lowered to -1 00°C for 30min and then fluoroacetyl chloride 
(1.4ml, 25mmol) was syringed slowly into the mixture. After 5min the reaction was 
quenched sequentially with sat. NH4Cl (25ml) and Et20 (25ml). After warming to room 
temperature, the aqueous layer was extracted into Et20 (3x25ml) and the combined 
organic extracts were washed with water (20ml), dried (MgS04) and evaporated to give 
the product as a white solid (193) (910mg, 57%). M.p. 197°C dec. [a]0 25 = +140° (c=1, 
CHC13). IR (CHC13): 3360m, 2960s, 1715s, 1695s, 1665m, 1415m, 1325m, 1119m, 
I 
1048s. H-NMR (CDC13): 8.10-7.60 (5H, m, arom), 5.50 (2H, m, H2C-F), 4.21 (1H, d, 
J=2.0, H-C(2)), 3.73 (1H, m, H-C(5)), 3.00 (3H, s, N-Me), 1.15 (9H, s, t-Bu). BC-NMR 
(CDC13): 197.7 (C-1', J=18.6), 170.6 (C-OPh), 165.0 (C-4), 135.8 (arom), 131.6 (arom), 
128.8 (arom), 127.6 (arom), 83.8 (C-2', d, J=l87), 80.4 (C-2), 66.2 (C-5), 40.3 (-
C(Me)3), 32.2 (N-Me), 26.1 ((Me)3), 19.3 (C-1 '). 19F-NMR (CDC13): -230.75 (t, 1=46.7, 
CHrF). MS: (EI); 321 (M++1, 22%), 320 (M+, 100%), 302 (17%), 300 (14%), 180 
(19%), 175 (12%), 121 (19%), 104 (39%), 100 (75%). CHN found C 63.52% H 6.63% 
N 8.63% C17H21N20 3F requires C 63.68% H 6.55% N 8.74%. 
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5.25 Preparation of 5-(2S.5S.J 'R)-( 1 '-benzoyloxy-2'-fluoroethyl)-2-(tert-
butyl)-3-methylimidazolidin-4-one (197) 
Sodium borohydride (50mg, 1.2mmol) was added to a solution of (193) ( 400mg, 
1.2rnmol) in methanol (60ml) and the reaction was left to stir at room temperature for 
5min and was then neutralised with IN HCI. The volatiles were removed under reduced 
pressure and the residue was suspended in H20 (20-30ml) and extracted into Et20 
(3x25ml). Removal of the solvent left a yellow gum which was purified by flash 
chromatography to afford the product as a yel-low oil (315mg, 67%). [a]0 20 = -13° (c=1, 
I 
CHC13). IR (CDC13): 3360m (br), 2958s, 1675s, 1645m, 1398m, 1310m, 1095m. H-
NMR (CDC13): 8.10-7.60 (5H, m, arom), 5.62 (lH, m, H-C-OBz), 4.91 (2H, d m, H2C-
F), 4.31 (1H, d, 1=2.1, H-C(2)), 4.15 (1H, m, H-C(5)), 3.02 (3H, s, N-Me), 1.15 (9H, s, 
(t-Bu)). 13C-NMR (CDC13): 172.5 (C-OPh), 165.4 (C-4), 133.2 (arom), 129.6 (arom), 
129.4 (arom), 128.3 (arom), 83.7 (C-2), 81.8 (C-2', d, 1=172.4), 72.1 (C-1', d, 1=19.4), 
58.2(C-5), 37.2 (-C(Me)3), 31.1 (N-Me), 25.3 ((Me)3). 19F-NMR (CDC13): -233.11, (dt, 
323.17709 
5.26 Preparation of 4-(2S.3S)-fluorothreonine (202) 
A solution of (197) (330mg, 1.02mmol) in 1 ON HCl (15ml) was heated under reflux for 
72h. The cooled solution was extracted into Et20 (3x10ml) and the aqueous phase 
evaporated to leave a residue which was adsorbed onto Dowex-50-W X8 ion exchange 
resin. The resin was primed by initially washing with water till neutrality followed by 
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acidification with dil. HCI. The product was eluted with 1.5M ammonia solution 
(250m!) which was evaporated under reduced pressure to afford (2S,3S) 4-
fluorothreonine. Recrystallisation of the crude material from ethanol : water /9: 1 
generated pure (202) (0.090g, 64%). Mp 182-183°C, lit. 181-182°C. [a]0 25 = -20° (c=5, 
H20), lit. [a]0 25 = -20° (c=0.060, H20). IR (KBr) 3500s, 3000s, 2800s, 1435m, 1130m. 
1H-NMR (D20): 4.52 (2H, ddd, 1=46.5, 10.5, 3.9, H-C(4)), 4.22 (1H, dq, 1=25, 4.6, H-
C(3)), 3.72 (1H, d, 1=4.8,H-C(2)). 13C-NMR (D20): 175.5 (C-1), 87.8 (d, 1=167.5, C-4), 
19 + 70.8 (d, J=19.1, C-3), 59.2 (C-2). F-NMR (D20): -229.73, (dt, J=47, 25). MS: 138 (M 
+ 1, 100%), 118 (2%), 104 (5%), 92 (42%), 75 (67%), 59 (28%), 54 (11 %), 46 (19%), 31 
(11 %). MS: Found (M(Ht) 138.05664 C4H8N03F requires 138.05682. 
5.27 Preparation of 5-(2S.5S. 1 'R)-([1 '}H]-1 '-benzoyloxy-2 '-
fluoroethyl)-2-(tert-butyl)-3-methylimidazolidin-4-one (203) 
Sodium borohydride was added to a stirred solution of (193) (400mg, 1.2mmol) in 
methanol (30ml) and the reaction left to stir at room temperature (5min) and then 
quenched to neutral pH with IN HCI. The volatiles were removed under reduced 
pressure, H20 (20-30ml) was added to the residue and the aqueous layer extracted into 
ethylacetate (3x25ml). The combined organic extracts were dried (MgS04) and 
evaporated to give the product as an oil (300mg, 77%). [a]0 25 =-17° (c=l, CDC13). IR 
(CDC13): 3369lm (br), 2910s, 1677s, 1685m, 1265m, 1210m, 1015m. 
1
H-NMR 
(CDC13): 8.11-7.58 (5H, m, arom), 5.5 (2H, m, H2-CF), 4.25 (IH, d, 1=2.0, H-C(2)), 
4.19 (IH, d, J=2.0, H-C(5)), 2.97 (3H, s, N-Me), 1.10 (9H, s, (t-Bu)). I3C-NMR 
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(CDC13): 171.8 (C-OPh), 163.5 (C-4), 132.2 (arom), 129.8 (arom), 128.6 (arom), 128.1 
(arom), 81.9 (C-2), 78.9 (C-2', d, 1=175.0), 67.1 (C-1', m), 60.1 (C-5), 38.9 (-C(Me)3), 
32.8 (N-Me), 26.3 ((Me)3). I9f-NMR (CDC13): -233.2 (t, 1=46.8, F-CH2). MS: (CI); 324 
(M(H)+, 6.78%), 263 (27.3%), 181 (3.7%), 143 (6.4%), 105 (3.3%), 86 (1.7%). CHN 
found C 63.22% H 7.69% N 8.65% C17H22N20 3F
2H requires C 63.16% H 7.53% N 
8.67%. 
5.28 Preparation of (3-~H)-4-(2S.3S)-fluorothreonine (204) 
A solution of (203) (300mg, 0.9mmol) in 1 ON HCl (15ml) was heated under reflux for 
72h. The resulting cooled solution was extracted into Et20 (3x10ml) and the aqueous 
phase evaporated to leave a residue which was adsorbed onto Dowex-50-W X8 ion 
exchange resin. The product was eluted with 1.5M ammonia solution (250ml). 
Evaporation of the solvent under reduced pressure afforded [3_2H]-4-fluorothreonine 
which was recrystallised from methanol (0.050g, 67%). Mp 179-181 °C. [a]0 25 = -14° 
I (c=2, H20). IR (KBr) 3469s, 3100s, 2791s, 1423m, 1030m. H-NMR (D20): 4.44 (2H, 
m, H2C-F), 3.68 (1H, s, HC-2). 13C-NMR (D20): 168.8 (C-1), 89.2 (d, 1=177.3.2, C-4), 
19 
74.3 (m, C-3), 57.0 (C-2). F-NMR (D
2
0): -229.62 (t, 1=46.3, F-CH2). MS: (EI); 136 
(M+-D, 1.3%), 118 (2.2%), 104 (5.2%), 93 (19.1%), 75 (91.1%), 46 (5.2%), 31 (6.1%). 
CHN found C 34.61% H 6.39% N 10.12% C4H7N03F
2H requires C 34.78% H 6.52% 
N 10.14%. 
198 
5.29 Preparation of DL-5-(1 '-benzoyloxy-2 '-chloroethyl)-2-(tert-butyl)-3-
methylimidazolidin-4-one (210) 
A solution of (144) (1.3g, 5mmol) in THF (20ml) was slowly added (via cannula) to a 
solution of diisopropylamine (0.70ml, 5mmol) and 1.6M butyllithium (3.87ml, 5mmol) 
in THF (25ml) at -78°C and left to stir at -78°C for 15min. The temperature was 
lowered to -100°C for 30min and chloroacetyl chloride (1.4ml, 25mmol) was syringed 
into the mixture. After 5min the reaction was quenched with sat. NH4Cl (25ml) and 
ether (25ml) added. The aqueous layer was extracted into Et20 (3x25ml) and the 
combined organic extracts were washed with water (20ml), dried (MgS04) and 
evaporated to give a yellow oil which was not characterised but was dissolved directly 
in methanol (60ml) and treated with sodium borohydride (50mg, 1.2mmol). The 
reaction was left to stir at room temperature for 5min and then quenched to neutral pH 
by addition of IN HCI. The volatiles were removed under reduced pressure and the 
residue was suspended in H20 (20-30ml) and extracted into Et20 (3x25ml). Removal of 
the solvent left a yellow gum which was purified by flash chromatography (ethyl 
acetate/ petrol, 3:2) to afford the product as a yellow oil (0.2g, 11.8%). IR (KBr): 3340m 
(br), 2962s, 1683s, 1661m, 1410m, 1110m. 1H-NMR (CDC13): 7.43-8.04 (5H, m, Ar), 
5.51 (lH, m, H-COBz), 4.29 (1H, m, H-C(5)), 4.20 (lH, d, 1=2.0, H-C(2)), 3.98 (2H, d, 
1=6.4, H2C-Cl), 2.92 (3H, s, N-Me), 1.02 (9H, s, t-Bu). 13C-NMR (CDC13): 171.3 (C-
OPh), 163.4 (C-4), 134.1 (arom), 129.9 (arom), 129.2 (arom), 128.7 (arom), 84.9 (C-2), 
72.9 (C-2'), 68.8 (C-1 '), 58.1 (C-5), 39.5 (-C(Me)3), 33.5 (N-Me), 23.9 ((Me)3). MS: 
(EI); 340 (M++2, 2.3%), 339 (M++1, 14.8%), 281 (18.9%), 161 (30.6%), 159 (95.7%), 
105 (100%), 77 (36.4%), 42 (30.4%). CHN found C 60.39 % H 6.63% N 8.24% 
C17H23N20 3Cl requires C 60.26% H 6. 79% N 8.27% . 
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5.30 Biological methods 
Experimental 
(Part II) 
5.30.1 General preparation of suspension cultures of S cattleva 
S. cattleya NRRL 8057 was supplied by Queen's University of Belfast and initiated onto 
agar slants. Suspension cutltures of S cattleya were grown using defined or complex 
media of nutrients. However in most cases, the defined medium was used. Cells of S 
cattleya were grown in the defined medium (90ml) dispensed into 250ml Erlenmeyer 
flasks stoppered with cotton wool and incubated on an orbital shaker (200rpm) at 28°C. 
Production cultures were initiated by inoculation (2ml) from the first generation culture 
stock. After 14 days a production medium was subcultured. Approximately 4-5 
generations were grown before returning to the 'authentic' frozen stock. In order to 
achieve asepsis, all relevant apparatus was sterilised using a portable gas heated 
autoclave maintaining a temperature of l20°C for 20min at 15psi. The rims of bottles 
and other vessels for dispensing materials were rendered sterile by flaming. All 
experiments were handled in a laminer flow hood, prewashed with 70% ethanol. 
Presterilised disposable instruments were used as often as required. 
5.30.1.1 Defined culture medium composition 107 
Suspension cultures grown on defined medium consisted of (g/ 500ml of H20) ; 
glycerol (5), mono sodium L-glutamate monohydrate (2.5), KH2P04 (1), NH4Cl (0.75), 
MgS04.7H20 (0.25), NaCl (0.25), inositol (0.2), NaF (0.042), FeS047H20 (0.012), 
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ZnS04. 7H20 (0.005), CoC12.6H20 (0.005), CaC03 (O.I25) and p-aminobenzoic acid (1 
x 10-5). The pH of the resulting solution was adjusted to pH 7.0 with IN NaOH. 
5.30.1.2 Complex culture medium composition 24 
Suspension cultures of S. cattleya grown on the complex medium consisted of (g/ 500ml 
of H20) ; D-(+)-glucose (5), Yeast extract (1), NaN03 (I), MgS04.7H20 (0.25), KCl 
(0.25), CaC03 (anhyd) (0.25), NaF (0.05), FeS04 7H20 (0.005). The pH of the resulting 
solution was adjusted to pH 7.0 with IN NaOH. 
5.31 Preparation of various culture media used to investigate the production of 
fluorinated metabolites by Streptomvces sp OH 5093 
Solid agar plates were initially inoculated with Streptomyces sp. OH 5093 obtained from 
Prof. S. Omura at the Kitasato Institute in Japan. The agar medium was composed of (g/ 
500ml of H20) ; Yeast extract (2), malt extract (5), glucose (2), agar (7.5). The pH of 
the resulting solution was adjusted to pH 7.0 with IN NaOH. The liquid agar medium 
( 4 Erlenmeyer flasks x 90ml) was subsequently sterilised in an autoclave at 1 00°C for 
20min at I5psi. The agar solutions were allowed to cool to 30-35°C and then poured 
onto petri-dishes to set. Growth of Streptomyces sp. OH 5093 was clearly visible after 
7days incubation at 28°C. 
Production cultures were initiated by loop transfer of spores to five different 
types of culture media, two of which are detailed in section 5.28. The remaining three 
media were denoted as complex (II), complex (III) and Omura (I). The composition of; 
201 
(a) complex (II) culture medium (g/ 500ml of H20) is ; yeast extract (2), malt 
extract (5) and glucose (2). The pH of the resulting solution was adjusted to pH 7.0. 
(b) complex (III) culture medium (g/ 500ml of H20) is ; glucose ( 4.5), soybean 
flour (13.5), CaC03 (2.7), FeS04.7H20 (4.94) and MgCl (0.027). The pH of the 
resulting solution was adjusted to pH 7.0 with IN NaOH. 
(c) Omura (I) culture medium (500ml ofH20) is; glucose (O.I%), starch (2.4%), 
peptone (0.3%), yeast extract (0.5%) and CaC03 (0.4%). The pH of the resulting 
solution was adjusted to pH 7.0 with IN NaOH. 
Each of the five types of culture media was incubated with Streptomyces sp. OH 
5093 spores in an orbital shaker (200rpm) at 28°C for 28days. Aliquots (lml) of 
supernatant were extracted, at intervals of 3days, from each of the five types of media 
and filtered through hyflo supercell, and subsequently concentrated and redissolved in 
2H20 (0.5ml) for 19F-NMR (200MHz) analysis. 
5.32 Preparation of resting cells of S. cattleya 
Six day old batch culture cells of S. cattleya . grown on the defmed medium were 
harvested by centrifugation (Beckman J2-2IM/ E Centrifuge at I4000 rpm for 15min), 
washed with SOmM MES pH 6.5 buffer (3x30ml) and resuspended in this buffer at a 
concentration of O.I5g wet weight mr1• The resting cells were used directly for 
incubation experiments. 
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5.33 General procedure for feeding experiments (conducted in Belfast) with 11CI 
2 
-H labelled precursors 
The precursor (200mM, 1ml) was added to a mixture of resting cells (0.75g wet weight) 
of S. cattleya already suspended in 50mM MES buffer (pH 6.5, 20.25ml) and 40mM 
fluoride (1ml) contained in a 1 OOml conical flask, plugged with a cotton wool stopper. 
This gave a final concentration of precursor at 1 OmM. The conical flasks were 
subsequently incubated at 29°C with shaking at 180 rpm for 24 and 48 hours. Two 
flasks of each treatment (24h and 48h) were removed, centrifuged and the supernatants 
stored at 4°C pending analysis. 
5.34 Analysis of feeding experiments conducted with resting cells of 
S. cattleya 
5.34.1 12F-NMR spectroscopy 
Fluoroacetate and 4-fluorothreonine in the culture supernatant were determined by 19F-
NMR and 19F eH}-NMR at 471MHz. The freeze dried supernatant, from a feeding 
experiment, was dissolved in 2H20 (1ml) and the resulting solution was filtered through 
glass wool to remove any particulate matter. Spectra were obtained with an acquisition 
time of -8-1 0 hours at ambient temperature. Chemical shifts were measured relative to 
the fluoride signal (-119ppm) present in all NMR samples. It must be noted that under 
the decoupling conditions, the protons are irradiated with a separate radiofrequency that 
causes indirect enhancement of the fluorine signals. The area under the fluorine peaks is 
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no longer an accurate representation of the proportion of the labelled and unlabelled 
fluorinated metabolites, thus generally 19F-NMR spectra are not integrated. 
5.34.1.1 .12EeH}-NMR data of supernatant from feeding experiments with : 
U= 1H]-glycolate 
19F-NMR (D20): -119 (s, fluoride); -216.8 (t, 1=46.7, fluoroacetate); -217.4 (dt, 1=47.7, 
~-shift= 0.058ppm); -229.54 (dt, 1=46.8, 24.8, 4-fluorothreonine) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -218.2 (s, fluoroacetate); -218.8 (s*, 19F-12C-
2H, ~-shift= 0.60ppm); -232.4 (s, 4-fluorothreonine); -233.0 (s*, 19F-12C-2H, ~-shift= 
0.60ppm). 
(*Expect a broad triplet but the signal is not resolved sufficiently) 
[2,2-1H2)-glycolate (refer to Fig. 3.5) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -218.8 (s, fluoroacetate); -219.4 (s*, 19F-12C-
2H, ~-shift= 0.60ppm); -233.2 (s, 4-fluorothreonine); -233.7 (s*, 19F-12C-2H, ~-shift = 
0.50ppm). 
(*Expect a broad triplet but the signal is not resolved sufficiently) 
U=UC]-glycolate (refer to Fig. 3.6) 
19FeH}-NMR eH20): -119.0 (s, fluoride); -213.45 (s, unidentified); -214.69 (s, 
fluoroacetate); -214.78 (d, 1=178.9, 19F-13C-12C, a-shift = 0.09ppm); -214.79 (dd, 
1=178.9, 17.4, 19F-13C-13C, a+~-shift = 0.11ppm); -229.24 (s, 4-fluorothreonine); -
229 6 (d 8 19 12 13c . 19 13 12 .2 , 1=1 , F- C- , ~-shift= 0.02ppm); -229.32 (d, 1=170.0, F- C- C, a-
shift= 0.080ppm); -229.34 (dd, 1=167.9, 19.5, 19F- 13C)3C, a+ ~-shift= O.lOppm). 
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U=13C)-glycine (refer to Fig. 3. 7) 
19 I 2 . 23 2 4 F{ H}-NMR ( H20): -119.0 (s, fluonde); -215.68 (s, fluoroacetate); -2 . 4 (s, -
fluorothreonine ). 
[1.2-13C2]-glycine (refer to Fig. 3.8) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -214.96 (s, fluoroacetate); -214.98 (d, 1=18, 
19F-12C-13C, ~-shift= 0.02ppm); -215.05 (d, 1=177.6, 19F-13C-12C, a-shift= 0.085ppm); 
-215.07 (dd, 1=178, 17.4, 19F-13C_I3C, a + ~-shift = O.lOppm); -229.51 (s, 4-
fluorothreonine); -229.53 (d, 1=18, 19F-12C-13C, ~-shift = 0.02ppm); -229.59 (d, 
19 13 12 .ft - d 7 19 13c 13 1=169.6, F- C- C, a-shi = 0.083ppm); -229.61 ( d, 1=167.9, 1 .9, F- - C, a+ 
~-shift= O.IOppm). 
.[kllC)-glycine (refer to Fig. 3.9) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -215.71 (s, fluoroacetate); -215.73 (d, 1=18, 
19F-12C-13C, ~-shift= 0.02ppm); -215.80 (d, 1=179, 19F-13C-12C, a-shift= 0.086ppm);-
215.82 (dd, 1=179, 17.6, 19F-13C-13C, a + ~-shift = 0.10ppm); -230.23 (s, 4-
fluorothreonine); -230.25 (d, 1=18, 19F- 12C-13C, ~-shift = 0.02ppm); -230.31 (d, 
1 .., 19 13 12 hift 8 19 13c 13 =166 . .,, F- C- C, a-s = 0.083ppm); -230.41 (dd, 1=166.3, 1 .4, F- - C, a+ 
~-shift = 0.1 Oppm). 
UJ.lHs]-glycine 
19F eH}-NMR eH20): -119.0 (s, fluoride); -215.0 (s, fluoroacetate); -215.80 (t, 1=6.6, 
19 12 2 . 19 12 2 . F- C- H, ~-shift= 0,058ppm); -216.16 (p, F- C-( H)2, 2 x ~-shift= 1.16ppm); -
229.53 (s, 4-fluorothreonine); -230.11 (t, ~-shift= 0.58ppm). 
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U=13CJ-Serine (refer to Fig. 3.14) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -215.61 (s, fluoroacetate); -215.70 (d, 
J=177.6, 19F-13C-12C, a-shift= 0.089ppm); -230,16 (s, 4-fluorothreonine); -230.25 (d, 
J=167.2, 19F-13C-12C, a-shift= 0.083ppm). 
U:13C]-pyruvate (refer to Fig. 3.15) 
19 I 2 · F{ H}-NMR ( H20): -119.0 (s, fluonde); -215.63 (s, fluoroacetate); -230.10 (s, 4-
fluorothreonine) 
U= 13C]-pyruvate (r~fer to Fig. 3.16) 
19F{ 1H}-NMR eH20): -119.0 (s, fluoride); -215.67 (s, fluoroacetate); -215.69 (d, 
J=18.8, 19F-12C-13C, ~-shift= o.02ppm); -215.77 (d, J=178.9, 19F-13C-12C, a-shift= 
0.080ppm), -230.12 (s, 4-fluorothreonine); -230.14 (d, J=18.3, 19F-12C-13C, ~-shift = 
0.02ppm); -230.20 (d, J=179, 19F-13C-12C, a-shift= 0.080ppm) 
J3=13C]-pyruvate (refer to Fig. 3.17) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -214.85 (s, fluoroacetate); -214.93 (d, 
J=178.0, 19F-13C-12C, a-shift = 0.09ppm), -229.26 (s, 4-fluorothreonine); -229.34 (d, 
19 13 12 . J=168.1, F- C- C, a-shift= 0.082ppm 
J3=13C]-alanine (refer to Fig. 3.19) 
19 I } 2 · F{ H -NMR ( H20): -119.0 (s, fluonde); -215.50 (s, fluoroacetate); -215.52 (d, J=18, 
19 12c 13 f.l .ft 19 13 12 . F- - C, p-shi = 0.02ppm); -215.59 (d, J=177.6, F- C- C, a-shift= 0.09ppm); -
2 5 60 (dd J 78 14 19p 13 13c f.l • 9 1 . , =1 , .6, - C- , a + p-shift = O.llppm), -22 .94 (s, 4-
fluorothreonine); -229.96 (d, J=18, 19F-12C-13C, ~-shift = 0.02ppm); -230.02 (d, 
6 19 Be 12 . J=1 8.1, F- - C, a-shift= 0.084ppm) 
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3)1C-3.3,3-1HJ]-alanine (refer to Fig. 3.20) 
19F-NMR eH20): -119.0 (s, fluoride); -216.40 (t, J=47.2, fluoroacetate); -217.60 (dp, 
J=164.8, 19F)3c-eH)2, a + 2~-shift = 1.28ppm); -230.92 (dt, J=25.0, 47.4, 4-
fluorothreonihe); -232.20 (dp, J=167.0, 19F-13C-eH)2, a+ 2~-shift = 1.28ppm) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -215.24 (s. fluoroacetate); -215.33 (d, 
J=177.3, 19F-13C_I2C, a-shift= 0.088ppm); -215.90 (dt, J=l73.5, 19F- 13C-2H, a+ ~-shift 
19 13 2 (.t • 
= 0.66ppm); -216.49 (dp, J=173.5, F- C-( H)2, a + 2p-shift = 1.25ppm); -229.78 (s. 
4-fluorothreonine); -229.87 (d, J=166.0, 19F-13C-12C, a-shift= 0.08ppm); -230.44 (dt, 
J=171.7, 19F-13C_2H, a+ ~-shift= 0.66ppm); -231.02 (dp, J=166.0, 19F-13C-eH)2, a+ 
2~-shift = 1.24ppm) 
[2.2,3,3-1H4]-succinate (refer to Fig. 3.21) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -214.71 (s, fluoroacetate); -215.28 (s* (br), 
19F-12C-2H, ~-shift= 0.58ppm); -229.26 (s, 4-fluorothreonine); -229.84 (s* (br), 19F-12C-
2H, P-shift = 0.58ppm). 
(*Expect a broad triplet but the signal is not resolved sufficiently) 
U= 13C]-acetate (refer to Fig. 3.23) 
19 I 2 · F { H}-NMR ( H20): -119.0 (s, fluonde); -214.37 (s, fluoroacetate); -214.39 (d, J=18, 
19p 12 13c .ft 6 19 13 12 . - C- , ~-shi = 0.02ppm); -214.4 (d, J=l77.6, F- C- C, a-shift= 0.09ppm);-
214.48 (dd, J=177.6, 17.4, 19F-13C- 13C, a + ~-shift = 0.11ppm), -228.88 (s, 4-
fluorothreonine); -228.90 (d, J=18, 19F-12C-13C, P-shift = 0.02ppm); -228.96 (d, 
19p 13 12 "ft 19 13 13 1=168.1, - C- C, a-shi = 0.082ppm); -228.98 (dd, 1=167.0, 18.1, F- C- C, a+ 
~-shift= O.lOppm). 
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(2,3.3-lH3]-aspartate (refer to Fig. 3.22) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -214.59 (s, fluoroacetate); -215.17 (t, 1=7.5, 
19F-12C-2H, J3-shift = 0.58ppm); -215.76 (m, [2,2-2H2]-fluoroacetate, 19F-12C-eH)2, 2J3-
shift = 1.16ppm); -229.21 (s, 4-fluorothreonine); -229.79 (t, 1=7.5, [4-2H]-4-
fluorothreonine, 19F-12C-2H, J3-shift = 0.58ppm); -230.36 (m, [4-2H]-4-fluorothreonine, 
19 12 2 .ft F- C-( H)2,, 2J3-shi = 1.14ppm) . 
.[k13C]-glycerol (refer to Fig. 3.25) 
19F eH}-NMR eH20): -119.0 (s, fluoride); -215.96 (s, fluoroacetate); -215.98 (d, 1=18, 
19F)2C-13C, J3-shift = 0.02ppm); -216.00 (d, 1=176.6, 19F-13C-12C, a-shift= 0.060ppm); 
-216.03 (dd, J=170.0, 24.0, 19F-13C-13C, a + J3-shift = 0.070ppm); -230.66 (s, 4-
fluorothreonine); -230.68 (d, J=18, 19F-12C-13C, J3-shift = 0.02ppm); -230.73 (d, 
J=165.8, 19F.I3C-12C, a-shift= o.070ppm); -230.75 (dd, J=l45.0, 20.7, 19F-13C-13C, a+ 
J3-shift = 0.090ppm). 
5.34.2 14C-Radiochemical experimental procedure 
*** Sodiumjluoroacetate is toxic and must be handled with great caution. 
The precursor (20 f.!Ci) was added to a mixture of resting cells (3g wet weight) of 
S. cattleya already suspended in 50mM MES buffer (pH 6.5, 20.25ml) and 40mM 
fluoride (lml) contained in a 1 OOml conical flask, plugged with a cotton wool stopper. 
The conical flasks were subsequently incubated at 29°C with shaking at 180 rpm for 24 
and 48 hours. Two flasks of each treatment (24h and 48h) were removed, centrifuged 
and the supernatants stored at 4 oc pending analysis. 
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Sodium fluoroacetate (30mg) was added to the supernatant solution (2ml) from a 
radiochemical feeding experiment and subsequently freeze dried to a powder. 
4-Phenylphenacyl bromide (1 OOmg, 1.25equiv) and 18-crown-6 (18mg) were added to 
this powder and the mixture suspended in toluene/ acetonitrile (1:1, v/v, 20ml) and 
heated under reflux for 12h at 75°C. The cooled solution was filtered and the solvent 
removed by evaporation using a stream of nitrogen gas. The remaining solid was 
purified by preparative tlc using silica gel GF254 as the adsorbate with toluene as the 
eluant. The band containing the 4-phenylacetophenone derivative of fluoroacetate was 
identified under UV light and scraped off the glass plate, and extracted with DCM 
(lOml). After filtration and removal of the solvent, again using a stream of nitrogen gas, 
the derivative (Mp. 138°C) was recrystallised from petroleum/ diethylether. An 
accurately weighed sample of the recrystallised derivative was dissolved in 'Ecoscint' 
scintillation fluid (5ml) and the radioactivity recorded as counts in dpm were recorded 
on a Packard 200CA liquid scintillation counter 
5.35 Preparation of 4-phenyphenacyl-fluoroacetate (87) 
***Sodium jluoroacetate is toxic and must be handled with great caution. 
Sodium fluoroacetate (30mg) was added to a mixture of 4-phenylphenacyl bromide (86) 
(1 OOmg, 1.25equiv) and 18-crown-6 (18mg) suspended in toluene/ acetonitrile (1: 1, v/v, 
20ml) and heated under reflux for 12h at 75°C. The cooled reaction mixture was filtered 
and the solvent was concentrated under reduced pressure to leave a yellow solution (1-
2ml). To follow, this yellow solution (-1ml) was purified by preparative tlc using silica 
gel GF254 as the adsorbate and toluene as the eluant. The single band containing the 
derivative (87) was scraped off the glass plate and extracted with DCM (1 Oml). 
Filtration and removal of the solvent afforded 4-phenyphenacyl-fluoroacetate which was 
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recrystallised from petroV Et20 (40-60°C). Mp. 138°C. IR (KBr): 3547br, 3407br, 
1684s, 1620s, 1316m, 1097s, 804m, 600m. 1H-NMR (CDC13): 8.00-7.45 (9H, m, arom), 
5.51 (2H, s, H2CO), 5.07 (2H, d, 1=47.7, CH2F). 13C-NMR (CDC13): 190.9 (CO), 167.5 
(C02, d, 1=18.2), 142.1 (C-CO, arom), 139.5 (C-4-(ehCO), 132.5 (C-1-(eh-Ph-CO), 
129.0 (arom), 128.5 (arom), 128.3 (arom), 127.6 (arom), 127.2 (arom), 75.9 (CO), 68.4 
19 + (CH2F, d, 1=251.1). F-NMR (CDC13): -231.10 (t, J=46.4). MS: (EI); 272 (M, 2.5%), 
182 (11.9%), 180 (100%), 152 (27.7%), 84 (8%), 69 (5.8%), 57 (5.5%), 43 (3.5%). 
CHN found C 70.71% H 4.73% C16H130 3F requires C 70.59% H 4.78%. 
5.36 Feeding experiment of calcium [2)H]-glycolate with suspensions cultures of 
S. cattleya 
A solution of calcium [2-2H]-glycolate (200mg, 1.29mM) in water (30ml) was 
administered to cultures (2 x 90ml) of S. cattleya via a micropore filter on the 6th, 8th 
and 1Oth days (5ml pulsed into each flask on each day). The cultures were harvested 
after 28 days, filtered through hyflo supercell and the volume reduced to 2ml. The dark 
solution was refiltered through glass wool and the resulting filtrate was analysed for 
incorporation into both fluoroacetate or 4-fluorothreonine by 19F {'H}-NMR. 
5.37 Feeding experiment of sodium [2.2-1H2]-glycolate with suspensions cultures of 
S. cattleva 
A solution of sodium [2,2-2H2]-glycolate (200mg, 1.29mM) in water (30ml) was 
administered to cultures (2 x 90ml) of S. cattleya via a sterile micropore filter on the 6th, 
8th and lOth days (5ml pulsed into each flask on each day). The cultures were harvested 
after 28 days, filtered through hyflo supercell and the volume reduced to 2ml. The dark 
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solution was refiltered through glass wool and the resulting filtrate was analysed by high 
field 19F {1H}-NMR (see Fig. 3.5, Chapter 3). 
5.38 Feeding experiment [2-1H2)-glycine of with suspensions cultures of 
S. cattleya 
[2-2H2]-Glycine (200mg, 1.29mM) was dissolved in water (15ml) and administered to a 
culture (90ml) of S. cattleya via a micropore filter on the 6th, 8th and 1Oth days (Sml 
pulsed into the flask on each day). The culture was harvested after 28 days, filtered 
through hyflo supercell and the volume reduced to 2ml. The dark solution was refiltered 
through glass wool and the resulting filtrate was analysed for incorporation into both 
fluoroacetate or 4-fluorothreonine by 19F eH}-NMR. 
5.39 Suspension culture of S. cattleya in 1H~ 
A suspension culture (90ml) of S. cattleya was administered with 2H20 (9ml) via a 
sterile micropore filter. The experiment was conducted with both defined and complex 
media. For each experiment the 2H20 (3x3ml) was pulsed into the system starting on 
day 6 and then another pulse on day 8 and the fmal volume on day 10 and then the 
cultures were incubated in a shaker for 28 days. The culture broths were filtered through 
hyflo supercell and the volume reduced to 2ml and refiltered through glass wool. The 
supernatant was subsequently analysed by 19F eH}-NMR (see Fig. 3.1, Chapter 3). 
5.40 Resting cell suspensions of S. cattleyain 1H~ 
Resting cells of S. cattleya (3g wet weight) suspended in 50 mM MES buffer (pH 6.5, 
18ml) and sodium fluoride (2mM) were treated with 2H20 (2ml). Each flask was 
2 I I 
plugged with cotton wool and subsequently incubated at 29°C with shaking at 120rpm 
for 48h. After 48h incubation, the resting cells were centrifuged and the supernatant 
collected and evaporated to dryness prior to analysis by 19F { 1H}-NMR. 
5.41 Incubation of [2-1H2)-glycine with resting cells of S. cattleya 
A solution of [2-2H2]-glycine (200mM, lml) was added to resting cells of S. cattleya 
(0. 75g wet weight) suspended in 50 mM MES buffer (pH 6.5, 20.25) and 40mM sodium 
fluoride (lml). The flask was stoppered with cotton wool and subsequently incubated at 
29°C with shaking at 120rpm for 48h. After 48h incubation, the resting cells were 
centrifuged and the supernatant collected and evaporated to dryness prior to analysis by 
I9F-NMR. 
5.42 Incubation of [2,2,3,3}H4]-succinate with resting cells of S. cattleya 
A solution of [2,2,3,3-2H4]-succinate (200mM, lml) was added to resting cells of 
S. cattleya (0. 75g wet weight) suspended in 50 mM MES buffer (pH 6.5, 20.25) and 
40mM sodium fluoride (lml). The flask was stoppered with cotton wool and 
subsequently incubated at 29°C with shaking at 120rpm for 48h. After 48h incubation, 
the resting cells were centrifuged and the supernatant collected and evaporated to 
dryness prior to 19F eH}-NMR analysis (see Fig. 3.21, Chapter 3). 
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A.l 5-(2S,3S)-(2' -Fluoroacet-1 '-one)-2-(tert-butyl)-3-
methylimidazolidin-4-one (186) 
A.2 4-(2S,3S)-Fluorothreonine (202) 
A.3 Packing diagram of 4-(2S,3S)-fluorothreonine 
A.4 5-(2S,3S)-(1 ' -Keto-2' -methyl)-2-(tert-butyl)-3-
methylimidazolidin-4-one (212) 
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0(3) 
A. I Crystal structure of 5-(2S,3S)-(2 '-jluoroacet-1 '-one)-2-(tert-butyl)-3-
methylimidazolidin-4-one (186) 
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A.l Crystal data 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
AbsorptioR coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on FA2 
Final R indices [I>2sigma(I)) 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
J 
96srv186 
C17 H21 F N2 03 
320.36 
296(2) K 
0.71073 A 
Orthorhombic 
P2(1)2(1)2 
a = 13.294(1) A 
b = 21.437(2) A 
c =_6.037(1) A 
1720.5(3) A""3 
4 
1.237 g/crn""3 
0.092 mrn""-1 
680 
alpha = 90 deg. 
beta = 90 deg. 
gamma = 90 deg. 
0.4 X 0.2 X 0.15 mm 
1.80 to 27.48 deg. 
-12<=h<=17, -~7<=k<=27, -6<=1<=7 
12388 
3936. [R(int) = 0.0408) 
None 
Full-matrix least-squares on F""2 
3916 I 0 I 225 
1.14'1 
R1 = 0.0503, wR2 = 0.1130 
R1 = 0.0782, wR2 = 0.1416 
-1(2) 
0.188 and -0.190 e.A""-3 
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1\COm~C COOI."UJ.UCl~l::~ \ .J\. .l.V ":1: I CU.LU 1:::\_,fU.l. VClJ.~LH.. J.:::iUl-.LVJ:,J.l.L: 
dis1~lacement parameters (AA2 x 10A3) for 1. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
X y z u (eq) 
0 (1) 7070(2) 7561(1) 9571(4) 77(1) 
0(2} 8707 ( 1) 6417(1) 6661(4) 69(1) 
0 (3) 6858(2) 5691(1) 3102(3} 73{1) 
F 9681(1) 6600(1) 10448(4) 13 5 ( 1) 
N ( 1) 6608(1) 6232(1) 6290(3) 46(1) 
c ( 2) 5999(2) 6711(1) 5158(4) 51(1) 
N(3) 6320(2) 7277(1) 6288(3) 54(1) 
C(4) 6809(2) 7176 (1) 8199(4) ~ 54 ( 1) 
c ( 5) 7067(2) 6476(1) 8303(4) 46 (1) 
c ( 1') 8214(2) 6452(1) 8321(5) 54(1) 
c ( 2 I) 8666(2) 6499(2) 10588(6) 86 ( 1) 
c ( 10) 6983(2) 5734(1) 5111(4) 52(1) 
C{11) 7495(2) 5226(1) 6390(4) 52(1) 
C(12) 7120(2} 5020(1) 8411(4) 61(1) 
c ( 13} 7569(3} 4521(1) 9498(6) 83(1) 
C(14) 8395(3} 4241(1} 8609 (7) 93(1) 
C(15) 8786(3) 4443(1) 6639(7) 88(1) 
C(16) 8325(2) 4934(1) 5483 (5) 70 ( 1) 
C(20) 4855(2) 6577(1) 5352 (5) 66(1) 
C(21) 4262(3) 7070(2) 4017(8) 106(1) 
C(22) 4529(3) 6598(2) 7768(6) 93 ( 1) 
C(23) 4622(3} 5934(2) 4375(6) 90 (1) 
C(30) 6170(3) 7907(1) 5400(6) 7 6 ( 1) 
Anlsotropic displacement parameters (AA2 x 10A3) for 1. 
The anisotropic displacement factor exponent takes the form: 
-2 pi A2 ( hA2 a*A2 U11 + ... + 2 h k a* b* U12 J 
U11 U22 U33 U23 U13 U12 
0 (1) 91 ( 1) 56(1) 84(1) -28(1) -7(1) 6 ( 1) 
0(2) 62 ( 1) 64(1) 81(1) -7(1) 19(1) -7{1) 
0(3) 113(2) 62 ( 1) 44(1) -7 ( 1) -3(1) 18{1) 
F 57{1) 200(3) 147(2) -57(2) -24 (1) -2 ( 1) 
N(1) 55(1) 40(1) 43(1) -1 ( 1) -2{1) 5 ( 1) 
C{2) 66 (2) 42 { 1) 45 { 1) 5 { 1) 2 ( 1) 7 ( 1) 
N(3) 65(1) 39(1) 59(1) 3 ( 1) 4 ( 1) 5 ( 1) 
C(4) 55 (1) 46(1) 63 ( 2) -7 ( 1) 7 ( 1) 3 ( 1) 
c ( 5) 50(1) 43 ( 1) 45(1) -3 ( 1) 3 (1) -2(1) 
c ( 1') 55(1) 42(1) 66 (2) -3 ( 1) 4 ( 1) -3 ( 1) 
c ( 2 I ) 58(2) 112(3) 87(2) -19(2) -16(2) 0 ( 2) 
c ( 10) 66(2) 42(1) 47(1) -2(1) 0 ( 1) 2 ( 1) 
c ( 11) 64(2) 36(1) 57(1) -8(1) -8(1) 1 ( 1) 
C(12) 85(2) 43 ( 1) 56 (1) -1(1) -8(1) 1 ( 1) 
C(13) 122(3) 54(2) 74(2) 6(1) -28(2) 5 (2) 
C(14) 119(3) 55(2) 106(3) 4 (2) -37 (2) 16(2) 
C(15) 77(2) 52 ( 2) 136(3) -19(2) -9 ( 2) 17(1) 
C(16) 7 5 ( 2) 48(1) 86(2) -10 (1) 8(2) 7 ( 1) 
C(20) 62(2) 64 (2) 71(2) 8 (1) -11(1) 3 ( 1) 
C(21) 87(2) 95(2) 135(4) 21 ( 2) -37(2) 20 (2) 
C(22) 65(2) 121 ( 3) 93 ( 2) 5 (2) 21 ( 2) -8 (2) 
C(23) 80(2) 84 (2) 105(3) 2 ( 2) -25 ( 2) -15(2) 
c (30) 93 ( 2) 4 2 ( 1 ) 92 ( 2) 1 0 ( 1 ) 7 ( 2) 10 (1) 
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Hydrogen coordinates ( x 10~4) and isotropic 
displacement parameters (A~2 x 10~3) for 1. 
X y z 
H{2) 6191(2) 6733(1) 3592(4) 
H (5) 6783(2) 6279(1) 9628(4} 
H (21') 8541(2} 6117(2) 11398(6) 
H ( 22 I ) 8353(2) 6840(2) 11390(6) 
H(12) 6567(2} 5217(1) 9040(4} 
H(13) 7305(3) 4378(1} 10832(6) 
H(14) 8697(3) 3910(1) 9348(7) 
H(15} 9358(3) 4254(1) 6063(7) if 
H(16) 8577(2) 5062(1) 4119(5) 
H(211) 4230(20} 7451(5) 4845(23) 
H(212) 4595(13} 7144(11} 2631(23} 
H(213} 3593(8) 6920(6) 3746(45) 
H(221) 4693(16) 6999(4} 8384(12) 
H(222) 3816(4) 6532(11} 7863(7) 
R(223) 4873(13) 6278(7) 8582(10) 
H (231 ;) 3912(3) 5857(5} 4458(35) 
H (232) 4833(16) 5922(4) 2855(13) 
H(233) 4975(14) 5620(2) 5199(25) 
H(301) 6338(16) 7912(3) 3854(10) 
H{302) 5478(5) 8026(4) 5584(33) 
H(303) 6593(13) 8195(2) 6180(25) 
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J 
U(eq) 
50(6) 
47 ( 6) 
99{12) 
117(13} 
82(10} 
108(13} 
110(12} 
106(12) 
61(8} 
146(10) 
146(10) 
146(10} 
119(8) 
119(8) 
119(8) 
112(7) 
112 (7) 
112(7) 
115(7) 
115(7) 
115(7) 
Hydrogen coordinates ( x 10~4) and isotropic 
displacement parameters (A~2 x 10~3) for 1. 
X y z 
H{2) 6191(2) 6733(1) 3592(4) 
H (5) 6783(2) 6279(1) 9628(4} 
H (21') 8541(2} 6117(2) 11398(6) 
H ( 22 I ) 8353(2) 6840(2) 11390(6) 
H(12) 6567(2} 5217(1) 9040(4} 
H(13) 7305(3) 4378(1} 10832(6) 
H(14) 8697(3) 3910(1) 9348(7) 
H(15} 9358(3) 4254(1) 6063(7) if 
H(16) 8577(2) 5062(1) 4119(5) 
H(211) 4230(20} 7451(5) 4845(23) 
H(212) 4595(13} 7144(11} 2631(23} 
H(213} 3593(8) 6920(6) 3746(45) 
H(221) 4693(16) 6999(4} 8384(12) 
H(222) 3816(4) 6532(11} 7863(7) 
R(223) 4873(13) 6278(7) 8582(10) 
H (231 ;) 3912(3) 5857(5} 4458(35) 
H (232) 4833(16) 5922(4) 2855(13) 
H(233) 4975(14) 5620(2) 5199(25) 
H(301) 6338(16) 7912(3) 3854(10) 
H{302) 5478(5) 8026(4) 5584(33) 
H(303) 6593(13) 8195(2) 6180(25) 
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J 
U(eq) 
50(6) 
47 ( 6) 
99{12) 
117(13} 
82(10} 
108(13} 
110(12} 
106(12) 
61(8} 
146(10) 
146(10) 
146(10} 
119(8) 
119(8) 
119(8) 
112(7) 
112 (7) 
112(7) 
115(7) 
115(7) 
115(7) 
Bond lengths [A] and angles [deg] for 1. 
) < 1 > -c < 4 > 1.221(3) o < 2 > -c < 1' > 1.200(3) 
) < 3 > -c < 10 > 1.227(3) F-C(2') 1.368(4) 
~ < 1 > -c < 10 > 1.376(3) N < 1 > -c < 5 > 1.457(3) 
~(1)-C(2) 1.476(3) C(2)-N(3) 1.456(3) 
::: < 2 > -c < 2 o > 1.553(4) N < 3 > -c < 4 > 1.341(3) 
~ < 3 > -c < 3 o > 1.467(3) C(4)-C.(5) 1.541(3) 
::: < 5 > -c < 1' > 1.526(3) c < 1' > -c < 2 , > 1.498(4) 
:(10)-C(11) 1.498(3) C(11)-C{16) 1.382(4) 
:(11)-C(12) 1.390(4) C(12)-C(13) 1.390(4) 
:(13)-C(14) 1.361(5) C(14)-C(15) 1.368(5) 
C(15)-C(16) 1.404(4) C(20)-C(22) 1.522(4) 
C(20)-C(23) 1.532(4) C(20)-C(21) 1.544(4) 
C(10)-N(1)-C(5) 123.9(2) C(10)-N(1)-C(2) 119.9(2) 
C(5)-N(1)-C(2) 111.5(2) N(3)-C(2)-N(1) 101.7(2) 
N < 3 > -c < 2 > -c < 2 o > 113.9(2) N(1)-C(2)-C(20) 111.9(2) 
C(4)-N(3)-C(2) 114.2(2) C(4)-N(3)-C(30) 122.0(2) 
C(2) -N(3) -C(30) 123.8(2) 0(1)-C(4)-N(3) 127.7(2) 
0(1)-C(4)-C(5) 124.6(2) N(3)-C(4)-C(5) 107.5(2) 
N < 1 > -c < 5 > -c < 1' > 114.4(2) N(1)-C(5)-C(4) 102.8(2) 
C(1')-C(5)-C(4) 104.8(2) o < 2 l -c (1' > -c < 2' l 123.3(2) 
o < 2 > -c < 1' > -c < 5 l 122.8(3) c < 2 I > -c < 1 1 > -c < 5 > 113.9(2) 
F-e< 2 I > -c <1 1 > 110.5(3) 0(3)-C(10)-N(1) 121.3(2) 
0(3)-C(10)-C(11) 121.1(2) N < 1 > -c (1 o > -c < 11 > 117.5(2) 
C(16)-C(11)-C(12) 119.3(2) C(16)-C(11)-C(10) 119.2(2) 
C(12)-C(11)-C(10) 121.4(2) C(13)-C(12)-C(11) 120.4(3) 
C(14)-C(13)-C(12) 119.9(3) C(13)-C(14)-C(15) 120.6(3) 
C(14)-C(15)-C(16) 120.3(3) C(11)-C(16)-C(15) 119.4(3) 
C(22)-C(20)-C(23) 109.8(3) C(22)-C(20)-C(21) 109.6(3) 
C(23)-C(20)-C(21) 108.1(3) C(22)-C(20)-C(2) 110.2(2) 
C(23)-C(20)-C(2) 109.6(2) C(21)-C(20)-C(2) 109.5(2) 
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HOBJ 
0(3) 
H!lAJ 
HOCJ 
H!3J 
0(2) 
H(22CJ 
H!22BI 
A.2 Crystal structure of 4-(2S, 3S)-jluorothreonine (202) 
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FOAl 
Idei1ltification code 
Empirical formula 
Fornmla weight 
Temperature 
WavE~ length 
Cry~~tal system 
Space group 
Unit: cell dimensions 
Volume 
z 
Number of reflexions used 
Crystal description 
Crystal colour 
Density (calculated) 
Absorption coefficient 
F(OClO) 
Crysta,l size 
Theta range for data collection 
Index ranges 
Experiment device 
Experiment methods 
Number of standard reflexions 
Interval Counts 
Reflections collected 
Independent reflections 
Refinement method 
Data restraints I parameters 
Goodness-of-fit on F"2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
.) 
97srvu~:> 
C4 H8 F N 03 
137.11 
296(2) K 
1.54178 A 
Orthorhombic 
P2(1)2(1)2(1) 
a= 5.2313(10) A 
b = 7.870(2) A 
c = 13.603(3) A 
560.0(2) A"3 
4 
alpha = 90 deg. 
beta = 90 deg. 
gamma = 90 deg. 
573 Unique, 549 Used.· 
Hexagdhal .pla"te 
Colourless 
1. 626 Mg /m"3 
1. 391 mm"-1 
288 
0.15 X 0.15 X 0.05 mm 
6.50 to 49.95 deg. 
-5<=h<=5, -8<=k<=8, -15<=1<=15 
RIGAKU AFC6S 
Omega scans 
3 
147 
730 
573 [R(int) = 0.0293] 
Full-matrix least-squares on F"2 
549 I 0 I 93 
1.023 
R1 = 0.0589, wR2 = 0.1413 
R1 = 0.0807, wR2 = 0.1625 
-0.2(11) 
0.271 and -0.215 e.A"-3 
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Atomic coordinates ( x 10"4) and equivalent isotropic 
displacement parameters (A"2 x 10"3) for 1. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensoi. 
X y z u (eq) 
li'H 1) 6241(10) 7621(6) 1622(4) 27(2) 
0(3) 7496(10) 8929(7) -186(3) 45(2) 
C(11) 9575(14) 9344(8) 2424(5) 31(2) 
0(2) 11950(8) 9673(6) 2475(4) 42(2) 
C(22A) 10582(18) 10932(13) 427(7) 56(2) 
1q1) 12449(13) 10004(11) 108(6) 62(3) 
C(22B) 10582(18) 10932(13) 427(7) 56(2) 
1:~ ( 1A) 10517(27) 11714(17) -387(10) 59(6) 
d~ ( 1) 8668(13) 8553(8) 1466(5) 25(2) 
(:(21) 8231(13) 9865(9) 661(4) ~ 36 (2) 
<) ( 1) 7998(10) 9613(8) 3068(4) 55(2) 
Anisotropic displacement parameters (A"2 x 10"3) for 1. 
The aJnisotropic displacement factor exponent takes the form: 
-2 piA2 [ h"2 a*"2 U11 + . . . + 2 h k a* b* U12 J 
Ull U22 U33 U23 Ul3 
N( 1) 3 3 (.}.) 15(3) 34 ( 3) 2 ( 3) 2(3) 
0 ( 3) 66(4) 40(3) 29 (3) 6(2) -16(3) 
c (11) 35(4) 21(4) 36(4) -1(4) -3 ( 4) 
0 (2) 3 3 ( 3) 41(3) 52 ( 3) -11(3) -9 ( 3) 
C (22A) 54(6) 51 (5) 65(7) 0(6) -2 ( 5) 
F(l) 44(5) 60(5) 83 ( 5) 9 ( 4) 15(4) 
C(22E) 54(6) 51(5) 65(7) 0(6) -2 ( 5) 
F ( lA) 79(11) 56(10) 42(9) 3 6 <7 r -5(8) 
C(1) 25(4) 17(4) 34 ( 4) -3 ( 3) 2(3) 
c (21) 43(5) 36(4) 30(4) -1(4) -7 ( 3) 
0 ( 1) 41(3) 82(5) 43 ( 3) -24(3) 6 ( 3) 
Hydrogen coordinates ( X 10"4) and isotropic 
displacement parameters (A"2 X 10"'3) for 1. 
X y z 
H ( lB) 6568(12) 6625(21) 1905(25) 
H(lA) 5477(35) 7450(41) 1046(5) 
H(lC) 5220(30) 8229(22} 2010(22) 
1-I (3 > 7238(10) 9585(7) -644(3} 
H ( 22A) 10145(18) 11772(13) -67(7) 
H(22B} 11121(18) 11531(13} 1014(7) ~m~: 10809(27) 11759(17) 948(10} 12067(27) 10194(17} 430(10) 9967(13) 7745(8) 1240(5) !H(21} 6826(13) 10617(9) 855(4) 
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U12 
-2 ( 3) 
-16(3) 
4 ( 4) 
3 ( 3) 
-13(6) 
-6 ( 4) 
-13(6) 
-24(8) 
6(3) 
-1(4) 
-6(3) 
u (eq) 
33 
33 
33 
67 
68 
68 
68 
68 
30 
44 
Bond lengths [A] and angles [deg] for 1. 
~H 1 > -c < 1 > 
~1(1) -H(1B) 
~l'( 1) -H ( 1A) 
:M(1)-H(1C) 
0(3)-C(21) 
0(3)-H(3) 
C(11) -0(1) 
C(11)-0(2) 
C(11)-C(1) 
C(22A)-F(1) 
C(22A) -C(21) 
C ( 22A) -H ( 22A) 
C ( 22A) -H ( 22B) 
C(22B)-F(1A) 
C(22B)-C(21) 
(':(22B)-H(22C) 
C(22B)-H(22D) 
C(1)-C(21) 
C(l)-H(1) 
C(21)-H(21) 
C(1)-N(1)-H(1B) 
C(1)-N(1)-H(1A) 
H(1B(.::N(1) -H(1A) 
C(1)-N(1)-H(1C) 
H(1B)-N(1)-H(1C) 
l-H1A) -N(1) -H(1C) 
C(21)-0(3)-H(3) 
o < 1 > -c <:w. > -o < 2 > 
0(1) -C(11) -C(1) 
0(2)-C(11)-C(1) 
F(1)-C(22A)-C(21) 
F(1)-C(22A)-H(22A) 
C(21)-C(22A)-H(22A) 
F(1)-C(22A)-H(22B) 
C(21)-C(22A)-H(22B) 
H(22A)-C(22A)-H(22B) 
F(1A)-C(22B)-C(21) 
F(1A)-C(22B)-H(22C) 
C(21)-C(22B)-H(22C) 
F(1A)-C(22B)-H(22D) 
C(21)-C(22B)-H(22D) 
H(22C)-C(22B)-H(22D) 
N(1)-C(1)-C(21) 
N(1)-C(1)-C(11) 
C(21)-C(1)-C(11} 
N(1) -C(l) -H(1) 
C(21)-C(1)-H(1) 
C(11)-C(1)-H(1) 
0(3)-C(21)-C(1) 
0(3)-C(21)-C(22A) 
C(1)-C(21)-C(22A) 
0(3)-C(21)-C(22B) 
C(1)-C(21)-C(22B} 
0(3)-C(21)-H(21) 
C(1)-C(21)-H(21) 
C(22A)-C(21)-H(21) 
1.482(8) 
0.89 
0.89 
0.89 
1.420(8) 
0.82 
1.222(9) 
1.271(8) 
1.521(9) 
1.294(10) 
1.523(11) 
0.97 
0.97 
1.27(2) 
1.523(11) 
0.97(2) 
0.97(2) 
1.522(10) 
0.98 
0.98 
109.5(3) 
109.5(3) 
109.5 
109.5(3) 
109.5 
109.5 
109.5(3) 
125.9(7) 
118.3(6) 
115.8(6) 
111.6(8) 
109.3(6) 
109.3(5) 
109.3 (5) 
109.3 ('4) 
108.0 
115.4(10) 
108.4(14) 
108.4(11) 
108(2) 
108.4(11) 
108(2) 
108.1(5) 
110.3(5) 
112.7(5) 
108.6(3) 
108.6(4) 
108.6(4) 
105.8(6) 
109.6(6) 
113.8(6) 
109.6(6) 
113.8(6) 
109 . 2(4) 
109.2(4) 
109.2(5) 
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A.J Diagram showing the 3-D network of hydrogen-bonded interactions 
between molecules of 4-(2S,3S)-jluorothreonine. 
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A.4 Crystal structure of 5-(2S,3S)-(J '-keto-2 '-methyl)-2-(tert-butyl)-3-
methylimidazolidin-4-one (212) 
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Identification code 
Empirical formula 
Formula weight 
Tempe·ra t ure 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (Calculated) 
Absorption coefficient 
F(000) 
Crystial size 
Theta range for data collection 
Index ranges 
Refl$ctions collected 
Inde~endent reflections 
97srv068 
C17 H22 N2 03 
302.37 
150(2) K 
0.71073 A 
Orthorhombic 
P2(1)2(1)2 
a = 12.636(1) A 
b = 21 . 459(2) A 
c = 6.059(1) A 
1642.9(4) A"3 
4 
1.222 g/cm"3 
0.084 mm"-1 
648 
alpha ,= 90 deg. 
beta = 90 deg. 
gamma = 90 deg. 
0.40 X 0.20 X 0.10 mm 
1.87 to 25.00 deg. 
-16<=h<=16/ -27<=k<=25, -7<=1<=7 
9842 
2905 [R(int) = 0.0641] 
Observed reflections, I>2sigma(I) 2289 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on FA2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
None 
Full-matrix least-squares on F"2 
2866 I 0 I 216 
1.143 
R1 = 0.0504, wR2 = 0.0978 
R1 = 0.0768/ wR2 = 0.1149 
0 ( 2) 
0.148 and -0.193 e.AA-3 
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. Atomic coordinates ( x 10A4) and equivalent isotropic 
displacement parameters (AA2 x 10A3) for 1. U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
N(1) 6577(2) 1205(1) 6287(4) 25(1) 
N(3) 6237(2) 2251(1) 6259(4) 27(1) 
0(1) 6925(2) 673(1) 3129(3) 38(1) 
0(4) 6845(2) 2535(1) 9691(3) 37(1) 
0(10) 8737(2) 1421(1) 6681(4) 36(1) 
C(1) 7023(2) 716(1) 5144(5) 28{1) 
c (2) 5979(2) 1686(1) 5040(5) "27(1) 
C(3) 6041(3) 2881(1) 5426(5) 3 6 (1) 
c (4) 6675(2) 2149(1) 8246(5) 27(1) 
C(5) 7014(2) 1460(1) 8338(5) 24(1) 
c ( 6) 4768(2) 1540(1) 4950(5) 31(1) 
C(7) 4296(3) 1587(2) 7274(6) 45(1) 
C(8) 4221(3) 2001(1) 3387(6) 47(1) 
C(9) 4586(3) 879(1) 4066(6) 47(1) 
C(10) 8239(2} 1472(1) 8376(5) 28(1) 
c ( 11.) 7559(2) 212(1) 6433(5) 26 ( 1) 
C(12) 8418(2) -90(1) 5459(5) 33(1) 
C(13) 8906(2) -582(1) 6555(6) 39(1) 
c ( 14) 8530(3) -780(1) 8583(6) 44(1) 
c ( 15) 7670(3) -485(1) 9539(5) 38(1) 
c ( 16) 7187(2) 14(1) 8478(5) 30(1) 
c ( 17) 8724(3) 1568(2) 10594(5) 45(1) 
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J 
Bond lengths [A] and angles [deg] for 1. 
N(1)-C(1) 
N(1)-C(2) 
N(3)-C(2) 
o (l1 > -c < 1 > 
0(10)-C(10) 
C(2)-C(6) 
C(,5) -C(10) 
c ('6 > -c < 9 > 
C(10)-C(17) 
C(11)-C(12) 
C(13)-C(14) 
C(15)-C(16) 
C(1}-N(1}-C(5) 
C(5}-N(1)-C(2) 
C(4)-N(3)-C(3} 
0(1}-C(1)-N(1) 
N(1)-C(1)-C(11) 
N < 3 > -c < 2 > -c < 6 > 
o < 4 > -c (4 > -N < 3 > 
N(3)-C(4)-C(5) 
N(1)-C(5)-C(10) 
c (7 > -c < 6 > -c < 9 > 
C(9}-C(6)-C(8) 
c < 9 > -c < 6 >.~c < 2 > 
0(10)-C(10)-C(17) 
c <1 7 > -c < 1 o > -c < 5 > 
C(16)'-C(11)-C(1) 
C(13)-C(12)-C(11) 
C(13)-C(14)-C(15) 
C(15)-C(16)-C(11) 
1.377(3) 
1.486(3) 
1.456(3) 
1.231(3) 
1.210(3) 
1.562(4} 
1.548(4) 
1.533(4) 
1.492(4) 
1.395(4) 
1.385(5) 
1.389(4) 
123.8(2) 
111.3(2) 
121.9(2) 
121.0(3) 
118.3(2) 
113.9(2) 
127.1(2) 
107.7(2) 
113.3(2) 
108. 9( 3) 
108.2(3) 
110.2(2) 
124.3(3) 
115.3(3) 
122.2(2) 
119.7(3) 
120.0(3) 
120.0(3) 
J 
N(1)-C(5) 
N(3)-C(4) 
N(3}-C(3) 
0(4}-C(4) 
C(1)-C(11) 
C(4)-C(5) 
C(6)-C(7) 
C(6)-C(8) 
C(11)-C(16) 
C(12)-C(13) 
C(14)-C(15) 
C(1)-N(1)-C(2) 
C(4)-N(3)-C(2) 
C(2)-N(3)-C(3) 
0(1)-C(1)-C(11) 
N ( 3.) -C ( 2) -N ( 1) 
N(1)-C(2)-C(6) 
0(4)-C(4)-C(5) 
N(1)-C(5)-C(4) 
c < 4 > -c < 5 > -c <1 o > 
C(7)-C(6)-C(8) 
C(7)-C(6)-C(2} 
C(8}-C(6}-C(2) 
0(10}-C(10)-C(5) 
C(16}-C(11)-C(12} 
C(12}-C(11)-C(1) 
C(14)-C(13)-C{12) 
C(14)-C(15)-C(16) 
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1.466(3) 
1.343(4) 
1.466(3) 
1.226(3) 
1.497(4) 
1.539(4) 
1.533(5) 
1.535(4) 
1.391(4) 
1.391(4) 
1.386(4) 
118.8(2) 
114.3{2) 
123.8(2) 
120.6(3) 
101.9(2) 
112.1(2) 
125.1(3) 
102.9(2) 
105.3(2) 
110.4(3) 
109.7(2) 
109.5(2) 
120.4(3) 
119.8(3) 
117.8(2) 
120.3(3) 
120.2(3) 
Hydrogen coordinates ( x 10A4) and isotropic 
displacement parameters (AA2 x 10"3) for 1. 
X y z 
H (2) 6265(2) 1717(1) 3506(5) 
H (3A) 6182(13) 2895(2) 3836(7) 
H (3B) 5301(5) 2994(3) 5701(26) 
H(3C) 6506(10) 3177(2) 6186(21) 
H(5) 6716(2) 1245(1) 9663(5) 
H (71) 4646(12) 1286(7) 8248(10) 
H(72) 4401(15) 2009(3) 7849(15) 
H(73) 3537(4) 1494(10) 7210(8) 
H(81) 4164(15) 2409(3) 4103(15) 
H(82) 4642(9) 2040(8) 2036(16) 
H (83) 3512(7) 1848(5) 3017(28) 
H(91) 4873(14) 846(3) 2568(14) 
H (92) 4942(14) 577(2) 5026(20) 
H(93) 3825(3) 791(4) 4038(32) 
H(12) 8667(2) 40(1) 4054(5) 
9505(2) -779(1) 5916(6) 
U(eq) 
27(7) 
45(5) 
45(5) 
45(5) 
27(7) 
68(7) 
68(7) 
68(7) 
65(7) 
65(7) 
65(7) 
54(6) 
54(6) 
54(6) 
35(8) 
28 ( 8) H (13) 
H (14) 8858(3) -1121(1) 9311(6) 56(10) 
H (15) 7408(3) -622(1) 10926(5) 46(9) 
H (16) 6602(2) 219(1) . 9143(5) 3 6 ( 8) 
H(171) 8348(11) 1902(7) 11368(15) 67(7) 
H(172) 9470(5) 1683(10) 10420(6) 67(7) 
H(173) 8673(15) 1182(3) 11452(13) 67 ( 7) 
Anisotropic displacement parameters (AA2 x 10"3) for 1. 
The anisotropic displacement factor exponent takes the form: 
-2 pi "2 [ h"2 a*A2 U11 + ... + 2 h k a* b* U12 ] 
U11 U22 U33 U23 U13 U12 
N(1) 29(1) 22(1) 24(1) -2(1) -1(1) 4 ( 1) 
N(3) 35(1) 19(1) 28(1) 1(1) -1(1) 2(1) 
0(1) 55(1) 35(1) 24(1) -3(1) 1(1) 10(1) 
0(4) 46(1) 29 ( 1) 35(1) -10(1) -1(1) 1 ( 1) 
0(10) 32(1) 32(1) 42(1) 1(1) 9 ( 1) -2(1) 
C(1) 32 ( 2) 25(2) 27(2) 2 ( 1) 3 ( 1) 1 (1) 
C(2) 33(2) 22(1) 25(2) 2(1) 1(1) 3 ( 1) 
c ( 3) 45(2) 22(2) 40(2) 6 ( 1) -1(2) 3 ( 1) 
C(4) 28(2) 25(2) 28(2) 2 ( 1) 6 ( 1) 0 ( 1) 
C(5) 28(1) 23(1) 20(1) -2 ( 1) 3 ( 1) -2(1) 
c ( 6) 33 ( 2) 27(2) 34(2) 3 (1) -7(1) 2 ( 1) 
C(7) 31(2) 56(2) 48(2) 5 ( 2) 8(2) -5(2) 
C(8) 43 ( 2) 41(2) 56(2) 7 ( 2) -18(2) 4(2) 
c ( 9) 39(2) 36(2) 66 ( 3) 1 ( 2) -18(2) -4(2) 
C(10) 31(2) 16(1) 36(2) 2 ( 1) -2 ( 2) 0 ( 1) 
C(11) 28(2) 21(1) 28(2) -2(1) -4(1) -2(1) 
C(12) 35(2) 24(2) 38(2) -6(1) 4 ( 2) 0 ( 1) 
C(13) 32 ( 2) 26(2) 59(2) -8(2) -3(2) 7 ( 1) 
C(14) 49(2) 28(2) 54(2) 4 ( 2) -20(2) 3 ( 2) 
C(15) 53 ( 2) 27(2) 34(2) 4 ( 1) -6(2) 0 ( 2) 
c ( 16) 36 ( 2) 22(1) 32 ( 2) -4(1) -3(2) 2 ( 1) 
I 39(2) 53 ( 2) C(17) 44(2) -3 ( 2) -11(2) -5(2) 
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B.l Colloquia, lectures and seminars from invited speakers 
B.2 Research Conferences attended 
B.3 Seminars and Poster presentations given 
B.4 Papers published and submitted 
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B.l Colloquia, seminars and lectures from invited speakers 
October 14 
October 20 
December 1 
February? 
March 9 
March 10 
October 19 
November 10 
November 16 
1993 
Dr. P. Hubberstey, University ofNottingham, 
Alkali metals: Alchemist's Nightmare, Biochemist's Puzzle and 
Technologist's Dream 
Dr. P. Quale, University ofManchester, 
Aspects of Aqueous ROMP Chemistry 
Prof. M.A. Mckervey, Queen's University, Belfast 
Synthesis and Applications of Chemically Modified Calixarenes. 
1994 
Prof. D. Young, University of Sussex 
Chemical and Biological Studies on the Co-enzyme 
Tetrahydrofolic acid 
Prof. F. Wilkinson, Loughborough University of Technology 
Nanosecond and Picosecond Laser Flash Photolysis 
Prof. S.V. Ley, University of Cambridge 
New Methods for Organic Synthesis 
Prof. N. Bartlett, University of California 
Some Aspects of Ag(ll) and Ag(III) Chemistry 
Dr. M. Block, Zeneca Pharmaceuticals, Macclesfield 
Large Scale Manufacture ofZD1542, a Thromboxane Antagonist 
Synthase Inhibitor 
Prof. M. Page, University of Huddersfield 
Four-membered Rings and ~-Lactamase 
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January 11 
January 25 
February 16 
February 22 
March 1 
May4 
November 1 
November 8 
December 8 
1995 
Prof. P. Parsons, University ofReading 
Applications ofTandem Reactions in Organic Synthesis· 
Dr. D.A. Roberts, Zeneca Pharmaceuticals 
The Design and Synthesis of Inhibitors of the Renin-Angiotensin 
System 
Prof. H. Kroto 
C60 - The Celestial Sphere that Fell to Earth 
Prof. E. Schaumann, University of Clausthal 
Silicon and Sulphur mediated Ring-Opening Reactions of 
Epoxides 
Dr. M. Rosseinsky, Oxford University 
Fullerene Intercalation Chemistry 
Prof. A.K. Kresge, University ofToronto 
The Ingold Lecture: Reactive Intermediates; Carboxylic acid 
Enols and Other Unstable Species 
Prof. W. Motherwell, UCL London 
New Reactions for Organic Synthesis 
Dr. D. Craig, Imperial College, London 
New Strategies for the Assembly of Heterocyclic Systems 
Prof. M. T. Reetz, Max Planck Institut, Mullheim 
Perkin Regional Meeting 
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January 17 
January 24 
February 21 
February 28 
March 13 
1996 
Prof. J.W. Emsley, Southampton University 
Liquid crystals, More than Meets the Eye 
Dr. A. Armstrong, Nottingham University 
Alkene Oxidation and Natural Product Synthesis 
Dr. C.R. Pulliam, University of Edinburgh 
Heavy Metal Hydrides- an exploration of the chemistry of 
stannanes and plumbanes 
Prof. E.W. Randall, Queen Mary & Westfield College 
New Perspectives in NMR Imaging 
Prof. D. Garner, Manchester University 
Mushrooming in Chemistry 
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December 1993 
December 1994 
December 1995 
March 1995 
July 1995 
May 1996 
December 1996 
B.2 Research Conferences Attended 
Bio-Organic Group Postgraduate 
Symposium, Exeter University 
Bio-Organic Group Postgraduate 
Symposium, Durham University 
Recent Developments in Stereochemistry, 
Sheffield University 
SCI Novel Organic Chemistry, 6th Graduate 
Symposium, York University 
Biological Challenges for Organic Chemistry, 
University of St. Andrews 
Isotopes Conference, Glaxo-Well come 
Foundation, Stevenage 
Bio-Organic Group Postgraduate 
Symposium, Liverpool University 
B.3 Seminars and poster presentations given 
December 1994 
December 1995 
April1996 
June 1996 
September 1996 
ICI/Zeneca Postgraduate Chemistry Poster 
Competition, University ofDurham 
Bio-Organic Postgraduate Group 
Symposium, University of Southampton 
(poster presentation) 
North Ea~t Universities Postgraduate 
Chemistry Symposium, University of 
Sunderland (oral presentation) 
Postgraduate Chemistry Seminars, 
University ofDurham (oral presentation) 
Scottish Highlands Meeting, Postgraduate 
Bio-Organic Symposium, Crieff, Scotland 
(poster presentation) 
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B.4 Papers published and submitted 
K.A. Reid, J.T.G. Hamilton, R.D. Bowden, D.O'Hagan, L. Dasaradhi, 
M.R. Amin, D.B. Harper, Microbiology, 1995, 141, 1385 
"Biosynthesis of Fluoroacetate and 4-Fluorothreonine by Streptomyces 
cattleya. Glycine and Pyruvate as Precursors", J.T.G. Hamilton, M.R. 
Amin, D.B. Harper, D. O'Hagan, J. Chern. Soc., Chern. Comm., 1997, 797 
"The Biosynthetic Origin of Fluoroacetate and 4-Fluorothreonine in 
S. cattleya", J.T.G. Hamilton, C.D. Murphy, M.R. Amin, D. O'Hagan, 
D.B. Harper, Microbial., 1997, (submitted) 
" A Short Highly Stereoselective Synthesis of the Fluorinated Natural 
Product 4-(2S,3S)-Fluorothreonine", M.R. Amin, D.B. Harper, J.B. 
Moloney, C.D. Murphy, J.A.K. Howard, D. O'Hagan, J. Chern. Soc., 
Chern. Comm., 1997 (submitted) 
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